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and Entamoeba 
Ross Stuart Low 
Abstract 
 
Parasitism has arisen independently in numerous lineages of eukaryotes. 
Investigating the origins of parasitism is a core question in evolutionary biology and 
allows identification of parasite-specific factors that aid in diagnosis and treatment. 
Comparative genomic studies have often been applied within clades of parasites, 
which allows their ancestral state to be imagined, but cannot elucidate the 
processes that surrounded the emergence of parasitism. This question must be 
approached by comparison with a free-living out-group, to reconstruct the ancestral 
non-parasitic state. In this thesis, I examine free-living relatives of two intestinal 
protists of global importance, Blastocystis sp. and Entamoeba histolytica, to explore 
their evolution. 
 
A draft genome sequence for Proteromonas lacertae, the non-pathogenic 
sister-taxon of Blastocystis, is presented along with a transcriptome for Cafeteria 
roenbergensis, a free-living out-group to the Blastocystis-Proteromonas clade. 
Together with the published Blastocystis sp. genome sequences, the P. lacertae 
genome and the C. roenbergensis transcriptome were used in a comparative 
genomic analysis. This revealed that the Blastocystis genomes are genuinely small, 
compared to other Stramenopiles and that this reduction is genome-wide as well as 
with respect to specific cellular apparatus, such as the flagellum and other motility-
associated genes, which have been totally lost from the ancestor of Blastocystis. 
Rather than observe the same loss of function from metabolic capability, this 
reduction was associated with loss of gene complexity and is indicative of genomic 
streamlining. This is coupled with gene family expansion of Ig-like domain-
containing proteins, potentially bestowing adhesive qualities to the cell surface.  
 
A transcriptome for Mastigamoeba sp., a free-living out-group to the 
Entamoeba genus, is also presented. The Mastigamoeba sp. transcriptome was 
used in a comparative analysis of the E. histolytica genome. This analysis revealed 
large-scale expansion of Ras-family proteins in the ancestor of Entamoeba, which 
may be linked to motility and phagocytosis required for pathogenesis. Analysis of 
cathepsins revealed processes of genomic reduction and expansion occurring within 
the same gene family indicating genomic streamlining and subsequent 
specialisation in the parasite. 
 
I have shown how we might revisit crucial questions in evolutionary biology 
using the latest genome sequencing technology. By generating new genomic 
resources for free-living protists, this thesis exposes the mechanism by which two 
common intestinal parasites of humans and animals evolved. It makes substantial 
contribution to our understanding of the origins of parasite genomes, and of 
microbial biodiversity, while revealing numerous parasite-specific features that will 
sustain future research.  
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Chapter 1. Introduction 
 
1.1 The vertebrate gut 
 
Along with the respiratory and urogenital tracts, the vertebrate gut is one of 
three major mucosal surfaces that interact with the environment. It is anaerobic, 
eutrophic and maintains temperature within a narrow margin. Food particles move 
through the lumen propelled by polarised movement of structures known as villi in a 
process called peristalsis. The villi provide a large surface area for the efficient 
diffusion of nutrients across the epithelial membrane and into the densely packed 
blood vessels surrounding it. The epithelium is coated in mucus, a layer of secreted 
enzymes, mucins, immunoglobulins and inorganic salts produced by goblet cells in 
the crypts between the villi. This mucosal layer is a thick protective barrier that 
defends against invasion of the epithelium by any of the diverse microbes which 
inhabit the gut and co-evolved with it [1]. 
 
In recent years there have been attempts to understand and catalogue the 
diversity of bacterial, archaeal, viral and eukaryotic components of a healthy 
intestinal microbiome, such that we might better understand its far-reaching 
implications for the vertebrate gut. The microbiome has multiple roles in the normal 
function of the gut in aspects such as secretion of cellulases by Clostridium, 
Citrobacter and Leptotrichia in herbivorous vertebrates and secretion of proteases 
by Halomonas in carnivorous vertebrates, which aid the digestion of food [2], 
priming both the adaptive and innate immune systems and influencing the host 
metabolic capabilities [3]–[6]. The association between the host and the microbiome 
is dynamic and enduring, though the scale of this association has yet to fully 
appreciated. Because of the importance of understanding this relationship, the 
majority of studies have been aimed at mammalian microbiomes with special focus 
on humans in order to explore how this relationship might be exploited to improve 
health and to diagnose and prevent illness.  
  
The microbiome plays important roles in allowing access to otherwise 
inaccessible nutrients such as within plant matter [7], [8], thereby allowing vitamin 
acquisition from food stuffs, and it contributes to normal immune development and 
function [3], [5], [6], [9], [10]. However, dysregulation of the intestinal flora 
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(dysbiosis) is associated with a number of health conditions including obesity [9], 
[11], malnutrition [12], inflammatory bowel disease [13], [14], neurological disorders 
[15] and cancer [16]. Some of the individual species that make up the microbiota 
may be opportunistic and, while incapable of causing disease themselves, they may 
be able to complicate or exacerbate existing diseases. 
 
1.1.1 Bacteria in the vertebrate gut 
 
The majority of the microbial flora, in terms of biomass and biodiversity, and 
the component that has been most studied, is bacterial. Only with the advent of 
sequencing technologies and metagenomic techniques has a concerted effort been 
made to determine a true measure of the bacterial diversity inhabiting the intestinal 
tract without the need to rely on culture methods, which are often inadequate at 
capturing the scale of diversity, especially of anaerobes [17], [18]. These sequence-
based estimates have predicted around 200 prevalent bacterial species and over 
1000 uncommon species [19]. Initial studies aimed to define a ‘core’ microbiome 
representing a subset of organisms ubiquitous across the human population. 
However, molecular techniques have shown that high variation is seen within 
human populations and even within the same individual sampled over time. This 
variation is heavily influenced by host factors such as age, gender, genetic factors 
and immune disorders as well as environmental ones such as diet, use of 
antibiotics, country of residence and proximity to animals. Therefore, a ‘core’ 
microbiome cannot be described using a species level description of the 
microbiome, however, this problem is solved at higher taxonomic levels, for example 
in adults, most species arise from a few phyla such as Bacteriodetes and 
Firmicutes, with Actinobacteria, Proteobacteria and Verrucomicrobia contributing 
smaller constituents [20]. Each of these components will share a particular 
relationship with the host, which may range between commensal, mutualistic, 
opportunistic and parasitic. Here, I will use the term ‘symbiont’ to define any 
organism in obligate association with a host, regardless of whether that relationship 
is beneficial or antagonistic. 
 
Alongside the bacterial aspect of the microbiome there are data that suggest 
that there are also archaeal [21], eukaryotic and viral components. Typically, these 
have been less studied and are less diverse than their bacterial counterparts. 
Eukaryotic gut symbionts are mostly Blastocystis and fungi [22], [23] and their 
diversity is often much lower than bacterial taxa; fewer than 10 eukaryotic 
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phylotypes may be recovered per individual, though as sampling of more diverse 
human populations increases, this figure may rise. Nonetheless, these components 
add more dimensions to the already complex community of interactions present in 
the intestine by introducing further competition [24], [25], mutualism between 
symbionts [26] and also predation on bacteria [27].  
 
1.1.2 Eukaryotes in the vertebrate microbiome 
 
The majority of the studies into intestinal eukaryotes has centred around 
disease and they are generally perceived as pathogenic [23]. This has resulted in 
focused studies that often do not appreciate the complexity of the setting. Recently, 
eukaryotic metagenomics has become a field in its own right, though less advanced 
than bacterial metagenomics [28]. The data that has been collected thus far, has 
shown that there are some parallels between eukaryotes and bacteria in the 
microbiome. Much like the bacteria, there appears to be no ‘core’ eukaryotic 
microbiome at the species level, but representatives from the same genus are often 
represented across diverse populations [11]. Secondly, despite relatively few genera 
being associated with symbiosis, there are a large number of individual species and 
strains within each genus, often capable of inhabiting a broad range of hosts. 
Blastocystis and Entamoeba spp. have a diverse range of hosts including mammals, 
birds, reptiles and amphibians (Figure 1.2.2) [29]. This indicates that while few 
transition events have occurred, once the hurdle is overcome, diversification and 
speciation is widespread. This may be due to the fact that the host intestine can be 
considered an extreme environment as it differs appreciably from a free-living one, 
primarily because of host immunity and microbial density [19]. 
 
Many organisms that have been investigated show evidence of pathology 
that reflects flexible phenotypes, for example, Entamoeba histolytica only causes 
symptoms in around 10% of cases [30]. There are also examples where normally 
absent or commensal organisms become virulent when abundant or when 
colonising the immunocompromised, for example Blastocystis spp. [31]. 
Manifestation of pathology may be dependent on multiple factors including the host, 
co-infection with multiple symbionts or composition of the bacterial microbiome. 
Comprehensive insight into the nature of these factors and their interplay will be 
instrumental in categorising, treating and preventing symptoms from eukaryotic 
symbionts. 
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In this thesis, I will focus on the evolution and adaptation of two eukaryotic 
components of the human microbiome; Blastocystis sp. STs and Entamoeba 
histolytica as these are two of the most common taxa associated with the human gut 
and both have been linked to disease. 
 
1.2 Blastocystis 
 
1.2.1 Discovery 
 
The Blastocystis genus was first named in the literature in 1911 by Alexeieff who 
classified the cells as intestinal yeast after differentiating them from Trichomonas 
intestinalis (now Pentatrichomonas hominis [32]) [33]. Eventually, the name 
Blastocystis hominis was proposed to refer to these cysts found in human stool 
samples [34]. However, this trend continued and species continued to be named for 
the hosts they were isolated from. Unfortunately, there is considerable overlap in 
host range between species of Blastocystis and it became increasingly necessary to 
cross-reference between nomenclatures in the literature until 2006 [35] when a 
broad consensus was established whereby each species name of human infective 
Blastocystis, regardless of what host is was isolated from, was replaced by 
‘Blastocystis sp.’ followed by the subtype (ST) designation (Figure 1.2.2). This 
nomenclature will apply throughout this thesis. 
 
Detailed morphological examination was not conducted until 1967 when 
Zierdt et al. [36] classified Blastocystis as protozoan rather than yeast. This 
assignation was based on the morphological features of the cell such as the 
nucleus, nucleolus, Golgi apparatus, smooth and rough endoplasmic reticulum, 
mitochondria with tubular cristae and the lack of a cell wall. Different morphological 
forms of Blastocystis were also identified which prompted a renewed interest in the 
organism. 
 
Since then Blastocystis sp. STs have been found in almost every country 
that has been searched. Certainly the distribution is worldwide [37], [38] but reports 
on prevalence vary, even within the same country, due to differences in 
identification technique, sensitivity and sampling of distinct populations within a 
country. It is considered the most common eukaryote found in human stool samples 
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and recent estimates suggest that there may be as many as 1 billion individuals 
carrying Blastocystis sp. STs [39]–[49]. 
 
1.2.2 Morphology of Blastocystis 
 
Blastocystis sp. STs can be collected from the stool of many vertebrates, 
including mammalian and avian hosts, and while isolates from different species may 
not be morphologically identical, they are similar enough to make differentiation 
based on morphology alone very difficult [50]. So far, four morphological forms have 
been confidently described: vacuolar, granular, amoeboid and cyst [36], [50]–[54]. 
Other forms have been observed, though many of these are unconfirmed and may 
be artefactual due to oxygen stress [52]–[55]. The vacuolar form is the most 
common in vitro and divides by binary fission, though there is considerable size 
variation (2 – 200 µm). They consist of a large central vacuole with the nuclei and 
mitochondria related organelles (MROs) located in the thin layer of cytoplasm at the 
periphery of the cell. Granular forms gradually become more prevalent as a culture 
ages and are categorised by the appearance of granules within the central vacuole, 
the function of which remains unclear [50]. Cysts are the smallest form of 
Blastocystis (2 – 5 µm) and are difficult to detect in stool samples, which is why they 
are the most recent form to be attributed to Blastocystis. They possess a multi-
layered cell wall and sometimes a loose outer coat. There is evidence to suggest 
the cysts are more resistant to oxygen, temperature and dehydration stresses than 
the other forms [50] with some studies showing survival for up to a month in water at 
25˚C and two months at 4˚C [56]. While there is some discrepancy in the literature 
as to their particular tolerances, these may be due to strain variations between 
isolates in each study [50], [56], [57]. The final form is the amoeboid, which is the 
least common. Typically they are 2 – 15 µm and may show features consistent with 
the vacuolar form with the exception of one or two pseudopodia, though there are 
conflicting reports possibly due to strain variation [50], [58], [59]. While this form is 
less frequently observed, it appears to be able to phagocytose bacteria suggesting a 
biological relevance in vivo. 
 
1.2.3 Taxonomy 
 
Conflicting reports in the literature reflect confusion about the morphological 
forms of Blastocystis sp. STs, its size, features and potential artefacts, which was 
compounded by inconsistency in the nomenclature. This confusion and uncertainty 
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resulted in Blastocystis being incorrectly assigned to a number of taxonomic 
positions including yeast, fungi, Sporozoa (now Apicomplexa), Amoebozoa and the 
cysts of a flagellate [51], [60], [61]. In 1989 Johnson et al. [62] made an attempt to 
use small subunit (SSU) rRNA sequence data to overcome the morphological 
discrepancies and definitively place Blastocystis taxonomically, however this 
attempt was unsuccessful and failed to group Blastocystis into an existing clade 
primarily because of their use of a restricted sample, seeking to place Blastocystis 
with either the Apicomplexa or yeast (Saccharomyces). In 1996 Silberman et al. [63] 
used the SSU rRNA sequence data to systematically test the placement of 
Blastocystis with each major eukaryotic lineage. Silberman et al. found that it 
robustly clustered on a deep branch within the Stramenopiles (or Heterokonts) 
(Figure 1.2.1). Since then, multigene analyses have been used to confirm the 
phylogenetic placement within the Stramenopiles [64], [65].  
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Figure 1.2.1 Relationship of Blastocystis (ATCC 50177 and 50578) among 
Stramenopiles as determine by phylogenetic analyses of SSU rRNA gene 
sequences. Redrawn from Silberman et al. 1996 [63] using Maximum-likelihood, 
Fitch-Margoliash, neighbour-joining and parsimony analyses show that Blastocystis 
is embedded in the Stramenopile lineage (only values from 100 bootstrap replicates 
of the latter three analyses supporting the major eukaryotic groups are shown). 
 
The Stramenopiles are an extremely diverse group of organisms belonging 
to the SAR clade (Stramenopiles; Apicomplexa; Rhizaria) and are categorised by 
tubular cristae in the mitochondria and tripartite hairs on one of two flagellar [66]. 
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This group includes organisms which contain an example of an independent 
acquisition of chloroplast giving rise to the brown algae and diatoms [67], a clade of 
plant, animal and fish parasites, known as the Oomycetes, single celled flagellates 
and a group intestinal anaerobes which includes Blastocystis. While the definitive 
morphological features are relatively well conserved across the large phylogenetic 
distances within this taxonomic group, molecular data has recently included 
members with more derived features, including Blastocystis which has MROs as a 
result of its adaptation to an anaerobic environment [68] and has yet to be observed 
with a flagellum. 
 
1.2.4 Subtypes 
 
Blastocystis can be isolated from the faeces of several birds and mammals, 
including humans, though there have been accounts of it appearing in the stool of 
reptiles, amphibians and even insects. It is unlikely that isolates from the latter hosts 
overlap much with Blastocystis species isolated from mammals and birds and they 
possess their own species names and, from what has been sampled to date, seem 
to represent distant species within the Blastocystis genus [54]. There are currently 
17 subtypes from mammalian and avian hosts each with their own distinct SSU 
rDNA sequence and each of these subtypes has its own zoonotic preference, for 
example only subtypes 1 – 9 are found in humans, though only 1 – 4 are common 
[69]. A breakdown of subtype host repertoires is shown in Figure 1.2.2 [70]. 
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Figure 1.2.2 Host range of Blastocystis subtypes in relation to subtype 
phylogeny. The phylogeny was redrawn from a maximum likelihood SSU rDNA 
phylogeny Alfellani et al. 2013 [71] and the host range is based on Tan 2008 [50]. 
Subtype host range indicated by symbols representing human, Artiodactyla (cow), 
Proboscidea (elephant), nonhuman primates (macaque), aves (chicken), rodents 
(rat) and marsupials (kangaroo).  
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1.2.5 Life cycle 
 
As Blastocystis sp. STs are capable of forming a cyst and are isolated from 
faecal samples, they are most likely transmitted via the faecal-oral route similar to 
other intestinal protozoa such as E. histolytica, Giardia lamblia, Trichomonas 
intestinalis and Cryptosporidium [51], [52], [61], [72]–[79]. This has yet to be 
confirmed experimentally which is likely due to the absence of a suitable animal 
model though several life cycles have been proposed with varying degrees of 
confidence [38], [51]–[53], [79], [80]. Adding to the confusion around the myriad 
morphological forms of Blastocystis are the proposed mechanisms of reproduction 
which have included binary fission, endodyogeny, schizogeny, plasmotomy and 
budding [79], [81], [82]. The current consensus on life-cycle (Figure 1.2.3) takes into 
account the unknown roles of various confirmed morphological forms and the 
uncertainty that surrounds the mode of transition between these forms. A few 
attempts have been made to examine the transition between forms using 
transmission electron microscopy, which showed that cyst forms can transition into 
vacuolar or granular forms [83], [84]. There is also some evidence that vacuolar 
forms are able to transition into amoeboid forms, though it is unknown whether this 
is a permanent or intermediary state [85], [86]. 
 
 
 
Figure 1.2.3 Proposed life cycle for Blastocystis. Infection in humans and 
animals is initiated when the faecal cyst is ingested. Faecal cysts develop into 
vacuolar forms, which subsequently reproduce by binary fission. Some vacuolar 
forms encyst and these faecal cysts lose their outer fibrillar layer as it matures. The 
environmental faecal cyst is transmitted to human and animal hosts via the faecal 
oral route and the cycle is repeated. The transition of other forms with respect to the 
vacuolar form is less well understood and is represented with dashed lines. 
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Due to the lack of an effective infection model, little is known about how 
Blastocystis interacts with the host and the rest of the microflora. While the 
amoeboid form exhibits phagotrophic behaviour the other forms may be biotrophic 
as they have been found in close association with digested food debris or with the 
host mucosa [87], [88]. Despite recent efforts to sequence the genomes of 
Blastocystis subtypes, little is also known about the molecular biology such as ploidy 
or whether it reproduces sexually [50], [89]. The karyotype is likewise unconfirmed; 
between 9 and 13 chromosomes have been observed in an analysis of 15 strains 
using a contour-clamped homogeneous electric-field (CHEF) system ranging 
between 2200 kbp and 260 kbp [90], however, pulsed-field electrophoresis of 
Blastocystis sp. ST7 characterised 15 chromosomic bands [91]. It is therefore likely 
that this feature is also variable based on subtype. 
 
1.2.6 Disease 
 
The role of Blastocystis in disease is still widely debated in the literature. 
Some authors consider Blastocystis to be an emerging pathogen [92]–[95], while 
others doubt the role of Blastocystis in disease [96], [97]. In the majority of cases, 
individuals ‘infected’ with Blastocystis exhibit asymptomatic carriage with only a 
small proportion developing symptoms. Recent metagenomics studies have shown 
that Blastocystis can have high prevalence in healthy individuals and so may be part 
of a healthy intestinal flora [98]–[100]. The tenuousness of the link with disease 
arises from the fact that no Blastocystis outbreaks have been verified and that there 
is only anecdotal evidence that treatment of Blastocystis results in improvement of 
clinical symptoms [39]. 
 
Having acknowledged that the evidence for Blastocystis causing disease is 
inconclusive, Blastocystis sp. STs have nevertheless been implicated in a range of 
non-specific gastrointestinal symptoms (occasionally known as blastocystosis), 
including diarrhoea, abdominal pain, flatulence, nausea, vomiting, constipation, 
weight loss and fatigue [50], [53], [101], [102] but is particularly associated with 
irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) [102]–[104]. 
Some studies suggest that Blastocystis persists at higher concentration in 
individuals with IBS [105]–[107], however, Blastocystis is not implicated as the 
cause of the symptoms and other studies have found insufficient statistical evidence 
of this association [108]. Blastocystis has also been implicated in the development 
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of non-intestinal symptoms including cutaneous legions and urticaria. All symptoms, 
including intestinal ones, can range from acute disease to chronic infection [50], 
[70], [109]–[112]. 
 
One hypothesis for the differences in outcome to infections was thought to 
be genetic variation between subtypes [50], [102], [104], [113], for example ST1 
[114], ST2 [109], [115] and ST3 [111] have all been found, independently, at higher 
prevalence in symptomatic patients. ST4 has been implicated in intestinal disease in 
European patients [116]–[118] while the amoeboid form of ST3 was implicated in 
the development of urticaria [119] by adhering to the host mucosa and causing 
inflammation followed by lesions [120]. Conversely, other studies either found the 
subtypes to be more associated with carriage [121], [122], or found no correlation 
between subtype and disease outcome [115], [122]–[127]. 
 
The confusion surrounding the pathogenicity of Blastocystis most likely results 
from the lack of knowledge about its biology and lack of an animal model. This has 
hindered work investigating pathogenesis, though several experimental models 
have been described and found to be unsuitable [50], [102].  
 
1.3 Entamoeba 
 
1.3.1 Discovery 
 
The first appearance of Entamoeba histolytica in the literature can be difficult 
to pinpoint. It may have appeared in the literature under a number of pseudonyms 
before its differentiation from Entamoeba coli by Schaudinn in 1903. Schaudinn 
posited that it be called ‘histolytica’ because of its ability to lyse tissues [128]. Later it 
was proposed that a second, morphologically similar species existed as well, 
Entamoeba dispar, though it took until 1978 until this proposition was taken 
seriously and until 1993 before E. dispar received its own classification [129]. E. 
histolytica is isolated from the intestinal tract of humans and has a proven 
association with intestinal disease.  
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1.3.2 Taxonomy 
 
Entamoeba spp. are located on a deep branch within the Archamoebae, 
which is the major anaerobic group of protists within the Amoebozoa. The 
Archamoebae consists primarily of amoeboid flagellates and amoebae and was 
created to combine the Pleobionts and the Entamoebae [130]. Currently, the 
Archamoebae consists of less than 500 individual species organised into five 
families: Entamoebidae, Pelomyxidae, Mastigamoebidae, Tricholimacidae, and 
Rhizomastixidae [131]. The majority of the species described in these groups are 
free-living, though there are distinct symbiont lineages including Entamoeba which 
falls into the Entamoebidae family (Figure 1.3.1) [132], [133]. 
 
Despite numerous attempts, the relationships between the branches within 
the Archamoebae were unresolved until recently. Morphological examination was 
inconclusive even between genera and there was confusion as to which characters 
were informative [134], [135]. SSU rDNA and actin trees were unable to robustly 
resolve the relationships between the families, despite monophyly of each family 
being confirmed, until a multigene analysis was conducted, made possible due to 
advances in sequencing technologies and sampling [131], [133], [135]–[137]. This 
analysis showed that Entamoebidae branches more deeply than the other families 
which contain the flagellate Archamoebae and are known collectively as the 
Pelobiontida [131].  
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Figure 1.3.1 Eukaryotic phylogeny showing the robust placement of 
Entamoeba histolytica among the Archamoebae. The phylogeny was redrawn 
from a concatenation of seven protein-coding genes from Pánek et al. 2016 [131] 
(actin, a-tubulin, b-tubulin, EF1a, EF2, HSP70, HSP90). The topology was 
constructed using CAT Poisson model. The values at nodes represent posterior 
probabilities, non-parametric bootstraps, and maximum likelihood bootstrap support. 
The values lower than 50% or 0.5 are marked by ‘‘*”. Branches that were missing in 
the best maximum likelihood tree topology are marked by ‘‘–”. 
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Several species of Entamoeba are known and have been classified primarily 
based on molecular data as morphological distinction is difficult and large generic 
variation exists between morphologically identical organisms. The classic example 
is E. histolytica and E. dispar, which are morphologically indistinguishable and yet 
have distinct phenotypes in vivo; E. histolytica is pathogenic while E. dispar is 
avirulent. Other Entamoeba species are associated with disease with varying 
degrees of severity, though as identification is based on the host, it is unclear to 
what extent taxa are synonymous [132]. Despite much molecular work focusing on 
Entamoeba much of its biology remains a mystery including chromosome number, 
ploidy and whether they can sexually reproduce [73]. 
 
1.3.3 Life cycle and distribution 
 
E. histolytica is acquired through ingestion of food or water contaminated 
with the infective cyst form of the amoeba [138]–[140]. Once in the ileum, the cyst 
develops into the potentially pathogenic trophozoite stage [141]. In this form it is 
often able to persist asymptomatically, dividing by binary fission and phagocytosing 
the surrounding bacteria [142], [143]. However, in a minority of cases it is able to 
cause the characteristic symptoms of infection including abdominal pain, dysentery 
and extra-intestinal abscesses. It is estimated that there are approximately 500 
million people infected with E. histolytica worldwide, though the majority of these are 
asymptomatic [144]. 10% of those infected, however, suffer from invasive 
amoebiasis which results in between 40,000 and 100,000 deaths per year [144]–
[146]. Due to the route of infection, areas with poor sanitation and sewage 
infrastructure are at higher risk of being endemic, for example, an annual incidence 
of children living in an urban slum in Bangladesh was as high as 40% [147]. There 
are also more affluent populations which are endemic, for example among those 
who engage in oral or anal sex, commonly homosexual men, whereby transmission 
is sexual [148]–[150]. 
 
1.3.4 Invasive amoebiasis 
 
In asymptomatic carriers, E. histolytica produces no symptoms presumably 
because the symbiont is not attacking the host tissues, however, invasive 
amoebiasis occurs when the trophozoite stage begins to degrade the host mucosa 
allowing adherence directly to the epithelium [151], [152]. This not only allows E. 
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histolytica to invade the epithelial layer but also allows other members of the 
microbiota to cause secondary infections [153]. Adherence to the unprotected 
epithelium causes an inflammatory response of cascading cytokines and 
trogocytosis triggers apoptosis [154]–[156]. The resulting invasion causes 
development of flask-shaped ulcers characteristic of the disease which leads to 
disruption of the absorptive qualities of the intestine and, eventually, dysentery 
[157].  
 
Trophozoites that penetrate the epithelium may then be disseminated to other 
organs, commonly the liver, whereby they form abscesses (Amoebic Liver 
Abscesses, ALA). A fatal outcome to infection is often due to destruction of the liver 
function caused by lytic enzyme damage to parenchymal cells. The lytic enzymes 
concentrate around the abscess and are released by trophozoite-induced apoptosis 
of hepatic immune cells [158]. It is still unclear which features dictate the outcome of 
disease, though undoubtedly it will involve a complex interplay of host, symbiont and 
environmental factors. Investigation into the evolutionary processes that have 
facilitated the ability of Entamoeba to cause disease may help to shed light on some 
of the colonisation factors involved in determining the outcomes of disease.  
 
1.4 Genome evolution 
 
1.4.1 Mechanisms of evolution 
 
Mechanisms of evolution can be broken down into two components: 
mutation, describing changes in the frequency of genotypes, and selection, 
describing changes in the frequency of phenotypes. Mutation is the process by 
which the genome sequence changes, which may or may not lead to phenotypic 
change. The smallest occurrence of mutation in the genome is a point mutation. 
This involves a substitution or the insertion or deletion (indel) of one nucleotide of 
nucleic acid. This will consequently involves a change to the complementary strand 
as well. Combinations of three nucleotides code for amino acids and therefore 
changes that involve a different amino acid being coded for are termed 
nonsynonymous and may result in a phenotypic change. If the phenotype is affected 
then the mutation is subject to selection. However, the genetic code is highly 
redundant and therefore a change to a nucleotide may not involve a change in 
amino acid, these are termed synonymous mutations. Indels have the additional 
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effect of imposing a frame shift. This means they do not only alter the nucleotides 
coding for a particular amino acid, but also all subsequent amino acids in a cistron. 
This assumes, however, that the mutation is occurring in a transcribed part of the 
genome. In fact, mutations occur continuously across the genome though where 
DNA is functional these are more likely to be subject to selective pressure. While 
non-coding DNA contains regulatory regions necessary for expression of a gene or 
genes, these non-coding regions are often under less selective pressure than 
coding regions.  
 
Large changes to the genome may occur by accumulation of point mutations 
but also by mutations on a larger scale. Some mutations produce multiple copies of 
genes [159], [160]. Gene duplication is the most important mechanism for evolution 
[161] and is usually categorised by the size of the duplication event [162], [163]. 
This serves to relieve selection on one copy of the gene, which is then allowed to 
accumulate mutations. This may result in a number of different outcomes such as 
neofunctionalisation, subfunctionalisation or pseudogenisation [164]. The most 
common outcome is pseudogenisation, whereby genes accumulate mutations, 
become non-functional and may be eventually lost. However, while less common it 
is possible for a copy of the gene to acquire a slightly different function 
(subfunctionalisation), such as the pax6 genes in zebrafish which preferentially act 
on different tissues [165]. Finally, it is possible for a gene to acquire a new function 
altogether, as was the case in the Antarctic zoarcid fish which developed a type III 
antifreeze protein from a copy of sialic acid synthase [166], though this type of event 
is rare [167], [168]. 
 
Segmental duplications give rise to tandem arrays and are most likely the 
result of ‘unequal crossing over’ during homologous recombination between 
paralogous sequences. The position of segmental duplications can be used to 
identify regions undergoing rapid evolution where diversity of function confers an 
advantageous [169], [170]. In primates segmental duplications may be responsible 
for large genetic variation and susceptibility to diseases [171]. Recombination is also 
responsible for deleting, inverting and rearranging the exons of existing genes, 
producing mosaic genes with varied functions [160], [172]. On a larger scale, whole 
chromosomes or even the entire genome may be duplicated [173], [174]. This would 
represent a large opportunity to contribute to the complexity of the organism but is a 
rare event, at least in sexually reproducing organisms, because of the necessity to 
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conserve the number of chromosomes and the proportions of dose dependent gene 
families [175]. 
 
Another way of obtaining functional genes is to acquire them via Horizontal 
Gene Transfer (HGT, sometimes also known as lateral gene transfer) [176]. HGT 
denotes a process whereby an organism obtains a gene or set of genes from 
another microorganism, often a bacterium that bestows a novel function to the 
recipient. The newly acquired genes may then be integrated into the recipient’s 
genome and be subsequently influenced by the processes discussed previously. 
The best examples of this are antibiotic resistance genes which may be transferred 
between pathogens [177] and metabolism-associated genes which confer selective 
advantages especially in anaerobic environments [168]. 
 
Selection acts on mutations that give rise to phenotypic changes and may 
also be broken down into three major components: positive, balancing and negative. 
Negative, or purifying, selection is the selective removal of deleterious variants from 
a population. It operates by eliminating the individual mutations that generate 
detrimental phenotypes and acts to preserve the adaptive characteristics of an 
organism. Typically, purifying selection will affect most of the coding sequences in a 
genome and is greatest in magnitude within those genes that produce the most 
essential proteins.  
 
Positive selection is the process by which an advantageous mutation 
becomes fixed within a population by conferring survival or reproductive advantage 
to an organism. Selectively neutral variants may also become fixed in a population 
by genetic drift, which complicates the detection of positive selection and also has 
implications for interpretation of fixed genotypic features, which may not be the 
results of adaptive evolution.  
 
Overall, selection tends to act on genotypic variants and regulates the 
phenotypes of individuals. However, selection does not just act on the genotypic 
variants. High throughput methods have allowed insight into the role of epigenetics 
in genome evolution [178]. Epigenetics refers to heritable changes in gene function 
that cannot be attributed to changes in the nucleotide sequence [179]. This 
principally refers to histone variation and DNA methylation which affect gene 
expression [180], [181]. DNA methylation in particular has been associated with 
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repression of genes, variants are often lethal [182] and thereby subject to purifying 
selection. 
 
There may be many more mechanisms affecting genome evolution that have 
yet to be described or that are specific to individual clades or genera. An example of 
this is poly-A termination in Blastocystis, whereby one or both final characters in the 
UAA stop codon are provided by the poly-A tail of the mRNA [183]–[185]. This may 
relieve selective pressure on part of the gene and have consequences for the 
evolution of parts of the genome. If individual groups of organisms possess their 
own mechanisms for genome evolution, then these groups may be subject to 
differential rates of evolution. 
 
1.4.2 Gene gain and loss 
 
Gene gain and loss through whichever mechanism determines the gene 
content of a genome. Investigation of gene gain and loss within a gene family is a 
popular method for studying genome evolution. A gene family is described as a 
group of homologues that includes orthologues (genes related by speciation) and 
paralogues (genes related by duplication) [186]. Due to the conservation of function, 
orthologues often retain common functionality better than paralogues [187] and are 
therefore commonly used to transfer gene annotation [188], [189].  
 
Once a gene family has been identified, its evolutionary history may be 
inferred from patterns of gene gain and loss [190]–[194]. The role of duplications in 
copy number variation and gene family amplification has been well documented 
[195]–[201]. Methods for investigating this evolutionary history relies on the 
discrepancy between the gene phylogeny and the species phylogeny [202], [203]. 
Differences in how the genes and species have diverged mean that reconciliation is 
a powerful tool in explaining the processes that produced the differences [202]. This 
method may be used to examine gene gain and loss across multiple genomes [190], 
[203]–[205]. By considering the function(s) of a gene family it may be possible to 
infer the causes that have led to the observed changes in phenotype of gene 
content between two genomes. 
 
If genotypic differences explain phenotypic differences, then where a gene 
family is expanded, it may be possible to conclude that components of the family are 
important to a phenotype of a particular organism. In the case of Trypanosomes, 
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they have expanded families of Variant Surface Glycoproteins (VSG) when 
compared with the free-living out-group Bodo saltans [206]. This is because the 
VSG are used to escape detection by the immune system. B. saltans does not need 
this function as it does not inhabit an environment with an immune system [206]. 
Expansion is also commonly associated with diversification of gene function 
(subfunctionalisation). Again, the VSG can be taken as an example, as 
monoexpression of a single variant followed by switching to another variant is the 
mechanism by which immune evasion is achieved. This is only possible because 
the VSG are non-identical and each variant instigates a different antibody response. 
Gene families that are expanded in parasitic genomes compared to free-living ones 
may signify that the function(s) provided by that family are be important in explaining 
the differences seen between the two organisms’ life strategy. 
 
In opposition to gene family expansion is gene family reduction. This occurs 
when the function of a particular gene or genes becomes non-essential to the 
survival or reproduction of the cell. Selection pressure is reduced and the gene is 
allowed to accumulate mutations, become non-functional and is eventually lost. 
Parasites were initially considered to be examples of genomic devolution, becoming 
reduced and less complex. However, genomic reduction is not seen in all parasite 
lineages, including nematodes [207], [208] and Oomycetes [209], [210] and parasite 
genomes that are reduced also show innovation and expansion suggestive of 
streamlining rather than simplification [206], [211], [212]. Gene loss is still an 
important feature of some symbiont lineages and is associated with the redundancy 
of function. An example would be the loss of components of the Electron Transport 
Chain (ETC) in the MROs of Blastocystis sp. STs. Blastocystis sp. STs are 
anaerobic and therefore have little use for a mechanism which uses O2 as the final 
electron acceptor. The ECT is therefore redundant and subsequently, elements 
have been lost [213].  
 
1.4.3 Genomic adaptations 
 
Expansion of a gene family is generally thought to reflect the functional 
necessity for the function of that family, while reduction is associated with the 
redundancy of function. The vertebrate intestinal tract is a highly specific 
environment, as discussed in Section 1.1.2, and therefore it may be expected that 
specific adaptations are necessary for survival therein. It was long thought that 
adaptation to a host environment is associated with reduction in genomic complexity 
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especially in the case of obligate parasites. The most extreme example of this is 
microsporidia, which is possibly the most host-dependent parasite identified [214] 
and shows not only reduction in gene repertoire but also contraction of the genome 
size [215] though examples of this can be seen across many parasitic lineages 
including Trypanosomes [216], Giardia [217] and the Apicomplexa [218]. However, 
there are also many examples of parasite genomes where there is no genome-wide 
reduction such as nematodes [219], [220], Schistosomes [221] and the Oomycetes 
[209], [210].  
 
This inconsistency among studied symbiont genomes would suggest that 
genomic reduction is not a hallmark of symbiosis that applies across all lineages. 
However, there does appear to be a pattern of genomic reduction when you 
consider the life strategy of these symbionts. Obligate intracellular parasites, such 
as Microsporidia, are the most extreme examples of genomic reduction, whereas 
nematodes show no evidence of reduction but part of their life cycle requires that 
they are free-living. Thus, they still require the machinery to persist outside of the 
host. This pattern can be seen across different symbiotic clades and suggests that it 
is not a symbiotic life-strategy per se that determines the genomic trend, but the 
level of dependence on the host throughout the life cycle, for example, in the 
Apicomplexa gene loss appears to be the strongest, though not the only 
evolutionary force at work [211], [222], [223]. The specific gene families that have 
been lost are dependent on the symbiont in question and, to a certain extent, the 
host it inhabits. One common theme, is a loss of metabolism-associated genes 
[224]. This is because one of the advantages of having a host is that nutrients are 
often readily available and easily accessible. Many symbionts lack the capacity to 
generate purines which are fundamental components of both nucleic acid and 
energy metabolism and must obtain these from the host throughout their life cycles 
[225]–[228].  
 
While reliance on the host shapes some aspects of genome loss, the host 
environment also represents novel challenges to the organisms that require 
genomic innovation. The host immune system necessitates the expansion of certain 
gene families that enable symbionts to persist and even invade. These adaptations 
are often novel and are typically lineage-specific and evolve independently but 
display some similarities that reflect their common target (i.e. immunity). Moreover, 
their functions may give insights into the mechanisms of disease and invasion. 
Common examples include expansion of variant protein families expressed at the 
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cell surface that enables various symbionts to successfully evade the immune 
response during chronic colonisation such as Trypanosomes [229]–[231], 
Apicomplexa [232], Diplomonads [198] and the Oomycetes [209], [233]. Expansion 
of proteases is also common and enables symbionts to degrade host proteins either 
in defence, such as cleaving bound antibodies in trematodes [234], [235], or attack, 
such as degrading the host mucosa allowing direct contact to the epithelium 
beneath such as in E. histolytica and Apicomplexa [236]–[238]. Given that the 
pattern of gene family amplification is indicative of those important for colonisation 
and persistence, it is often possible to detect important families by examining copy 
number and divergence between symbionts and free-living organisms. 
 
In this thesis, I’ll be considering the contributions of gene gain and loss to the 
molecular evolution of the Blastocystis and Entamoeba genomes.  
 
1.5 Comparative genomics 
 
The comparative method is the principal method by which evolutionary origins 
and mechanisms are investigated. Since the advent of genome sequencing, it has 
become possible to examine the evolution of symbiont adaptations at the level of 
individual genes and even nucleotides. Hence, comparative genomics is the method 
through which two or more genomes are compared in order to infer the genotypic 
changes that explain observed phenotypic differences. Choice of phylogenetic 
distance between comparators is determined by the nature of the question being 
asked. Thus, by comparing closely related organisms it is possible to create a 
detailed reconstruction of the last common ancestor and investigate ‘recent’ 
evolutionary events by looking at preservation and divergence in contemporary 
genome sequences [239]. Large phylogenetic distances can be used to give clues 
about essential processes that are present in all forms of life. By using a 
combination of phylogenetic distances in an analysis it is possible to build detailed 
records of the evolutionary events in the ancestors of organisms of interest and 
allow interrogation of a particular moment associated with a phenotypic change, 
such as the origin of parasitism, and speculate about the processes that drove 
them. In order to gain meaningful insights into particular evolutionary events, it is 
important to carefully consider phylogenetic distances and sampling of different 
events.  
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1.5.1 Sampling and phylogenetics 
 
The main issue with attempting to infer the evolutionary changes from 
comparison of the contemporary genotypes of related organisms is the sampling of 
the genomes used. By using an incomplete sample, it is possible that the outcomes 
of the investigation may be artefactual or misleading. This is akin to the choice of 
treatment in an experimental setting. Meaningful results can only be collected where 
sensible treatment choices allow questions to be asked of the data. 
 
As with phylogenetic studies, sampling can have an important effect on the 
accuracy of comparative genomics [240]–[246]. While phylogenetic studies are 
subject to sampling error at both that the individual gene level and the species level 
[247], [248], comparative genomics utilises multiple genes from across the genome. 
This relieves some of the sampling error at the gene level and can help to overcome 
error introduced by differential rates of evolution between genes, however, sampling 
at the species level can still have a measurable effect on the outcomes of the 
inference [249]. 
 
1.5.2 Free-living out-groups 
 
Comparison of symbionts, both morphological and molecular, has a long 
history [212]. However, these typically compare symbionts with each other, which 
allow identification of species differences and for reconstruction of the ancestral, 
symbiotic state but often cannot provide data on the evolutionary transition to a 
symbiotic life strategy. Reconstruction of this ancestor requires an out-group that is 
entirely free-living but as closely related to the symbiont of interest as possible. 
Inclusion of this out-group makes it possible to determine the features that are 
involved in symbiosis from those that are features of the organisms generally [206]. 
In the case of symbionts, this out-group is very important because it may give clues 
about how an organism evolves to become symbiotic from free-living [250]. As both 
Blastocystis sp. STs and E. histolytica are predicted to have small genomes 
compared with other eukaryotes, our inclusion of the free-living out-groups will show 
whether this feature is indicative of the symbionts or whether this is a feature of the 
organisms generally. 
 
There are many examples in the literature of studies that have used 
comparative genomics to investigate the genomes of symbiont lineages. This has 
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included comparisons over multiple phylogenetic differences including between 
strains, such as Jerlström-Hultqvist et al. 2010 [217], who showed that, despite a set 
of well conserved ‘core’ Giardia genes, there was significant genome variation 
between isolates and Ankarklev et al. 2015 [251], who suggested that these 
differences may play key roles in determining the host range and virulence of each 
isolate. Longer distances such as those between species like Mazurie et al. 2013 
[74] and Cai et al. 2013 [252] who investigated species differences in 
Cryptosporidium and Plasmodium respectively. These studies focused on genotypic 
differences that awarded interesting phenotypes such as drug resistance, host 
range, infectivity and pathogenicity. Similarly, within Trypanosomes [253] and 
Leishmania [254] comparative analyses have identified ‘core’ genes shared 
between species as well as species-specific families. This allowed detection of 
important parasitic factors, diagnostic and potential drug targets. However, even 
larger distances have been studies including comparisons between species 
belonging to different genera in the Kinetoplastids and Apicomplexa. These have 
provided more detail and data on the biology of the parasites and the host-parasite 
interactions, including identification of key parasite molecules that elucidate the 
mechanisms of these complex diseases [255], [256]. Studies have investigated both 
gene expansion and reduction between parasite species [214], [257] but while these 
studies can provide details about the individual parasites studied, they do not 
sample widely enough to ask questions about the origin of parasitism in each of 
these lineages. In order to investigate this moment in evolutionary history, 
reconstruction of the parasitic ancestor is necessary and this requires a free-living 
out-group. This allows identification of factors specific to parasites and investigation 
into how these parasite factors have evolved [206], [233], [258]. It allows 
differentiation between adaptations that are necessary for parasitism and those that 
are features of the organisms in question, regardless of their life strategy [259]–
[261].  
 
In this thesis, I will use free-living relatives of Blastocystis and E. histolytica as 
out-groups in a comparative genomics analysis, to investigate adaptations to 
symbiosis and disease.  
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1.6 Genome sequencing 
 
To create genome and transcriptome sequences for free-living relatives of 
Blastocystis and Entamoeba, I have utilised two types of sequencing technology in 
order to obtain genome information about the organisms of interest; Illumina and 
PacBio. These technologies are based on different sequencing techniques and both 
have advantages and disadvantages associated with them. 
 
1.6.1 History 
 
Genome sequencing has been a popular scientific tool for 20 years but in 
that time, has followed a classic example of Moore’s law [262] becoming faster, 
more efficient and cheaper with each generation. The first generation was 
developed in 1977 by Sanger and is based on chain-termination method (Sanger 
Sequencing). Because of its ease to use and the lack of radioactive reagents this 
was the first sequencing technology to become commercially available [263]. Shortly 
after this an automated sequencing machine was developed by Applied Biosystems 
which utilised capillary electrophoresis improving speed and accuracy so that by 
1995 it was possible to sequence 2.88 million bases per day with read lengths up to 
900 bases. The use of these technologies in the Human Genome Project helped to 
drive the search for faster, more accurate methods that were cheaper and less 
manually intensive [264]. Thus, the era of Next Generation Sequencing (NGS) 
began. These technologies differ from Sanger sequencing in their reduced cost and 
parallel analyses, allowing for much higher throughput [263].  
 
1.6.2 Illumina Sequencing 
 
Illumina sequencing is an example of NGS and works using a method of 
Sequencing By Synthesis (SBS). A library is generated using single stranded, short 
DNA sequences (or cDNA sequences in the case of RNA-sequencing [265]) which 
are ligated to adaptors and fixed to a flow cell in the presence of oligonucleotides 
which complement the adaptors at the ‘free’ end. This causes the (c)DNA to form a 
bridge, which has an incomplete complementary strand. Clonal DNA fragments are 
then produced in a process known as bridge amplification [266]–[268]. The actual 
sequencing step incorporates four nucleotides (ddATP, ddTTP, ddGTP and ddCTP) 
with a fluorescent dye and a cleavable blocking group. As each nucleotide is 
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incorporated the dye is excited by a laser and is detected by a Charge-Coupled 
Device (CCD).  
 
Illumina HiSeq is able to produce approximately 650GB per run, which takes 
about 4 days to complete, depending on which system is employed. Illumina MiSeq 
is even faster using smaller flow cells and reduced imaging times, though this is 
achieved by producing shorter read lengths [269]. Overall, Illumina produces the 
biggest output and the lowest running cost compared to competing NGS 
technologies [263], [266], [268]–[270].  
 
1.6.3 PacBio sequencing 
 
The short read-lengths generated by NGS technologies mean that assembly 
software must be used to piece together genomes from very short length reads. 
Progressively innovative algorithms have been produced in an attempt to 
compensate for this. However, there has been little attempt to compensate for the 
bias introduced during the amplification step which is affected by factors such as 
high or low GC content [271].  
 
Single-Molecule Real-Time (SMRT) sequencing, herby referred to as 
‘PacBio sequencing’, is able to produce much longer reads (from hundreds of bases 
to tens of thousands of bases per read) and sequences from a single molecule of 
DNA. The lack of an amplification step has led to this technology being referred to 
as ‘Third Generation Sequencing’ (TGS) [272]. This is achieved by capturing the 
sequence data during the replication process of the target DNA. A template is 
produced using the target dsDNA to which hairpin adaptors are ligated at both ends, 
creating a dumbbell-shaped template or ‘SMRTbell’ [273]. A SMRTbell sample is 
then loaded onto a chip called a SMRT cell where it diffuses into a sequencing unit 
called a Zero-Mode Waveguide (ZMO) [274]. A ZMO is a unit with a single 
polymerase molecule fixed at the bottom and contains the minimum volume that 
allows for light detection. The SMRTbell enters the ZMO, binds to the polymerase 
via the adaptor and is allowed to begin the replication process [275]. Fluorescent 
nucleotides are added to the SMRT cell and as each one is added to the SMRTbell 
a pulse of light at a specific wavelength is emitted and detected by a camera. 
Depending on the reagents the SMRT bell can be sequenced multiple times 
(passes) in a Continuous Long Read (CLR). In this instance the adaptors are 
trimmed, producing sub-reads, and a Circular Consensus Sequence (CCS) is 
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produced by mapping multiple reads with high accuracy [276]. If the SMRT bell is 
too long or there are insufficient passes then no CLR is produced and the sub-reads 
are output instead.  
 
The main advantage of PacBio sequencing is the long read-lengths. At the 
time of writing, the PacBio RSII system using C4 chemistry is able to produce 
average read lengths of 10kb [277], compared to Illumina which is typically paired 
end ~250bp [278]. However, due to physical restraints on the SMRT cells, such as 
loss of the polymerase or multiple SMRTbells per ZMO, the throughput of PacBio is 
much less than that of Illumina [276]. It also has a high error rate (11%-15%) for the 
CLR [279], though this is random and therefore repeated sequencing improves CCS 
accuracy up to >99% with 15 passes [275]. This means that the read length and 
read accuracy are a trade-off, as CLR length is determined by the durability of the 
polymerase [280]. While PacBio is faster than NGS it is also more costly [276]. 
 
The long reads produced by Pac Bio mean that it is well suited to the task of de 
novo assembly. The long reads are able to overcome some of the limitation of NGS 
in producing large scaffolds which are able to cut down computational load during 
assembly, span repetitive regions and close gaps in existing genome assemblies 
[281], [282].  
 
1.7 Aims of the Thesis 
 
We have learned a great deal about obligate symbiont genomes and their 
evolution in the past 10 years. However, these have often lacked appropriate free-
living comparators. This thesis will investigate the evolutionary origins of two 
neglected unicellular symbionts, Blastocystis sp. and Entamoeba histolytica, utilising 
free-living counterparts to infer the ancestral state of each genome and explore the 
adaptations exhibited by these genomes during their transition into the host 
intestinal environment. 
 
In Chapter Two the genome and transcriptome of Proteromonas lacertae strain 
LA is sequenced, assembled and annotated providing the first draft reference 
genome and transcriptome for this organism. These resources are then analysed in 
terms of their contiguousness and completeness in an effort to judge their suitability 
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as a robust representation of this lineage and therefore their usefulness in a 
comparative analysis conducted in Chapter Four.  
 
In Chapter Three the transcriptome of the free-living Cafeteria roenbergensis is 
sequenced providing the first transcriptomic dataset for this organism. The 
transcriptome is then analysed for its usefulness as an out-group to both 
Blastocystis and Proteromonas to be utilised in a comparative analysis conducted in 
Chapter Four.  
 
Chapter Four makes use of the newly generated P. lacerate genome and the C. 
roenbergensis transcriptome in a comparative analysis with three previously 
published genomes for Blastocystis sp. ST1 [283], ST4 WR1 [284] and ST7 [91] as 
well as five other published Stramenopile genomes representing diversity across the 
Stramenopile clade. This allows the identification of gene families and genomic 
features absent or specific to Blastocystis.  
 
In Chapter Five the transcriptome of free-living Mastigamoeba sp. is sequenced 
and analysed for its completeness. It is then included in a comparative analysis with 
E. histolytica [285], Mastigamoeba balamuthi [286] and Dictyostelium discoideum 
[287] in order to investigate adaptations in Entamoeba that may be linked to its life 
strategy and its ability to cause disease. 
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Chapter 2. Sequence and analysis of the Proteromonas 
lacertae strain LA genome  
 
 In order to investigate evolutionary events in the ancestor of Blastocystis, a 
genomic resource for a non-pathogenic outgroup is required. As no such resource 
exists, it was necessary to produce a de novo genome assembly for P. lacertae that 
allows for a comparative analysis with Blastocystis. The genome was sequenced 
using PacBio RSII technology to take advantage of the long read lengths produced 
by this technique. This data was then assembled and assessed for its completeness 
and contiguousness. The draft genome produced here is a useful representation of 
an intestinal Stramenopile and is a good comparator to Blastocystis sp. STs.  
 
2.1 Introduction 
 
The intestinal tract of all vertebrates is a melting pot of bacterial and 
eukaryotic flora each contributing to the environment. Organisms that colonise this 
environment lie on the spectrum between commensal, parasitic, opportunistic and 
mutualistic. Eukaryotes associated with the host mucosa, such as Blastocystis, are 
often assumed to be pathogenic [23]. In order to investigate the genomes of 
Blastocystis an appropriate out-group is required. While there has been no attempt 
to establish pathogenicity of species within the Proteromonas genus, no pathogenic 
effects have been observed in the hosts these protists have been isolated from 
[288], [289]. In order to include Proteromonas lacertae in a comparative genomic 
analysis and identify changes associated with the Blastocystis genomes, a genomic 
resource for this organism is required. In this chapter, I present the first draft 
genome and transcriptome for P. lacertae and assess its usefulness as an out-
group to Blastocystis.  
 
2.1.1 What is Proteromonas lacertae? 
 
P. lacertae is an anaerobic protist isolated from the intestinal tract of lizards, 
urodelans and rodents [290], [291]. It is a single-celled protist belonging to the 
Stramenopiles and thought to be closely related to Blastocystis based on 
morphological and molecular comparisons [65], [291]–[294]. However, unlike 
Blastocystis, it possesses some of the characteristic features used to define the 
Stramenopiles, in particular it possesses two flagella The anterior flagellum is 
covered with tripartite hairs (mastigonemes) and the posterior flagellum is slightly 
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shorter and smooth [294]. Notable features inside include an anterior cell surface 
which is corrugated, with each fold being supported by a single microtubule and a 
posterior cell surface covered in tubular hairs (somatonemes) [295]. Sub cellular 
features include a single, large mitochondrion with tubular cristae often found in 
proximity to the nucleus [294]–[297] (Figure 2.1.1). 
 
 
 
Figure 2.1.1 Light and electron micrographs of P. lacertae and Blastocystis sp. 
showing differences in morphology. A. Light micrograph of a Giemsa-stained cell 
~13 x 3 µm from Pérez-Brocal et al. 2010 [294]. The anterior of the cell bears two 
flagella, one thicker and longer than the other. The single nucleus (n) is visible at the 
anterior pole of the cell. B. Electron micrograph of P. lacertae showing the nucleus 
(n) is in proximity to the single large mitochondrion (m) and the corrugation of the 
cell surface (c) is clearly shown. C. Light micrograph of Blastocystis from Tan 2004 
[38]. The vacuolar form is spherical with a large central vacuole (CV) and a resultant 
thin rim of peripheral cytoplasm, where organelles such as the nucleus and 
mitochondria-like structures reside (arrow). D. Electron micrograph of healthy 
Blastocystis from Yin et al. 2010 [298] in vacuolar form with large central vacuole 
(CV) and crescent shaped chromatin in the nucleus (N).  
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 In vitro the flagellated cells are highly motile and must be grown in rich 
medium or in the presence of a bacterial food source, suggesting that P. lacertae 
may utilise a phagotrophic and/or pinocytic life strategies in vivo. The cells are also 
capable of encysting, most likely in order to transmit between hosts via the faecal-
oral route [56], [61].  
 
2.1.2 The phylogenetic position of P. lacertae 
 
The taxonomic placement of P. lacertae has been relatively straightforward, 
aided by the creation of an axenic culture. SSU rRNA and rDNA sequence data 
place P. lacertae within the Stramenopiles and more specifically as a sister clade to 
the Bicosoecida and Blastocystis within the Slopalinida [63], [65], [291]–[293], [299], 
[300] (Figure 2.1.2). Its position was used to place Blastocystis within the 
Stramenopiles despite the highly derived morphological characteristics of the latter, 
such as a large central vacuole and lack of observable flagella in vitro. In this 
chapter, I will attempt to confirm the phylogenetic position of P. lacertae through a 
multigene phylogenomics analysis.  
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Figure 2.1.2 Bayesian phylogeny of SSU rDNA from 36 Stramenopile taxa and 
seven Alveolate and haptophyte out-groups. Phylogeny redrawn from Kostka et 
al. 2007 [291]. Bootstrap values from maximum likelihood (100 replicates), 
maximum parsimony (1000 replicates), Fitch-Margoliash method with Log Det 
distances (1000 replicates), maximum likelihood distances (1000 replicates) and 
Bayesian posterior probabilities are shown at the nodes, respectively. Asterisks (*) 
represent bootstrap value lower than 50%. A. eichhornii was shown by maximum 
Likelihood and Bayesian analysis to be the sister group to Developayella, but other 
methods resolved it as a sister group to Slopalinida and Blastocystis. Statistical 
support for both positions is shown. 
 
2.1.3 Comparison between P. lacertae and Blastocystis 
 
The Stramenopiles have been the subject of many investigations as they 
contain an example of independent chloroplast acquisition [299] and agriculturally 
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important plant pathogens, the Oomycetes [209], [210], [301]–[306]. However, the 
intestinal Stramenopiles have not received the same attention. As a result, there are 
only three annotated genomes for Blastocystis sp. and none for closely related 
genera. P. lacertae is a useful organism to investigate as an out-group to 
Blastocystis for a number of reasons. Firstly, it is one of the closest known relatives 
to Blastocystis in phylogenetic analyses [65], [291], [293]. It also inhabits a similar 
intestinal environment but is not associated with disease and it is easy to culture 
axenically, which makes it easy to obtain abundant genetic material. For these 
reasons P. lacertae has been used previously to examine the structure and function 
of the unusual Blastocystis MROs. Pérez-Brocal et al. (2010) [294] sequenced the 
mitochondrial genome of P. lacertae and found that it was linear, with a unique 
central region flanked by two inverted repeats. Comparison with the Blastocystis 
MRO sequence showed that there were surprising similarities between the encoded 
machinery despite the structure and organisation being markedly different. This 
suggests that despite the divergence between Blastocystis and P. lacertae, they 
remain close enough to clues about their common ancestor and therefore shed light 
on Blastocystis-specific adaptations.  
 
2.1.4 ‘PacBio’ sequencing 
 
 When producing genome sequences de novo, i.e. without existing reference 
sequences, it is important to maximise sequence contiguity and minimise gaps. 
There is, therefore, desirable to maximise read length, increase the overlap between 
tiled reads, and so reduce assembly artefacts. PacBio sequencing is able to 
produce longer reads than the older technologies (from hundreds of bases to tens of 
thousands of bases per read) and by sequencing from a single molecule of DNA, 
rather than requiring an amplification step, it avoids bias in the sequencing process 
[272]. Despite the increased cost and lower throughput [276], I have chosen to 
sequence the P. lacertae genome using this technology for two reasons. The Long 
read lengths (up to 10 kb) will mean that a highly contiguous assembly is more likely 
and less computationally intensive to produce. This will also reduce the likelihood of 
collapsing repetitive regions and help to sequence closer to regions with unusual 
composition such as the sub telomeres. The second reason is that, while the 
molecular composition of the organism was unknown, I wanted to avoid issues 
arising from bias in the sequencing of regions such as those with low GC content. It 
is accepted that, while PacBio sequencing has a high error rate relative to other 
methods, it lacks the systematic bias with respect to specific nucleotide formations 
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(e.g. purine strings) that affects other methods. The unbiased error rate may be 
solved by massive parallel sequencing, but the systematic bias of other methods is 
inherent [271], [275]. 
 
2.1.4 Aims and objectives 
 
In this chapter, the aim is to produce a genome and transcriptome for P. 
lacertae, suitable for use in comparative genomic analyses with Blastocystis 
(Chapter 4). There are seven specific objectives: 
 
1. Culture P. lacertae cells successfully and obtain electron microscopy images of 
the ultrastructure 
2. Prepare high molecular weight DNA and RNA preps from cultures 
3. Sequence the DNA with PacBio and sequence the mRNA with Illumina 
4. Optimise the assembly of the genome and transcriptome into contiguous drafts  
5. Annotate the genome and provide a measure of completeness for the gene set 
and transcriptome 
6. Survey the general features of the P. lacertae genome 
7. Build a multigene phylogeny to confirm the position of P. lacertae with respect to 
Blastocystis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  35 
2.2 Materials and methods 
 
2.2.1 Culture maintenance and origin 
 
P. lacertae was isolated from the rectal contents of a Eurasian sand lizard 
(Lacerta agillis) [290]; the initial isolate contained bacterial and yeast contamination 
from the intestinal environment. Axenic cultures were established by Prof. Graham 
Clark (London School of Hygiene and Tropical Medicine) though treatment with 
antibiotics and repeated migration protocols [290]. Axenic cultures were grown in 
LYI-S-2 medium as previously described [307]. Cultures were kept upright at room 
temperature inside a switched-off incubator in sealed glass screw-capped tubes 
containing approximately 15 ml of medium. Complete medium contained: 0.5% 
neutralised liver digest, 2.5% yeast extract, 10.0 g glucose, 1.0 g L-cysteine 
hydrochloride, 2.0 g sodium chloride, 0.2 g ascorbic acid, 1.0 ml of 22.9 μg/ml ferric 
ammonium citrate, 1.0 g potassium phosphate, dibasic and 0.6 g potassium 
phosphate, monobasic. Medium was adjusted to pH6.8, autoclaved and 
supplemented with 10% heat inactivated adult bovine serum and a vitamin mixture.  
 
2.2.2 Preparation of cells for electron microscopy 
 
 In order to collect data on the ultrastructure of P. lacertae, 1.0 x 108 free-
swimming flagellated cells at log phase were pelleted and washed in 0.1M 
phosphate buffer (PB) pH 7.4 to remove growth medium and fixed in 0.1M PB pH 
7.4 containing 2.5% electron microscope grade glutaraldehyde. The samples were 
then passed to Alison Beckett, Department of Cellular and Molecular Physiology at 
the University of Liverpool. These were washed in 0.1M PB pH 7.4 and fixed with 
3% agarose and iced for 30 minutes prior to being cut into pieces. Samples were 
then stained with 2% OsO4 and 1.5% potassium ferrocyanide in ddH2O, 1% TCH in 
ddH2O and 2% OsO4 in ddH2O. After each stain step samples were heated in a 
Biowave 20s on, 20s off, 20s on, 20s off; 20Hg and washed 3 x 5 minutes in ddH2O. 
The final stain was 1% UA in ddH2O overnight at 4˚C followed with a final wash as 
described above. Samples were dehydrated in graded acetone dilutions for 8 
minutes each on ice (30%, 50%, 70%) and 100% for 2 x 10 minutes. Infiltration was 
in graded TAAB hard in 100% ethanol (1:1 v/v) and 2 x 100% resin. Samples were 
then embedded in TAAB hard in mould and cured for 48 hours at 600C. Images 
were taken on an FEI 120kV Tecnai G2 Spirit BioTWIN transmission electron 
microscope.  
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2.2.3 DNA preparation, sequencing and QC 
 
To produce genomic information for P. lacertae 4.0 x107 free-swimming 
flagellated cells were pelleted at 3000 x g for 10 minutes and genomic DNA was 
extracted using DNeasy mini kit (Qiagen) according to manufacturer’s protocol. 
Quantification was carried out on a Tecan bio-analyser using Magellan software. 
This method uses the QuantiFlor dsDNA System that employs fluorescent dsDNA-
binding dyes, which reduces interference from ssDNA and RNA; this is then plotted 
onto a 5-point control curve to determine the concentration in a given sample. Using 
this method, 20 µg of DNA of high molecular weight was submitted for sequencing 
in 200 µl total volume. 
 
The single-molecule, real-time (SMRT) sequencing by Pacific BioScience 
was carried out by the University of Liverpool’s Centre for Genomic Research 
(CGR) [276]. Libraries were prepared by shearing DNA to approximately 10kb 
fragments and sequencing was done on primarily on a single SMRT cell (P5 / C3 
chemistry). The output from the single SMRT cell was assembled using default 
parameters and the assembly metrics was then plotted (Figure 2.2.1). Further 
SMRT Cells were sequenced and added to each assembly until the assembly 
metrics plateaued. Adding SMRT Cell data to each assembly decreased the total 
number of contigs and increased both the N50 contig length and overall size of the 
genome smoothly. The increase of maximum contig length was more jagged, 
however, the addition of the ninth and final SMRT Cell failed to improve the overall 
genome metrics. Therefore, a total of nine SMRT Cells were used to build the final 
assembly.  
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Figure 2.2.1 Assembly metrics for P. lacertae genome assembly when 
successive SMRT Cells were added. Assembly metrics including the total number 
of contigs, the maximum contig length, the N50 contig length and the total size of 
the genome were used to determine at which point the addition of more SMRT Cells 
failed to improve the quality of the assembly. 
 
2.2.4 RNA preparation, sequencing and QC 
 
As no gene expression data exists for P. lacertae, whole RNA was isolated 
to produce a transcriptome. 4.0 x107 free-swimming flagellated cells were pelleted at 
3000 x g for 10 minutes and whole RNA was extracted using RNeasy kit (Qiagen) 
according to manufacturer’s protocol. Quantification was carried out on a Tecan bio-
analyser using Magellan software. 
 
RNA samples from four cultures were pooled and processed by the 
University of Liverpool’s Centre for Genomic Research (CGR) using poly-A selection 
according to the manufacturer’s protocol. These were used to produce three 
Illumina RNASeq libraries from enriched RNA using the strand-specific ScriptSeq 
kit. Paired-end sequencing (2x125bp) was carried out on one lane using Illumina 
HiSeq platform generating in excess of 180M clusters. Post sequencing qc (fastqc) 
and trimming of adapters resulted in a final dataset of 196,300,790-paired reads. 
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2.2.5 Assembly of DNA 
 
To assess the potential size of the assembly, kmer frequencies were 
estimated using Jellyfish v2.2.6 [308] and used to estimate genome size from the 
filtered reads [309]. This works based on the principle that for a sequence of length 
l, and a kmer size of k, the total kmers is given by (l - k) +1. This is prone to high 
error for very short sequences but this decreases exponentially for longer 
sequences. For genome length sequences, this approach can provide a very 
accurate estimation of the genome size. Kmers of 19, 21 and 23 were used here; 
this is a trade-off between accuracy (longer kmers are more accurate) and 
computational intensity. A range was chosen to ensure consistency. Kmer 
frequencies were counted and plotted against total number of kmers for a given 
frequency to calculate the mean coverage. Genome size is then estimated from N = 
total number of kmers / mean coverage. 
 
In order to produce the best assembly possible, assembly of the raw reads 
was performed de novo by SMRT Portal software (HGAP 3 algorithm) using default 
parameters except expected genome size which was altered to 35,000,000 to reflect 
the findings of the Kmer analysis and minimum seed read length which was 
increased from 6,000 to 10,000. Canu v1.5 was also used to assemble the genome 
de novo with default parameters, except genome size, which was kept consistent 
between the two assemblers as an independent measure of the quality of the 
assembly. Canu produced a more fragmented genome assembly consisting of 
shorter contigs. 
 
In order to obtain an in-silico prediction of the ploidy of P. lacertae the filtered 
reads were mapped back to the genome in the SMRT Portal. The resulting BAM file 
was tested against ideal histograms of base frequencies for diploidy: N(0.5, 0.5), 
triploidy: N(0.33, 0.04) + N(0.67, 0.04) and tetraploidy: N(0.25, 0.04) + N(0.5, 0.5) + 
N(0.75, 0.04) using two methods in nQuire [310]. Firstly, this programme performs 
linear regression on the y-values of the empirical and ideal histograms. Secondly, it 
utilises a Gaussian Mixture Model (GMM) to describe the data as a mixture of 
distribution that represents the probability distribution of observations across the 
whole genome. The likelihood of certain assumptions based on this model given the 
empirical data is maximised using an Expectation-Maximisation algorithm.  
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2.2.6 Assembly of RNA 
 
Reads were mapped to both the assembled genome sequence and, initially, 
to an individual contig using TopHat [311] in order to aid identification of protein 
coding regions on the genome sequence. In order to assess the completeness of 
the genome, the transcriptome was also assembled de novo by Trinity v2.1.1 [312] 
using a Kmer size of 25 and default parameters into 27,952 transcripts. A Kmer of 
25 was used as per the recommendation of Trinity. 
 
2.2.7 Gene finding and sequence annotation 
 
In order to produce a gene set for P. lacertae, two independent gene 
prediction software packages were used. AUGUSTUS [313] and SNAP [314] both 
require a ‘training set’ of protein sequences from the target organism, or related 
species, in order to customise the parameters to a particular genome in terms of 
start and stop codons and splice sites. To generate this training set the largest 
contig from the default SMRT assembly was taken and annotated manually in 
Artemis v16.0.0 [315] using open reading frames (ORFs) over 100 bp and in 
conjunction with transcript data mapped to the contig using TopHat. Of the 188 gene 
models, 78 contained introns. Exons were annotated if there was corroborating 
transcript evidence for expression, including RNA read pairs spanning the intron, 
and presence of a splice site. Both AUGUSTUS and SNAP packages were provided 
with the resulting training set of 188 gene models. Each programme offers slightly 
different interpretations of gene models leading to large overall differences in the 
number and structure of the predicted genes. To compensate for this, each gene 
model was inspected manually to provide consensus across both prediction outputs 
additionally aided with mapped transcript data (above) and correlation scores. 
Correlation scores are provided by Artemis and show the correlation between amino 
acid composition and globular proteins in TREMBLE.  
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Figure 2.2.2 Snapshot of the integration of data used to aid gene calling in Artemis. Gene model predictions were provided by 
AUGUSTUS and SNAP and manually curated using transcript data and correlation scores to provide consensus where the gene model 
predicted by each package differed.  
4
0
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Initial annotation of the curated gene models was applied by homology 
searching using BLAST2GO v4.1 [316] with default parameters. This was done 
using a BLASTX search against a non-redundant protein database.  
 
 To gain more detailed information about gene models the coding sequences 
(CDSs) were subjected to a suite of independent programmes. InterProScan v5.21-
60.0 [317] uses a number of domain databases to assign domain annotations to 
sequences based on a signature rather than sequence similarity. TMHMM [318] 
develops a Hidden Markov Model (HMM) in order to identify transmembrane helices 
in proteins and can distinguish between soluble and membrane proteins. SignalP 
v4.1 [319] was used to predict cleavage sites and presence and location of signal 
peptides. ModPred [320] was used to predict post-translational modification sites 
including GPI-anchor amidation sites, glycosylation sites, phosphorylation and 
SUMOylation among others. Functional predictions were used to manually refine the 
gene models for many genes. Other software was applied to better characterise 
non-protein coding sequences. RfamScan v1.1.1 [321] was used to search a 
database of various nuclear-encoded RNAs using a HMM for each sequence. 
RepeatModeler v1.0.4 [322] is a programme which runs two complimentary de novo 
repeats finding programmes (RECON and RepeatScout). Differences in repeat 
content between assemblies was assessed using a Chi2 test in R. LTRfinder v1.0.5 
[323] identifies full-length LTR retrotranspsons. All software was used with default 
parameters unless otherwise stated.  
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Figure 2.2.3 Sources and information that contributed to gene annotation.  
 
Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations were 
assigned to protein sequences by GhostKoala [324] and BLAST2GO and were 
mapped to KEGG pathways using KEGG Mapper – Reconstruct Pathway [325]. 
 
2.2.8 Calculating completeness 
 
In order to gain an objective description of how complete the genome was it 
was given to BUSCO v1.1b1 [326] (Benchmark Universal Single-Copy Orthologs), a 
programme that assigns a score to an assembled genome based on its BUSCO 
content. The rationale behind this approach is that all eukaryotes should contain 
orthologs of a set of 429 core genes. The score is assigned based on how many of 
these are present in the annotation.  
 
As a validation method for the genome annotation the gene set was tested 
with a reciprocal BLAST hit to the transcriptome using BLAST. This was to ensure 
that gene models annotated on the genome reflected assembled transcripts. Genes 
with no reciprocal hit were examined and splice variants in the transcriptome were 
included in the dataset. Transcripts with no BLAST result were compared to the 
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contigs and, where applicable, gene models were modified to reflect transcriptomic 
data.  
 
2.2.9 Phylogenomics 
 
MUSCLE [327] was used to align sequences from 891 orthogroups (Chapter 
4) containing orthologues from at least 8 Stramenopile genomes, including P. 
lacertae and Blastocystis sp.. Each alignment was passed to Gblocks [328] which 
curates the alignment by removing segments which are poorly aligned and 
concatenated into a single alignment containing 83,410 characters. PhyML v3.0 
[245] generated maximum likelihood phylograms using smart model selection (SMS) 
[329] and provided maximum likelihood bootstrap support. SMS uses Akaike 
information criterion (AIC) [330] to evaluate the quality of statistical models. This is 
needed to select the substitution matrix and model for rates across sites. Rather 
than test all combinations, SMS uses a heuristic approach comparable to other 
model estimation software [329]. MEGA v7.0.14 was used to provide maximum 
parsimony and neighbour joining bootstraps.  
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2.3 Results 
 
2.3.1 Electron microscopy 
 
  The ultrastructure of P. lacertae has been previously reported and its 
morphology was used to place it with the Stramenopiles prior to the availability of 
sequence data [294], [297], [331]. I have both confirmed previous findings and 
report previously unobserved features for P. lacertae. 
 
 I have confirmed the observation that there is a single, large mitochondrion 
with tubular cristae and that this is often seen in close proximity to the nucleus, 
which often contains darkly stained chromatin (Figure 2.3.1). I also observed the 
Golgi apparatus although no rhizoplast, which has been shown to pass through the 
Golgi. Extracellular features include the flagella, but no evidence for the kinetosome 
and the corrugation of the cell surface, which is clearly visible only in certain planes 
and sections of the cell.  
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Figure 2.3.1 Transmission electron micrographs of P. lacertae. 1.0 x 108 cells 
were fixed in 3% agarose, stained with 1% UA overnight and embedded in TAAB 
hard mould. Images were taken an FEI 120kV Tecnai G2 Spirit BioTWIN 
transmission electron microscope. A. Cell with an electron-dense nucleus (N) and 
showing parts of the surface coat, which have detached (arrowheads) and potential 
pinocytosis (P). B. A close-up of the surface coat, which has clearly disconnected 
from the body of the cell (arrowheads). 
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Figure 2.3.1 Transmission electron micrographs of P. lacertae. C. Cell with the 
large mitochondrion (M) in proximity to the nucleus (N) with chromatin. The flagella 
are also clearly seen (F). D. Single cell showing the large mitochondrion (M) in 
proximity to the nucleus (N) and the very electron dense Golgi apparatus (GA). The 
surface coat (SC) is seen here still attached to the cell membrane and there is 
another incidence of pinocytosis (P). 
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While the complexity of P. lacertae ultrastructure is markedly different from 
that of Blastocystis, there are some interesting similarities with Blastocystis, some of 
which have not yet been reported. There are multiple examples (Figure 2.3.1 A and 
C) of small, pinocytic pits in the membrane, which are distinct from cell surface 
corrugation because they are more electron dense than the surrounding membrane 
and cytoplasm. These may be examples of clathrin-mediated endocytosis, whereby 
the cell is able to take up nutrients from the environment in the absence of a 
bacterial food source. 
 
It also appears as though P. lacertae may possess a surface coat similar to 
that exhibited by Blastocystis, sometimes referred to as the fibrillar layer, slime layer 
or capsule (Figure 2.3.1 A and C). The surface coat of P. lacertae is homogeneous 
but may be being continuously shed into the environment by an as yet unidentified 
mechanism (Figure 2.3.1 A and B). This behaviour has been observed in 
Blastocystis but a function has not yet been confirmed [332].  
 
2.3.2 Genome assembly 
 
In order to produce a genome sequence a single 10 kb library was 
sequenced on a PacBio RS II machine in 9 SMRT cells. This generated 278,301 
paired end reads where the mean read length was 9,642 bp and the N50 was 
14,691 bp, of these, 267,828 were mapped. 
 
Genome assembly was performed using SMRT Portal. The reads were 
initially assembled using default parameters in order to provide a benchmark for 
subsequent analysis (Figure 2.3.2). In order to optimise the assembly, the genome 
size was estimated from the filtered reads using a kmer frequency analysis. Kmer 
frequencies were counted and plotted against total number of kmers for a given 
frequency to calculate the mean coverage. Genome size is then estimated from N = 
total number of kmers / mean coverage. Kmer frequency estimation suggested a 
genome size of between 35 and 37 Mb for kmer sizes of 19, 20 and 21 bp. The 
predicted genome size was used along with a range of other genome sizes to 
sequentially investigate the best assembly. Other parameters that were also altered 
include minimum seed read length and maximum divergence. The best metrics 
were then combined in an assembly using an estimated genome size of 35 Mb and 
a minimum seed read length of 10,000, which yielded 1,449 contigs where the 
maximum contig length was 864,525 bp, the N50 contig length was 92,586 bp. It is 
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worth noting that although the predicted genome size used in the assembly was 35 
Mb, the assembly produced totalled 52 Mb. Multiple iterations of this process failed 
to reconcile these values and increasing the predicted genome size failed to 
reproduce this increase (Figure 2.3.2).  
 
The contigs were concatenated where the shortest contig was 1003 bp and 
the average CG content across the genome was 27.1 % (Table 2.3.1). To test 
whether this assembly was better than one produced using a different approach, the 
reads were also assembled using Canu. The reads were assembled into a 55.8 Mb 
genome consisting of 3,068 contigs where the N50 was 31,981 bp and the max 
contig size was 450,152 (Figure 2.3.2). As this assembly is more fragmented than 
the HGAP assembly, the HGAP assembly was preferred to the Canu one.  
  49 
 
 
Figure 2.3.2 Assembly statistics for P. lacertae genome assemblies to determine the optimum parameters. Genome size (GS) and 
minimum seed read length (MSRL) were altered sequentially and compared to assemblies produces by HGAP 3 and Canu with default 
parameters.
4
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 The assembly statistics of the genome are comparable to the 
published genomes of Blastocystis sp. STs, which are the closest relatives with 
genome data available. The largest difference comes from the size disparity; the P. 
lacertae genome is much larger than the Blastocystis sp. ST genomes. As a result, 
the genome is made up of more contigs, though the N50 value is higher than those 
for Blastocystis sp. ST1 and ST4, so there is confidence that the genome is not 
more fragmented. The proportion of the genome that is protein coding is similar 
between the P. lacertae genome and Blastocystis sp. STs, contributing between 60 
– 70% with the exception of Blastocystis sp. ST7. Differences are notable for GC 
content, and gene density, which are lower and higher respectively in P. lacertae. 
The BUSCO score for P. lacertae can be broken down into details, the gene set 
contains 245 complete single-copy BUSCOs, 101 duplicated BUSCOs, 122 
fragmented BUSCOs and only 62 BUSCOs missing rendering the overall 
completeness >85%, again comparable to the existing Blastocystis genomes.  
 
As this assembly is composed of long reads it is likely that the approach has 
managed to sequence over long repetitive regions and therefore is a good 
estimation of the actual genome size. Interestingly, during the assembly process, 
the default parameter for genome size estimation was set at 5 Mb (the HGAP 
algorithm was optimised for bacterial genomes). When assembled under default 
parameters, the whole assembly was compressed in to 31 Mb (Figure 3.2.2). 
Increasing the expected genome size to 35 Mb had the effect of almost doubling the 
size of the assembled genome to 52 Mb and the N50 to 92,586 bp. This was 
Table 2.3.1 Assembly and genome statistics for P. lacertae, Blastocystis
sp. ST1, ST4 and ST7
P. lacertae
Blastocystis 
sp.  ST1
Blastocystis 
sp.  ST4
Blastocystis 
sp.  ST7
Scaffolds - 580 1,301 54
Contigs 1,449 1,092 1,355 155
N50 (bp) 92,586 36,659 29,524 296,810
Genome size (Mb) 52.25 16.4 12.92 18.82
Gene number 35,706 6,544 5,707 6,020
GC (%) 27.1 53 39.7 45.2
Average coverage 54.3 80 300 12.4
BUSCO (%) 85.55 85.08 81.81 78.79
Total gene length (Mb) 33.1 11.6 7.9 7.8
Total gene length (%) 63 70 61 41
Gene density (Genes/Mb) 684 399 442 320
Intergenic length (Mb) 19.1 4.8 5 11
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potentially due to collapsing repetitive regions and discarding reads that were too 
divergent.  
 
To test this, RepeatModeler predicted repeats across both the 31 Mb 
assembly (default HGAP) and the 52 Mb assembly (optimised HGAP). It showed 
that the default assembly was repetitive over 24% of the total length, whereas the 
optimised assembly was repetitive over 37% of the total length, suggesting that 
collapse of repetitive reads may have been partially responsible for the reduction in 
genome size. Distribution of repeat size was also significantly different between the 
two assemblies, X2 (20) = 577.79, p < 0.0001, meaning that the repeats in the 
default assembly were significantly shorter. Increasing the estimated genome size 
up to 100 Mb was not associated with a similar expansion of genome size.  
 
2.3.3 Gene annotation 
 
There were 188 manually generated gene models used to train AUGUSTUS 
and SNAP. 78 (41%) of these had multiple exons the rest were single exon. 24 
(12.7%) of these genes did not have a BLAST hit to a sequence in the database. Of 
the remaining gene models, 32 (17.0%) were best matched to proteins annotated as 
‘hypothetical protein’ and the rest had BLAST hits to annotated proteins of various 
functions. Each gene was >100 bp beginning with a start codon and ending with a 
stop. All 188 gene models were annotated in conjunction with transcript data 
mapped to the longest contig in the assembly. 
 
 The gene model predictions from AUGUSTUS and SNAP differed in both the 
number of genes and their positions within the genome. AUGUSTUS predicted 
22,869 genes while SNAP predicted 151,750. This difference was resolved by 
manual curation of each gene model aided by the inclusion of transcript data 
mapped to the whole genome. This curation of the gene models resulted in 40,042 
predicted genes. These genes were given functional annotations by a suite of 
programmes, which allowed refinement of some of the models. In some cases 
where adjacent genes received the same annotation or where a single gene 
received multiple annotations gene models were revised, again with the support of 
transcript data. This refinement resulted in 35,685 gene models of which 28,067 
(79%) had transcriptomic support. 
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 As a validation method for the gene models the de novo assembled 
transcriptome was compared to the gene set by reciprocal BLAST. 13,950 (39%) of 
the gene models had a reciprocal best hit to a transcript and vice versa. 
 
2.3.4 Transcriptome assembly +QC  
 
 In a reciprocal BLAST search between the gene set and the transcriptome 
13,950 of the 27,952 transcripts (50%) had a reciprocal best hit to a gene model. 
However, this may have been due to the splice variants in the transcriptome. If there 
were several isoforms of a gene expressed in the transcript only one would receive 
a reciprocal BLAST hit. When investigated, it transpired that without the splice 
variants, the transcriptome consists of 15,101 transcripts of which only 8563 (56%) 
had a reciprocal best hit to the proteome. This is very similar to the former result and 
suggests that there is some disagreement between the transcriptome and the 
predicted proteome, however, 28,067 gene models have transcript support when 
the reads are mapped to the contigs.  
 
In order to get an independent measure of the assembly quality it was also 
assessed by BUSCO, which measures how complete the transcriptome is by 
measuring how many BUSCOs it contains. BUSCO estimated that the P. lacertae 
transcriptome is 75.9% complete.  
 
2.3.5 General features of the P. lacertae genome 
 
 The ploidy of P. lacertae and Blastocystis sp. STs are not known, so in an 
effort to investigate the features of the P. lacertae genome and gain insight into the 
change in genome size between assembly parameters, the genome was used in an 
in-silico analysis of ploidy. Reads were mapped back to the genome and the base 
frequencies were then tested against assumptions based on predicted frequencies 
for diploid, triploid and tetraploid genomes. The programme nQuire does this in 
several ways firstly by calculating the sum of squared residues (SSR) of empirical 
vs. ideal frequencies. The assembly showed best fit against the tetraploid ideals 
showing a low SSR, a positive slope and a high r2 (SSR = 0.0482166, y-y = 
0.59435, r2 = 0.0554398), compared with the fit against the diploid (SSR = 
0.102001, y-y = -0.1535, r2 = 0.01) and triploid (SSR = 0.0754403, y-y = -0.181506, 
r2 = 0.0125269) frequencies. The nQuire programme also uses a Gaussian Mixture 
Model to calculate delta log-likelihoods for each model. Again the P. lacertae 
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genome scored highest when compared to the tetraploid (80860430.427226) model 
and negatively for both the diploid (-837038.879166) and triploid (-545848.790561) 
models (Figure 2.3.3). 
 
 
 
Figure 2.3.3 Graph of delta log-likelihood values for the P. lacertae genome 
compared against diploid, triploid and tetraploid models.  
 
The genome assembly is comprised of contigs each representing a 
continuous region of DNA. A search of the contigs using BLASTn revealed the 
presence of telomeric repeats (CCCTAA) at the ends of 55 contigs. Examination of 
these contigs revealed that there appear to be no subtelomeric regions; the coding 
regions end abruptly with the telomere. No contigs were observed with telomeric 
repeats at both ends, suggesting that there are no contigs representing whole 
chromosomes.  
 
2.3.6 Protein coding genome 
 
The majority of the proteins coding genes have no significant similarity with 
databases and are therefore annotated as ‘hypothetical protein’. This accounts for 
65% of the predicted proteome. This is comparable to the Blastocystis sp. STs 
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genomes where ‘hypothetical’ or ‘uncharacterised’ proteins account for 94%, 49% 
and 34% of the genomes for ST7, ST4 and ST1 respectively. For other published 
Stramenopile genomes (Chapter 4) this proportion ranges from 97% for 
Phytophthora sojae to 28% for Pythium ultimum. These proteins are often annotated 
by software packages with vague domain descriptions that do not provide useful 
information on the function of the protein, such as repeat domain-containing or 
transmembrane superfamily, which may refer to a wide array of proteins and 
functions. The annotations performed by InterProScan assigned 4,015 domains to 
17,832 proteins.  
 
 
 
Figure 2.3.4 Gene density plotted across the P. lacertae genome. Number of 
genes is plotted against 1 Mb bins. 
 
P. lacertae has an average gene density of 673 genes per Mb. While there 
are some regions with slightly lower or higher gene density overall it is fairly 
consistent across the genome (Figure 2.3.4). The gene density does however, 
appear to drop off at both ‘ends’ of the genome. The contigs at the lowest gene 
density are in the final (53rd) bin. Because the genome is less than 53 Mb in length, 
this bin accounts for only 0.25 Mb, which may explain its low density. However, 
position 1 accounts for a full Mb but only contains half the average number of 
genes. Examination of contigs 28 and 973 which contribute to this Mb revealed few 
insights, other than some large proteins 00473 (59 Kb, including introns) and 00351 
(41 Kb, including introns) in this region, there is nothing to suggest such a drastic 
reduction in gene density. 
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2.3.7 KEGG mapping 
 
  Annotation and mapping of the P. lacertae genome to KEGG pathways 
revealed that 4,490 proteins mapped to 328 pathways (Figure 2.3.5). Thus, the P. 
lacertae genome contains representatives from the most common pathways 
expected for a unicellular protist, such as lipid, amino acid, carbohydrate and 
vitamin metabolism. Interestingly, there seem to be components from the citrate 
cycle (TCA) missing, including citrate synthase (K01647, EC:2.3.3.1), aconitate 
hydratase (K01681, EC:4.2.1.3) and isocitrate dehydrogenase (K00031, 
EC:1.1.1.42). This might be linked to the anaerobic environment that P. lacertae 
inhabits. The pathways with the most genes mapped to them included 03040 
spliceosome (77 genes), 03010 ribosome (73 genes), 03013 RNA transport (62 
genes) and 00230 purine metabolism (62 genes). These may suggest that high 
copy number of genes in these pathways is important for P. lacertae persistence.  
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Figure 2.3.5 P. lacertae protein dataset mapped to KEGG pathways. Blue lines indicate where proteins with KEGG annotations mapped. 
5
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2.3.8 Phylogenomics 
 
The closest relative of Proteromonas is Blastocystis however; this genome 
was produced with the intention to study aspects of the Blastocystis genus. 
Therefore, using Blastocystis sp. STs genomes to inform annotation of the P. 
lacertae genome could potentially skew a comparative analysis. There are other 
published Stramenopile genomes, which may offer comparison, however, these are 
more distantly related to Proteromonas and are therefore less useful. In order to 
confirm the placement of P. lacertae within the Stramenopiles and in proximity to 
Blastocystis I built a multigene phylogeny using conserved orthologues from 
published Stramenopile genomes (Figure 2.3.6).  
 
 
Figure 2.3.6 Maximum likelihood phylogeny of Stramenopile genomes 
showing the relationship between P. lacertae and other published genomes. 
Alignment was generated from representative sequences from 528 conserved 
orthogroups. The alignment contained 83,410 informative sites. Nodes marked with 
a point are supported 100/100/100 by bootstraps from maximum likelihood, 
maximum parsimony and neighbour-joining, 100 replicates each. The tree was 
rooted with the algae and diatom sequences following Pérez-Brocal et al. 2010 
[294]. 
 
  The phylogeny robustly places P. lacertae as the sister taxon to 
Blastocystis, confirming previous results but with a much-improved character 
sampling. There is also high bootstrap support for the Oomycete and photosynthetic 
clades as well as for the proximity of Cafeteria roenbergensis to Blastocystis and 
Proteromonas.  
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2.4 Discussion 
 
 I have investigated the ultrastructure of P. lacertae and made observations 
about its behaviour in vitro consistent with those seen in Blastocystis. I have 
sequenced and assembled the first draft genome for P. lacertae and determined 
that the assembly is contiguous and that the gene set is >85% complete. I have also 
assessed the relevance of P. lacertae as an out-group to Blastocystis by confirming 
their close relation in a multigene phylogeny. 
 
2.4.1 Electron Microscopy 
 
 I have confirmed the observation that the ultrastructure of P. lacertae is 
highly different from the derived morphology of Blastocystis but I have also shown 
there are surprising similarities between them. Of particular interest is the 
occurrence of the surface coat, previously only seen in Blastocystis sp. [59], [333]. 
Further, I have shown that this coat may be extruded into the environment in a 
similar manner to Blastocystis [332], [334]. Zaman et al. 1997 [332] were the first to 
record this phenomenon in Blastocystis and postulated that it may be involved in 
capture and degradation of surrounding bacteria or, less convincingly, involved in 
resistance to changes in osmotic pressures. It is possible that this mechanism is 
also used in immune evasion. There are several examples of symbionts that utilise 
membrane shedding to avoid detection by the hosts immune system including 
helminths [335], and Entamoeba which moves bound immunoglobulins and other 
bound factors to the uroid region and is extruded as a vesicular cap [336], [337]. 
The observation of this behaviour in P. lacertae may suggest that this machinery 
was present in the intestinal ancestor of both Proteromonas and Blastocystis and 
may therefore play a role in persistence in the intestinal environment.  
 
2.4.2 Evaluation of genome assembly 
 
 Two independent software packages were used to assemble the P. lacertae 
genome. The assembly produced by HGAP was preferred because it produced a 
less fragmented assembly. The biggest difference was between the number of 
contigs. The Canu assembly was made up of more than twice the number of 
contigs. This is also reflected in the maximum contig length, which was halved in the 
Canu assembly, and the N50, which was tripled in the HGAP assembly. While there 
have been studies which have attempted to compare genome assembly software for 
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TGS technologies [338], [339], there is no direct comparison between the HGAP 
algorithm and Canu. Judge et al. 2016 [338] compared the assemblies produced by 
three software tools (PBcR, Canu and miniasm) using MinION sequencing reads 
and concluded that Canu produced the best result both in terms of low error rate 
and high contiguity. Liao et al. 2015 [339] compared PBcR with HGAP and 
concluded that both these technologies were able to produce high quality genome 
assemblies. While this is not a direct comparison, these studies suggest that the 
Canu assembler might produce higher quality assemblies; however, both of these 
studies were conducted using bacterial genomes. We have seen that HGAP 
produces a more contiguous assembly than Canu for the P. lacertae genome, which 
may suggest that the size and complexity of the genome is an important factor.  
 
While the assembly statistics for the P. lacertae genome are comparable 
with the Blastocystis ones, the Blastocystis sp. STs genomes were sequenced using 
454, Illumina or Sanger technologies. As PacBio sequencing is able to produce 
longer reads than these other methods, it might be expected the assembly for the P. 
lacertae genome would be more contiguous and made up of larger contigs. When 
compared to the statistics for the Blastocystis sp. ST7 assembly, the P. lacertae 
assembly contains more contigs and a lower N50 value (Table 2.3.1). However, it is 
worth noting that contig number and N50 are not independent of genome size. The 
P. lacertae genome is more than double the size of the Blastocystis sp. STs 
genomes but does not contain double the number of contigs or half the N50. Thus, it 
may be concluded that the P. lacertae genome is not as fragmented as the 
Blastocystis sp. STs genomes.  
 
 The P. lacertae HGAP assembly compares well to other Stramenopile 
genome assemblies produced using PacBio sequencing technology: the genome of 
Oomycete Phytophthora nicotianae (unpublished) is 71 Mb but is made up of 5,654 
contigs with an N50 of 27,164 bp. Some of the Stramenopile genomes are also 
larger than P. lacertae, Oomycete Sclerospora graminicola has a 299 Mb genome 
(unpublished) made up of 28,799 contigs and has an N50 of 15,902 bp and 
Saccharina japinoca (Phaeophyceae) has a 543 Mb genome assembled into 35,750 
contigs with an N50 of 44,573 bp [340], [341]. These statistics show that the P. 
lacertae genome is comparable not only to the Blastocystis sp. ST genomes but to 
other Stramenopile genomes sequenced using the same technology. 
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The changes in genome size with increase of expected size during the 
assembly process raises another issue for the assembly of the P. lacertae genome. 
P. lacertae is estimated to be tetraploid and therefore the difference in genome size 
between the two parameters in the assembly may indicate that the software has 
segregated a number of divergent, heterozygous regions. The smaller estimated 
genome size of 5 Mb may have forced the programme to compress heterozygous 
reads into a single sequence (or else discard them), whereas the larger estimated 
genome size of 35 Mb allowed the programme to segregate and retain these 
regions. If the genome was tetraploid, though, then increasing the genome size 
should, conceivably, have increased the overall size by four rather than by two. This 
notwithstanding, no large-scale duplication of gene content in the annotation is 
observed, and so the ploidy of the organism has not had an observable impact on 
the predicted proteome for P. lacertae.  
 
2.4.3 Evaluation of gene annotations 
 
More than 65% of the genes predicted for the P. lacertae genome have no 
homologues in the database. While it is expected that there will be some genes 
specific to this species, and the presence of genes that are not specific but are yet 
to be investigated, the high proportion of these raises questions about the validity of 
the gene annotation.  
 
 There may be reasons why the gene models did not share homology with 
sequences in the databases. The databases are biased towards ‘model’ and well-
studied organisms that do not include P. lacertae and its Stramenopile relatives. 
Many of the gene models that did not share homology with sequences in the 
database were assigned functional annotations based on other methods of 
comparison such as HMMs. 
 
Despite considerable evolutionary distance, other published Stramenopile 
genomes show varying degrees of species-specific genes. For example, the 
Oomycetes, which have been extensively studied, show a much smaller proportion 
of proteins with no homology in the database compared with more distantly related 
organisms, which have not been as extensively studied such as the diatom 
Thalassiosira pseudonana [209], [342]. However, the proportion of P. lacertae 
genes without homologs in the database is higher than even T. pseudonana. 
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 Nonetheless, I have shown that the genome is >85% complete using 
BUSCO and it is these genes that will be of use in the comparative analysis. In the 
event that the P. lacertae genome does contain erroneous gene models, these will 
not influence the results of the comparative analysis with Blastocystis (Chapter 4). 
The comparative analysis will serve to identify conserved genes between 
Blastocystis and the other Stramenopiles and will not use or comment on the 
species-specific repertoire of each genome.  The BUSCO score is comparable to 
both the Blastocystis sp. ST genomes and the genomes of other Stramenopiles 
which are typically ~90% (Figure 4.1.1). The final 10 - 15% of BUSCO orthologues 
may be missing through annotation or though sequence divergence. By using a 
range of Stramenopile genomes along with our assembly for P. lacertae it was 
hoped that the majority of the core Stramenopile genes would be captured.  
 
 Only 13,950 gene predictions had reciprocal best hits to de novo assembled 
transcripts. This represents 50% of the overall transcriptome. This implies that the 
other portion of the transcriptome has no orthologous counterpart in the gene set. I 
have shown that this is not due to splice variants in the transcriptome. The 
difference may be due to errors in the transcripts assembly by Trinity, or the gene 
set may still be incomplete. As the genome contains 28,067 gene models that are 
associated with transcriptomic evidence, it is unlikely that these are misannotated in 
the genome. Both the transcriptome and the gene set scored highly when examined 
by BUSCO, though the gene set scored higher and so will be used as the 
representative proteome for P. lacertae.  
 
 The P. lacertae genome has a predicted proteome of 35,706 proteins, which 
is more than double the average for published Stramenopile genomes (Figure 
4.1.1). Nannochloropsis gaditana has the smallest proteome of any Stramenopile 
[343] containing 3,558 genes in its 34 Mb genome but the largest proteome belongs 
to Thalassiosira oceanica and comprised 34,642 proteins [344]. In order to prevent 
poor gene models from influencing the subsequent analyses in Chapter 4, the 
dataset was reduced to contain only genes with transcriptomic support. This 
reduced the number of proteins to 28,067, which produced a BUSCO score of 
75.05%.  
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2.4.4 Conclusion 
 
In this chapter I have presented the genome assembly and annotation of P. 
lacertae. The assembly is comparable to other Stramenopile genomes and is a 
valuable taxon to add to the understanding of protist genomes, particularly within the 
Slopalinida. While the annotation is largely specific it represents a good starting 
place for the investigation of Blastocystis and would benefit from functional 
characterisation, particularly of novel sequences. Resolution of the number of 
chromosomes and discovery of the ploidy would also add to the understanding of 
the behaviour of data during assembly.  
 
 Overall, this genome is a useful tool in investigating the biodiversity of the 
Stramenopiles with particular respect to the evolutionary processes that have led to 
the development of symbiosis in Blastocystis.  
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Chapter 3. Sequence and analysis of the Cafeteria 
roenbergensis transcriptome 
 
 The P. lacertae genome described in Chapter 2 is a useful resource with 
which to compare Blastocystis. However, as P. lacertae is also an intestinal 
anaerobe, it is necessary to include a data point from a related, yet entirely free-
living organism to distinguish between adaptations for pathogenesis and symbiosis. 
However, no genetic resource is available for such an organism, therefore a 
transcriptome was produced for C. roenbergensis and assessed for its usefulness in 
a comparative analysis with Blastocystis and P. lacertae. The transcriptome 
produced here was successfully separated from the bacterial component of the 
cultures and shown to be a useful out-group to the Blastocystis-Proteromonas 
clade.  
3.1 Introduction  
 
 In Chapter 2 I presented a P. lacertae genome sequence. It was clear from 
the genome annotation that P. lacertae possesses a large number of novel, 
hypothetical proteins. Not all of these will be P. lacertae-specific, and so, in order to 
differentiate conserved hypothetical genes that have been lost from Blastocystis and 
species-specific hypotheticals that are unique to Proteromonas (and not pertinent to 
present aims), an out-group was required to Blastocystis and Proteromonas, 
preferably with an entirely free-living life strategy. The majority of Stramenopiles that 
have an associated genome sequence are not free-living, and those that are free-
living, such as the diatoms, are too phylogenetically distant to form a useful 
comparison.  
 
Marine ecosystems are some of the most diverse and least well-understood 
food webs. Their ecological importance also has large and rapid impacts on a 
number of issues such as global warming. Cafeteria roenbergensis (ATCC 50561) 
represents a single link in the complicated diversity of marine life and has been 
studied to that effect. C. roenbergensis is a single-celled marine flagellate that feeds 
on bacteria. First described by Fenchel and Patterson (1988) [345] it is now 
considered to be among the most common, ecologically significant species of 
heterotrophic nanoflagellate in marine biology. Based on the phylogenetic position 
of C. roenbergensis, it forms a useful comparator to Blastocystis and P. lacertae.  
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3.1.1 Cafeteria roenbergensis: a common marine flagellate 
 
 C. roenbergensis was first identified in cultures based on water samples 
from Limfjord, Denmark in 1981. Initial analysis of its morphology, show that C. 
roenbergensis has two flagella inserted sub-apically; where one extends laterally 
and carries tubular hairs while the recurrent flagellum anchors the cell to the 
substrate during feeding in vitro. It is possible that in vivo cells adhere to debris 
where they are able to persist in oligotrophic conditions. Cultures were established 
from an isolation of Rhizochromulina marina where it appeared as a contaminant. It 
was isolated by serial dilution into sterilised natural seawater or enriched seawater 
medium bacterized with Klebsiella aerogenes [346]. Since its identification it has 
been found in all areas where it has been searched for suggesting that it may be 
more widespread and potentially of greater ecologically importance than previously 
though [347]–[352].  
 
3.1.2 The phylogenetic position of C. roenbergensis 
 
Morphological features of C. roenbergensis are consistent with defining 
features of the Stramenopiles and along with the lack of observable chloroplast or 
lorica its initial placement was with the heterokont (Stramenopile) flagellates, 
specifically within either the Bicosoecid or Chrysomonad flagellates [345]. SSU 
rRNA sequence data was able to bolster the morphological analysis and place C. 
roenbergensis within the Stramenopiles, however it was often found on very deep-
rooted braches and accompanied by little support [67], [299]. General consensus 
from these trees did show that despite the long branches and deep nodes, it was 
often proximal to P. lacertae when included. Subsequent analyses have added 
support to these nodes through use of SSU rDNA and the mitochondrial genome 
sequence data (Figure 1.2.2) [291]–[294], [353]. In Chapter 2 the phylogenetic 
position of C. roenbergensis was confirmed with a multigene analysis (Figure 2.3.3).  
 
3.1.3 C. roenbergensis value in comparative genomics 
 
  As described above, both Blastocystis sp. STs and P. lacertae inhabit an 
intestinal environment and therefore an out-group was required, which is free-living. 
As a marine flagellate, C. roenbergensis is not associated with symbiosis and 
represents an essential component in identifying adaptations to symbiosis in both P. 
lacertae and Blastocystis.  
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 The 43 Kb mitochondrial genome of C. roenbergensis can be found online at 
NCBI (NC_000946.1). The entry describes 34 protein-coding sequences 
(unpublished). This contrasts with the mitochondrial genomes of Blastocystis (28 
Kb) and P. lacertae (48 Kb) which differ greatly in size and structure between 
themselves, but which contain similar gene repertoires of 27 protein-coding 
sequences (Figure 3.1.1) [294], [354]. The difference in gene content between these 
and C. roenbergensis is most likely due to the loss of genes from the anaerobic 
mitochondria such as the cox and cob encoded cytochrome complexes that are 
essential in aerobic C. roenbergensis. There is also high variation between all three 
mitochondrial genomes with respect to their tRNA content. P. lacertae contains the 
most with 25, C. roenbergensis is next with 22 and Blastocystis has the smallest 
repertoire with 18 tRNAs. Already this organism has shown insight into the 
adaptations shared between Blastocystis and P. lacertae.  
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Figure 3.1.1 ACT gene order comparison between the mtDNA of Blastocystis sp. NandII (linearised), P. lacertae (single repeat only) 
and C. roenbergensis (linearised). Based on the comparison of Pérez-Brocal et al. 2010 [294]. Only protein-coding genes have been included 
for simplicity. Lines indicate synteny of single genes and blocks indicate synteny with conserved order, either forward (red) or reverse (blue) 
orientation. 
6
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3.1.4 Metagenomics 
 
 The xenic nature of the C. roenbergensis cultures means that sequence data 
prepared from them will represent a meta-genomic dataset. There have been a 
number of methodologies developed that attempt to remove systemic bacterial 
contamination from sequenced samples and these may be used singularly or in 
combination. In the first instance, it may be possible to remove much bacterial 
contamination prior to sequencing. This may be achieved either by using antibiotics 
to destroy bacterial cells or by enriching for eukaryotic sequences. Eukaryotic 
mRNA can be selected for using poly-A selection, as bacterial RNA is poorly 
adenylated [355]–[358]. However, rather than resulting in purification, this method 
produces a sample enriched for mRNA as non-adenylated sequences may still be 
carried through [359]. Therefore, bioinformatic approaches have been developed to 
remove bacterial contamination post sequencing. In order to determine which 
sequences originated from the eukaryotic aspect of the sample, approaches can be 
employed based on homology, differential genomic signatures [360], [361] and 
coverage profiles [362], [363].  
 
Homology is a very common method and may utilise a tool such as BLAST. 
Differential genomic signatures utilise codon preference, GC content and kmer 
frequencies, which allow clustering of ‘like’ sequences. Translational selection is 
important in bacterial genomes and shapes the most highly expressed genes to 
favour the most abundant tRNAs. Codon usage and GC content are also linked 
because optimal codons are those most likely to maintain the GC value of that 
organism [364]. A Kmer is described as a motif, built up of a number of characters 
(Kmer distribution analysis is primarily based on tetranucleotides [360], [365]) and 
that may occur numerous times along a length of nucleic acid. The number of times 
a kmer appears throughout the genome can be used to group ‘like’ sequences 
together (e.g. for GC rich or repetitive regions). Coverage profiles group sequences 
based on the assumption that certain taxa within the sample will be more or less 
abundant than others. Especially with respect to bacterial and eukaryotic cultures, 
components of the bacterial component may be far less numerous than others after 
poly-A selection and therefore have been sequenced less deeply. Grouping reads 
based on coverage provides another method for differentiating prokaryotic from 
eukaryotic sequences (e.g. prokaryotic reads may be sequenced less deeply as 
they are less abundant after poly-A selection). In this thesis, I will use a combination 
of methods to remove bacterial contamination from the cultures of C. roenbergensis.  
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3.1.5 Aims of the chapter 
 
In this chapter, the aim is to produce a transcriptome for C. roenbergensis to 
serve as a free-living out-group to the Blastocystis – Proteromonas clade, which will 
allow precise identification of gene gains and losses in both genomes during the 
comparative analyses (Chapter 4). There are five specific objectives: 
 
1. Prepare high integrity RNA preps from cultures 
2. Sequence the mRNA with Illumina 
3. Assemble the reads into a transcriptome 
4. Remove contaminating transcripts from the assembly 
5. Annotate the transcriptome and provide a measure of completeness for the 
protein dataset 
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3.2 Materials and methods 
 
3.2.1 Culture optimisation 
 
 Cafeteria roenbergensis (ATCC 50561) was maintained in artificial seawater 
for protozoa (ASWP) at 4˚C or at room temperature in light-shielded T-25 culture 
flasks. Complete medium contained 33.6 g ‘Ultramarine Synthetica’ sea salts 
(Waterlife Research Industries Ltd), 0.5 g tricine, 10.0 ml stock solution and 50.0 ml 
soil extract made up to 1 l with distilled H2O and adjusted to pH 7.6 – 7.8. Stock 
solution contained 5.625 g NaNO3, 0.225 g Na2HPO4 and 0.188 g K2HPO4 (BDH) 
made up to 1 l with distilled H20. Soil extract was prepared by taking soil from 
undisturbed deciduous woodland and sieving through a 1 cm mesh. Soil was 
spread, air-dried and hand-picked for small invertebrates and roots. This was then 
sieved through a 2-4 mm mesh. 105 g of this was added to 660 ml distilled H2O, 
autoclaved twice and left to settle for one week. Supernatant was decanted, filtered 
and adjusted to pH 7.0 – 8.0. 
 
The final medium contained a single autoclaved corn kernel (Marks & 
Spencer) and supplemented with 0.1% yeast extract (BDH). Cell density was 
established using a haemocytometer under a light microscope. 
 
3.2.2 RNA preparation, sequence and assembly 
 
 Five replicate cultures were produced under four different conditions: 1. 
treated with Penicillin-Streptomycin (150 μg/ml) (Thermo-Scientific) for 24 hours; 2. 
heat shocked (40˚C) for 10 minutes prior to RNA collection; 3. both antibiotic and 
heat treatment and 4. left under normal conditions. These steps allowed capture of a 
more ‘complete’ expression profile and to reduce the proportion of bacteria in the 
culture. Cultures were processed at peak density (determined by cell counts) and 
pelleted at 3000 x g for 10 minutes and RNA was extracted using RNeasy (Qiagen) 
according to the manufacturers protocol. RNA quantification was assessed with 
Tecan spectrophotometer and Magellan software according to the manufacturer’s 
protocol. Integrity was assessed on a 1% agarose gel stained with SYBR safe 
(Invitrogen) run at 100v for 30 minutes. 
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Figure 3.2.1 1% agarose gel showing integrity of RNA collected from five 
replicates of four treatments.  
 
 RNA samples from the four conditions were pooled and processed by the 
University of Liverpool’s Centre for Genomic Research (CGR) using poly-A selection 
according to the manufacturer’s protocol. These were used to produce three 
Illumina RNASeq libraries from enriched RNA using the strand-specific ScriptSeq 
kit. Paired-end sequencing (2x125bp) was carried out on one lane using Illumina 
HiSeq platform generating in excess of 180M clusters. Post sequencing QC (fastqc 
v0.11.4) and trimming of adapters resulted in a final dataset of 69,013,377-paired 
reads. Reads were assembled de novo by Trinity v2.1.1 [312] using a kmer size of 
25 into 40,858 transcripts.  
 
3.2.3 Resolution 
 
In order to remove contaminating bacterial transcripts, those with homology 
to sequences in the database were used to define bacterial and C. roenbergensis 
control groups, i.e. a ‘negative’ control group of certain bacterial transcripts (>98% 
sequence identity to a known bacterium) and a ‘positive’ control group of high 
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confidence eukaryotic transcripts (>40% sequence identity to a known eukaryote or 
a top hit to a known Stramenopile gene). Transcripts with weak or no homology to 
databases sequence were assigned to either bacterial contamination or C. 
roenbergensis based on their sequence properties. Specifically, the base 
composition and codon usage were measured and each plotted against read depth. 
Kmer frequency distribution was also used and related to the control groups, to 
distinguish between transcripts of bacterial origin and those from C. roenbergensis. 
In order to ensure consistent results, kmer frequencies were estimated for kmers of 
3, 4 and 5 nucleotides for each transcript. A principle components analysis (PCA) of 
kmer values was carried out using R v3.2.4 [366] in R Studio v1.0.136 [367]. 
Principle component analyses are a statistical method for converting a set of 
observations into a set of values of linearly uncorrelated variables called principle 
components. 
 
Transcript metrics were estimated using programmes from the EMBOSS 
v6.3.1 toolkit [368]. Base composition was calculated per transcript using the 
EMBOSS infoseq package and codon usage was calculated per transcript using the 
EMBOSS chips package. Read depth was calculated per transcript by using 
Bowtie2 [369] to map the trimmed reads to the assembled transcriptome and the 
samtools v0.1.18-r580 depth programme calculated read depth per position, which 
was averaged to give a value per transcript. EMBOSS compseq was used to 
estimate Kmer values.  
 
3.2.4 Transcriptome annotation 
 
Initial annotation was assigned based on homology assigned by BLAST in 
BLAST2GO [316]. KEGG annotations were assigned to protein sequences by 
GhostKoala [324] and BLAST2GO and were mapped to KEGG pathways using 
KEGG Mapper – Reconstruct Pathway [325]. TransDecoder [312] was used to 
extract peptide information from the transcripts. 
 
In order to gain an objective description of how complete the transcriptome 
assembly was it was given to BUSCO v1.1b1 [326] (Benchmark Universal Single-
Copy Orthologs). This programme asses based on BUSCO content. The rationale 
being that all eukaryotes should contain orthologs of a set of 429 core genes. The 
score is assigned based on how many of these are present in the annotation. The 
C. roenbergensis transcriptome scored 70.40% with BUSCO.  
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3.3 Results 
 
3.3.1 Optimisation of C. roenbergensis cultures 
 
 C. roenbergensis cultures were grown xenically with bacteria isolated at the 
time of its collection. Cultures were passaged into fresh medium at peak density. In 
order to successfully sequence the C. roenbergensis transcriptome, effort was made 
to optimise the cultures, which included increasing the overall proportion of C. 
roenbergensis. Optimal growth conditions were established when supplementing the 
medium with 0.1% yeast extract and incubating at 4˚C rather than RT (Figure 3.3.1). 
The addition of yeast extract allowed the bacterial population to increase, which 
increased the food source for C. roenbergensis. Incubation at the lower temperature 
was sufficient to suppress the growth of the bacteria to ensure they did not overgrow 
C. roenbergensis. The alteration of these conditions produced higher yields of cell 
number 1 x 106-7 rather than 1 x 103-5 as previously reported [370].  
 
 
 
Figure 3.3.1 Cell counts of cultures under different growth conditions at log 
phase. Cell counts are expressed as an average of two cultures. Cultures were 
either grown at room temperature or 4˚C, medium was supplemented with Yeast 
Extract (YE) at a final concentration of 0.1%, 0.01% or 0%. 
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3.3.2 Resolution of contaminants from the C. roenbergensis transcriptome 
 
 The C. roenbergensis transcriptome was assembled into 40,858 unique 
transcripts from reads that were selected for by poly-A selection. Although poly-A 
selection should exclude the majority of bacterial transcripts, contaminants may still 
have been sequenced and assembled. To identify contaminating transcripts and 
remove them, an initial annotation of the transcripts was assigned using BLASTX 
against a non-redundant protein database. The 10,000 sequences with the highest 
score (based on E-value) were taken and their best BLAST hit interrogated to 
provide a positive benchmark with which to group sequences based on sequence 
identity. Any transcript with a top BLAST hit to a eukaryote with >40% sequence 
identity was classed as positive (confidently ascribed to C. roenbergensis), the 
negative group was defined as any transcript with a top BLAST hit >98% sequence 
identity to a bacterial sequence. Transcripts that did not fall into either of these 
categories were labelled unassigned (Figure 3.3.2). 
 
 
Figure 3.3.2 Pie chart showing proportions of the 10,000 transcripts with the 
highest E-value, which fall into each category. Positives are those confidently 
ascribed to C. roenbergensis, negatives are most likely bacterial contamination and 
unassigned are those with low homology determined by sequence identity. 
 
 The remaining 30,858 sequences that did not fall into the top 10,000 BLAST 
hits were also labelled unassigned and each transcript had read depth, base 
composition and codon usage (Nc) calculated. These values were plotted pairwise 
against each other (Figure 3.3.3) in order to identify if there was a clear distinction 
1734
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between the positive and negative groups, and to identify which unassigned 
transcripts clustered with these groups. This would allow visual identification of the 
bacterial transcripts, which could then be excluded from the analysis. Base 
composition was calculated as GC percentage per transcript, read coverage as 
RPKM and codon usage as effective number of codons (Nc) per transcript. 
 
A 
 
B 
 
 
Figure 3.3.3 Pairwise comparison of codon usage, read coverage and base 
composition for 3 groups defined within the C. roenbergensis transcriptome. 
Metrics were plotted pairwise against each other: A. read coverage vs. base 
composition, B. read coverage vs. codon usage. 
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The results from this comparison show that it may be possible to partially 
separate these groups based on sequence composition, but there is no clear 
distinction. Ideally the two groups would cluster independently. Instead, I tried a third 
approach to separating bacterial and eukaryotic transcripts using kmer frequencies, 
calculated per transcript and applied to a Principle Components Analysis (PCA) in 
R. Each Kmer value used to calculate frequencies produced the same output, 
therefore only frequencies calculated with 3mers is shown (Figure 3.3.4).  
 
 
Figure 3.3.4 A principle components analysis of 3mer values. PC1 and PC2 
account for >95% of the variation. Sequences above the line were removed from the 
transcriptome; sequences below the line were included except for negative 
sequences below the line and positive sequences above the line. 
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 This approach proved to be very effective; it was possible to draw a single 
line between the positive and negative control groups, with unassigned transcripts 
aligning with one or other control quite clearly. Consequently, removing any 
transcript that was above the line, except for those already identified as positive, 
and retaining any transcript below the line removed 11,633 transcripts from the 
transcriptome. The positive transcripts that fell above the line were examined and 
found to code for mitochondrial proteins already described in C. roenbergensis 
including mitochondrial encoded ribosomal proteins (NP_051143.1), NADH 
dehydrogenase subunit 7 (NP_051138.1), an unidentified orf169 (NP_051135.1) 
and ATP synthase F1 subunit alpha (NP_051156.1). The removal of the 
contaminating bacterial sequences produced a transcriptome containing 28,952 
transcripts. BUSCO was used to assess this transcriptome and determine the 
completeness. The transcripts scored 70.40% with BUSCO containing 203 complete 
BUSCOs, 61 duplicated BUSCOs, 38 fragmented and 127 absent BUSCOs. 
 
In order to extract protein-coding sequences from the transcripts the longest 
open reading frame (ORF) from each transcript was extracted using TransDecoder. 
This protein dataset contained 18,439 proteins and scored 49.41% with BUSCO 
containing 137 complete BUSCOs, 32 duplicates, 75 fragmented BUSCOs and 217 
absent. The protein dataset was annotated using InterProScan, which assigned 
2,596 domain annotations to 6,400 transcripts, and was also the dataset utilised in 
the comparative analysis presented in Chapter 4.  
 
3.3.3 KEGG mapping 
 
 As the protein dataset scored lower than the transcriptome when assessed 
with BUSCO, it was mapped to KEGG pathways to determine if there were any 
portions of the metabolism obviously absent. The protein dataset mapped 3,414 
sequences to 349 pathways (Figure 3.3.5) which is comparable to the number of 
pathways mapped to by P. lacertae (4,490 protein mapped to 328 pathways) 
Blastocystis sp. STs (~3,750 proteins mapped to ~310 pathways), see Chapter 4, 
section 4.3.10. While fewer sequences were mapped they mapped to a broader 
range of pathways compared to both P. lacertae and Blastocystis sp. STs.  
  77 
 
 
Figure 3.3.5 C. roenbergensis protein dataset mapped to KEGG pathways. Blue lines indicate where proteins with KEGG annotations 
mapped. 
7
7
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3.4 Discussion 
 
 In this chapter, I have produced a transcriptome for C, roenbergensis from 
xenic cultures and assessed the quality of this resource as a representative of this 
group of organisms and its usefulness as a free-living out group to the 
Proteromonas – Blastocystis sister taxon. Its usefulness was tested by obtaining 
independent measures of the assembly quality, transcriptome integrity and its 
completeness. 
 
3.4.1 C. roenbergensis cultures 
 
 The cultures were optimised to produce the highest proportion of cells 
without allowing the bacterial food source to overgrow and choke the culture. 
Previous reports from attempts to culture C. roenbergensis have reported cell 
density of approximately 1 x 103 cells/ml [352], [370]. Here it has been shown that 
the population of heterotrophic flagellates can be altered by modification of 
maintenance protocols. The ability to grow highly populated cultures within a shorter 
time frame is useful when attempting to retrieve sequence data from any slow-
growing and low-density culture. The approaches taken here do have drawbacks; 
while the increased richness in the medium triggered a longer log phase for C. 
roenbergensis it also increased the population of the bacterial food-source. This 
increases the mass of the contaminants, which must be filtered out during the 
process as the number of bacterial cells far outnumbers the protists. The changes in 
growth conditions is also likely to have a greater effect on some bacterial species 
than others, as could the change in temperature, and could lead to alterations in the 
make-up of the bacterial flora. This may have implications in the variety of bacteria 
available for feeding and as a result the expression profile of C. roenbergensis.  
 
3.4.2 Resolution of the transcriptome 
 
 The RNA isolated from C. roenbergensis cultures was subjected to poly-A 
selection and therefore should contain relatively few bacterial contaminants. 
However, inefficiencies in the enrichment protocol meant that there may have been 
bacterial contamination carried into the sequencing [359]. There is also evidence 
that many bacteria, including Escherichia coli and Caulobacter crescentus, contain 
molecules that can be isolated using techniques developed for the capture of 
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eukaryotic mRNA which have a 3’ poly adenylated tail [355]–[358]. In order to 
identify these post-sequencing, I used a BLAST search against known bacterial 
sequences. The threshold of >98% sequence identity was chosen in order to 
differentiate between bacterial sequences and bacterial-like sequences in the C. 
roenbergensis genome. Genuine bacterial sequences will be highly similar to 
existing environmental sequences in the database, whereas, bacterial-like 
sequences in C. roenbergensis will show higher divergence, as they will have 
diverged once transferred into the eukaryotic genome. We might expect there to be 
many bacterial-like sequences that genuinely belong to C. roenbergensis acquired 
via HGT through phagocytosis [371], [372]. HGTs play a major role in the make-up 
of many genomes including Blastocystis and therefore I attempted to preserve as 
many of these as possible [91], [283], [284]. As the resource is transcriptomic it is 
likely that there are HGT genes that are not constitutively expressed that will be 
absent from the dataset, our aim was to include as many as were available whilst 
preventing environmental contamination that would itself conflate the contribution of 
HGT.  
 
 While none were observed by light microscopy, it is conceivable that the 
culture contained not only a range of bacterial diversity but also eukaryotes. This 
would present a serious issue if true, as the approach taken here could not 
differentiate and subsequently remove these sequences. The approach taken here 
was to use sequence similarity to sequences in the database. A cut-off of >40% to a 
known eukaryote was used to identify ‘positive’ Cafeteria sequences. A large 
majority of these BLAST matches were to Blastocystis or other Stramenopiles 
(42%), and top matches to other eukaryotes had lower identities. Furthermore, 
annotation of the transcriptome has shown no large-scale duplication of genes, 
which would result from multiple eukaryotic genomes. Together, these observations 
mean that there is no good evidence for the presence of another eukaryote in the 
culture besides C. roenbergensis.  
 
3.4.3 Completeness of the transcriptome 
 
 The final transcriptome size is comparable to some of the genome sizes 
published for other Stramenopiles [209], [305], [342]–[344], [373], [374]. However, 
as discussed in Chapter 2, the Stramenopiles are an extremely diverse group of 
organisms that exhibit vast differences in both genome size and gene content. 
BUSCO was also used to assess the completeness of the transcriptome.  
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 BUSCO provided a score of 70.4% for the assembled transcriptome, which 
dropped to 49.41% after peptide prediction with TransDecoder. This drop in both 
number of sequences and completeness is concerning as potentially, up to 20% of 
the transcriptome has been lost through this method. TransDecoder attempts to 
extract protein-coding regions within transcripts by identifying all open reading 
frames (ORFs) over 300 bases long, beginning with an in-frame start codon and 
ending with a stop codon. The top 500 longest ORFs are used to build a 5th order 
Markov models, which are used to select the best ORF where more than one is 
available in a single transcript. If these conditions are not met then no protein-coding 
region is reported for the transcript.  
 
 The transcriptome mapped to 349 KEGG pathways, which is comparable to 
the genomes of Proteromonas and Blastocystis. This would indicate that the 
genome is not 50% incomplete, unless C. roenbergensis is usually far more 
metabolically competent than either intestinal counterpart. This analysis would 
suggest that the transcriptome represents a relatively complete gene set but that it 
may be missing copies of certain genes as fewer sequences were mapped than 
either P. lacertae or Blastocystis.  
 
In spite of the disagreement between the completeness measures, this 
resource is a useful tool with which to investigate Blastocystis and Proteromonas. I 
conclude this because it was always the intention to generate a transcriptomic 
resource for C. roenbergensis, therefore this resource would always lack information 
about the gene content that may otherwise be provided by a genome. Use of this 
resource in a comparative analysis may be criticised if used to infer gains in the 
genomes of P. lacertae and Blastocystis because absence from C. roenbergensis 
cannot be attributed to gene loss. However, presence in C. roenbergensis can still 
be used to infer loss from Blastocystis and Proteromonas. In this way, the 
completeness of the transcriptome only affects the resolution with which losses can 
be inferred. It may also prove useful in the annotation process should a genome 
sequence become available.  
 
3.4.4 Conclusions 
 
 In this chapter, I have presented the C. roenbergensis transcriptome. 
Bacterial contamination has been filtered using a bioinformatic approach and 
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suggests that this resource contains reliable information about this organism. The 
data may also be used as an annotation tool should a genome sequence become 
available.  
 
 Overall this transcriptome forms a useful outgroup to the Proteromonas – 
Blastocystis clade and will be used as a complementary resource in the comparative 
analysis discussed in Chapter 4. While it cannot be used to infer gain in either 
organism it may prove useful in identifying genes and gene families that have been 
subsequently lost from the genomes of other Stramenopiles. 
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Chapter 4. Comparative analysis of genome evolution in the 
Stramenopiles 
 
 In order to investigate the evolutionary history of Blastocystis, the newly 
generated resources from Chapters 2 and 3 were used in a comparative analysis 
with three Blastocystis sp. STs as well as other Stramenopile genomes. This 
analysis showed that the Blastocystis genomes are genuinely small within the 
Stramenopiles and that this is due to genome wide reduction in Blastocystis sp. 
STs, even in otherwise conserved gene families. Blastocystis sp. STs have also lost 
aspects of ‘typical’ Stramenopile morphology like the flagellar apparatus and other 
motility associated genes. Despite this, the Blastocystis genomes have also 
innovated and expanded a number of gene families including proteases and 
globular domain-containing proteins, which may hint at a process of genomic 
streamlining consistent with a change in life-strategy. 
4.1 Introduction 
 
 In Chapters 2 and 3 I produced a genome sequence for P. lacertae and a 
transcriptome for C. roenbergensis respectively. Here I have used these new 
resources in a comparative analysis with the published genomes of Blastocystis sp. 
ST1, ST4 and ST7, along with the genomes of Pythium ultimum, Phytophthora 
sojae, Saprolegnia diclina, Ectocarpus siliculosus and Thalassiosira pseudonana, to 
investigate evolutionary changes that occurred in the ancestor of Blastocystis, and 
which might be associated with the evolution of symbiosis.  
 
4.1.1 Blastocystis sp. STs genome sequences 
 
 Several genome assemblies for Blastocystis sp. subtypes have been 
published, though only three of these have annotations associated with them: ST1, 
ST4 and ST7. All three of these subtypes are found in humans but show different 
prevalence and preferences for zoonotic reservoirs (  1.2.2) [71]. Blastocystis sp. 
ST1 is found in the stool of many mammals including primates, sheep, cows, dogs 
and pigs, Blastocystis sp. ST4 is found in rodents and Blastocystis sp. ST7 is 
associated with an avian reservoir [70]. 
 
Denoeud et al. 2011 provided the first assembly and annotation of a 
Blastocystis genome using subtype 7. The genome is 18.82 Mb with a GC content 
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of 45.2% and contains 6,020 genes [91]. The assembly is made up of 54 scaffolds 
representing 15 chromosomes. This represents a highly compact genome, both in 
terms of genome size and number of genes, when compared with previously 
published genomes for the Oomycetes and other Stramenopiles [91]. The genes 
account for 42% of the overall genome but showed an interesting structural feature 
whereby 19% of the genes (1,141) are arranged in around 400 duplicated blocks. 
The majority of these genes are present in two copies apart from histone and 
ferredoxin domain-containing proteins which are present in large multi-copy families.  
 
Denoeud et al. 2011 also inferred the presence of 133 candidates for HGTs, 
some of which they suggest may be involved either with adaptation to the intestinal 
environment or parasitism itself. These included two copies of Major facilitator 
superfamily (MFS) transporters which may confer the ability to absorb nutrients in 
the intestinal environment or when attacking host tissues. They further noted 26 
copies of immunoglobulin domain-containing proteins, including some that also had 
a cadherin domain and may be responsible for cell-cell adhesion, and five hydrolase 
domain-containing proteins that may be responsible for degradation of host tissues. 
Finally, Denoeud et al. 2011 also identified short-chain dehydrogenases and 
oxidoreductases that they suggested confer advantageous metabolic qualities 
especially in an anaerobic environment [91]. 
 
A large part of the original genome study was focused on the MROs present 
in Blastocystis sp. STs which appear to contain features consistent with both 
mitochondria and hydrogenosomes, having adapted to the anaerobic environment 
of the intestine and lack a complete oxidative phosphorylation chain and citric acid 
cycle [375]. Denoeud et al. 2011 also made an attempt to investigate potential 
virulence factors encoded in the Blastocystis genome. They were able to identify 75 
proteins expressed; potentially at the cell surface and that may have a direct link 
with pathology such as proteases, hexoses, lectins, glycosyltransferases and 
protease inhibitors. The cysteine protease families were of particular interest as 
96% of these genes are predicted to be surface expressed. 
 
The genome sequence of Blastocystis sp. ST7 provided a platform and a 
standard against which other Blastocystis sp. STs genomes could be judged and 
compared. Wawrzyniak et al. 2015 [284] sequenced and assembled a 12.9 Mb 
genome for Blastocystis sp. ST4 with a GC content of 39.7%. The assembly 
contains 1,301 contigs and 5,707 genes. In comparison with the Blastocystis sp. 
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ST7 genome, this assembly contained fewer duplicated blocks and more than 30% 
of the genes annotated in Blastocystis sp. ST4 had no ortholog in Blastocystis sp. 
ST7, including seven secreted proteases. The differences between the two 
assemblies suggest that there may be high genetic diversity within the Blastocystis 
genus.  
 
Shortly after the Blastocystis sp. ST4 genome became available, the Statens 
Serum Institut deposited the genome sequences of five Blastocystis sp. STs in the 
database, without publication (https://www.ncbi.nlm.nih.gov/genome/13540). No 
annotation was made available for these assemblies and so comparison between 
gene repertoire has not been done, however, the differences between the genome 
sizes and GC contents of each assembly does reflect the diversity already seen 
between Blastocystis sp. ST4 and ST7. Blastocystis sp. ST2 (a mammalian subtype 
(Figure 1.2.2)) was assembled into a 12.6 Mb genome with a GC content of 54%. 
Blastocystis sp. ST3 is the smallest assembled Blastocystis genome, 11.6 Mb, is 
most commonly found in human hosts and has a GC content of 52%. Blastocystis 
sp. ST6 is an avian subtype and has a genome size of 15.4 Mb and a GC content of 
43.1%. Blastocystis sp. ST8 has a large host range including mammals and avians. 
Its genome is 12.2 Mb with a GC content of 39.7%. Finally, Blastocystis sp. ST9, 
which is only found in humans, has a genome size of 11.7 Mb and a GC content of 
43%.  
 
The most recent annotated genome to be sequenced was produced from 
Blastocystis sp. ST1 (ATCC 50177/Nand II) by Gentekaki et al. 2017 [376]. This 
genome assembly was 16.4 Mb, had a GC content of 53% and contained 1,092 
contigs and 6,544 genes. This study was primarily concerned with defining the HGT 
gene content and inferring their roles in the adaptation of Blastocystis sp. STs to the 
intestinal environment. They showed that up to 2.5% (167 genes) of the Blastocystis 
sp. ST1 genome was acquired through HGT and that this proportion is variable 
among subtypes, both in gene content and in the divergence between orthologues.  
 
Eme et al. 2017 [283] found that HGT has played an important role in 
facilitating the transition into the intestinal environment by providing genetic material 
to cope with oxygen stress, carbohydrate metabolism and acquisition, nitrogen 
metabolism and anaerobic metabolism has particularly benefitted from HGT 
acquisition. Additionally, they postulated that Blastocystis might have acquired 
genes for immune evasion and pathogenicity. The most striking example of this is 
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the presence of a cholesterol-alpha-glucosyltransferase. This is potentially involved 
in alpha-glycosylation of cholesterol which has been shown to promote escape from 
phagocytosis by Helicobacter pylori [377]. Interestingly, evidence for HGT is not 
restricted to donations from bacteria. They propose that a beta-1,3-
galactosyltransferase was obtained from animals and is involved in molecular 
mimicry, potentially as camouflage from the host immune response. If true, this 
would be the first instance of a eukaryote utilising a mechanism such as this. 
Virulence factors associated with HGT included a type I polyketide synthase, 
potentially involved in host dysbiosis and inflammation, that was previously 
described by Denoeud et al. 2011 [91]. Eme et al. 2017 [283] confirmed its presence 
in all other Blastocystis subtypes and also described an O-methyltransferase and a 
malonyl transferase potentially involved in polyketide biosynthesis and also of 
bacterial origin. Finally, they described a bacterial-like tryptophanase, which most 
likely produces indole. Indole, previously thought to be produced by bacteria, is able 
to diffuse through the plasma membrane and influence a number of physiological 
processes including host-cell invasion, inflammation and virulence [378], [379].  
 
 From these genome sequences, it is clear that Blastocystis have the 
smallest Stramenopile genomes sequenced to date and that there is high diversity 
within the Blastocystis genus in terms of genome size, GC content and gene 
repertoire. The MROs of Blastocystis are interesting as they contain machinery 
common to both mitochondria and hydrogenosomes and so represent an 
opportunity to investigate the evolution of these organelles. The Blastocystis 
genomes may also be heavily influenced by HGT, which has facilitated the transition 
into the intestinal environment in terms of metabolism, persistence in the face of an 
immune response and, potentially, virulence.  
 
4.1.2 Blastocystis and parasitism 
 
 There is much debate in the literature about whether Blastocystis sp. STs 
are genuinely parasitic or merely commensal. The greatest cause of controversy 
has been the prevalence of Blastocystis sp. in asymptomatic patients. There are 
roughly an equal number of publications that report either significantly higher 
prevalence of Blastocystis sp. STs in symptomatic patients or no difference at all 
[54]. Blastocystis has been linked to Irritable Bowel Syndrome (IBS) and patients 
often have up to double the infection rate than non-suffers [41], [103], [105], [107]. 
However, it may also be that Blastocystis are able to better colonise the gut of 
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people suffering from IBS [54]. This is compounded by the fact that IBS is often 
diagnosed by ruling out other common causes. 
 
There has been very little data collected on the virulence of Blastocystis, due 
to the lack of an effective infection model. Lab mice have been deemed unsuitable 
because, while Blastocystis is able to cause symptoms during experimental 
infections, these are often different to those observed in humans and the infections 
themselves are self-limiting [102]. It has been shown, however, that Blastocystis 
cysteine proteases are able to modulate the immune response and induce host 
interleukin (IL)-8 [380] and that some proteases are able to cleave human 
immunoglobulin and disrupt the tight junctions of epithelial cells thereby increasing 
the permeability of the gut [381]–[383]. Secreted products were also shown to 
induce apoptosis in epithelial cells in vitro [384].  
 
 The genomes of the various Blastocystis subtypes that have been annotated 
revealed many gene families that have been associated with immune evasion and 
tissue degradation in other systems: hydrolases, proteases, adhesion-like proteins 
and protease inhibitors. Differences in copy number and expression between 
subtypes may explain differential infection rates and host specificity [91], [102], 
[283], [284], [385]. However, these gene families are also abundant in non-parasitic 
genome and thus their presence is not indicative of pathogenicity. 
 
The lack of conclusive data describing Blastocystis as parasitic or not cannot 
be answered by comparative genomics alone, but neither does it compromise the 
comparative approach taken here. Whether or not Blastocystis spp. are capable of 
being the primary cause of a disease, they are still adapted to the intestinal 
environment and comparison with other organisms can help to understand how 
these adaptations evolved. Overall there is evidence to suggest that Blastocystis sp. 
STs have the ability to damage host tissues; but it remains to be conclusively shown 
whether Blastocystis sp. STs are a cause of disease, or an effect of more complex 
disorders with many causes and outcomes.  
 
4.1.3 Other Stramenopile genome sequences 
 
 The Stramenopiles are an extremely diverse group of organisms (Figure 
4.1.1). Ranging from photosynthetic lineages including single-celled diatoms and 
multicellular brown algae (kelp), to parasitic slime moulds and marine heterotrophs. 
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There is high variation in terms of morphology, genome structure and content, life-
strategy and reproduction within this group [353].  
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Figure 4.1.1 Stramenopile phylogeny showing the relationships between the 
genomes used in the comparative analysis. This is a representation phylogeny 
redrawn from Derelle et al. 2016 [353] and Beakes et al. 2012 [386]. Taxa in bold 
were used in the comparative analysis showing the spread of genomes selected 
from across the Stramenopiles and coloured taxa show corresponding genome 
statistics for each assembly.  
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The most highly studied group within the Stramenopiles are the Oomycetes, 
pathogens of plants and fish, which were investigated because of their significant 
economic impact on crop and fish farming. Over 80 species of Phytophthora have 
been named including Phytophthora infestans, which was responsible for the Irish 
potato famine in the mid- 19th century. Phytophthora sojae is a parasite of soybeans 
causing root and stem rot and costs the industry millions of (US) dollars each year 
[303]. P. sojae is hemibiotrophic and transitions through several stages during the 
course of an infection beginning with biotrophism but quickly becoming necrotrophic 
and obtaining nutrients from decaying plant tissue [303]. Tyler et al. 2006 [209] 
sequenced the 82 Mb genome of P. sojae. The genome was assembled into 82 
scaffolds and 862 contigs and contains 26,489 genes, which scored 91% 
completeness with BUSCO. Initial analysis of the genome revealed an expansion of 
protein families associated with plant infections such as hydrolases, ABC 
transporters, toxins, protease inhibitors and, in particular, a superfamily of 700 
proteins with similarity to known Oomycete virulence genes [209], [306]. 
 
  Related to Phytophthora but also within the Oomycetes is Pythium ultimum. 
Members of this genus mostly inhabit soil although some are able to survive in 
aquatic environments. They are classed either as saprobes or opportunistic plant 
pathogens and cause a wide array of diseases for a wide variety of hosts, including 
animals [387], [388], though some preference for monocot or dicot hosts has been 
observed in plants. P. ultimum is a ubiquitous plant pathogen and one of the more 
pathogenic species for crops. Its genome was sequenced by Lévesque et al. 2010 
[305] and assembled into 975 scaffolds with 1,747 contigs. The overall genome size 
is 42 Mb, almost half the size of P. sojae. However, the gene complement is 15,323, 
which accounts for 93% of the total genome according to BUSCO. The main 
difference between Pythium and Phytophthora is the process of zoospore 
production which differs because Pythium spp. produce them in vesicles whereas 
Phytophthora spp. produce them from sporangia [389].  
 
 The final Oomycete genome included in the analysis is Saprolegnia diclina, 
which is a more basal-branching member of the Class. This is an aquatic parasite of 
fish and amphibians which has received somewhat less attention than its land-
based counterparts [390], [391]. Despite this, it is an economically and ecologically 
significant parasite targeting eggs and causing severe damage to farmed, as well as 
wild, species. Only recently has the cause of the infections been attributed to 
several different species of Saprolegnia, S. diclina among them [390]. The 62 Mb 
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genome was sequenced in 2013 by the Broad Institute and deposited in the NCBI 
database [392]. The assembly contained 390 scaffolds and 3,878 contigs. There are 
17,448 genes annotated and these account for 95% of the genome as predicted by 
BUSCO.  
 
 A free-living out-group for the Blastocystis lineage is the phaeophyte alga 
Ectocarpus [353]. These are brown algae in the form of filamentous seaweed that 
are only very distantly related to green plants and are some of the only 
Stramenopiles to have evolved complex multicellularity. E. siliculosus is a model 
organism for brown algae and is closely related to the kelps. It is free-living and has 
a large 195 Mb genome made up of 1,561 scaffolds and 13,533 contigs. the 
genome contains 16,811 genes that includes a huge arsenal of signal transduction 
genes linked to its evolution of multicellularity [374]. The gene content has a 
BUSCO score of 94%.  
 
 Related to, but distinct from, the algae are the diatoms. These are 
unicellular, photosynthetic algae that have a defining morphological feature in the 
form of a silicified cell wall; a frustule, and unusual chloroplasts [342], [344], [393]. 
Like brown algae the photosynthetic characteristics of these organisms occurred 
independently of the acquisition of chloroplasts associated with green plants, though 
secondary endosymbiosis of a photosynthetic eukaryote. Thalassiosira pseudonana 
is diploid containing 24 chromosome pairs and contains all the metabolic capabilities 
to support a photoautotrophic organism. The genome is 32 Mb assembled into 64 
scaffolds, 115 contigs and codes for 11,673 genes, which is 88% complete by 
BUSCO. Up to half of the predicted proteins have no orthologs in the database and 
may reflect novel functions undertaken in this highly unusual organism [342].  
 
4.1.4 Aims of the chapter 
 
 In this chapter, I will utilise the P. lacertae genome (Chapter 2) and C. 
roenbergensis transcriptome (Chapter 3) in a comparative genomic analysis with 
Blastocystis in order to investigate the changes that occurred in the ancestor of 
Blastocystis that have facilitated the transition into the intestinal environment. There 
are four specific objectives: 
 
1. Cluster homologous genes between representatives from across the 
Stramenopiles 
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2. Identify conserved gene families between Blastocystis, P. lacertae and C. 
roenbergensis  
3. Identify gene gain and gene loss across the Blastocystis genomes using P. 
lacertae as an out-group 
4. Identify adaptations in the ancestor of Blastocystis that are associated with 
adaptation to the intestinal environment 
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4.2 Materials and methods 
 
4.2.1 Selection of appropriate diversity and quality of genome 
 
 At the time of writing the number of Stramenopile genomes in the NCBI 
database is 68. However, only 28 of these were associated with an annotation and 
were selected for further refinement. A mix of both parasitic and free-living 
Stramenopiles was required, to keep bias to a minimum, i.e. to prevent over-reliance 
on a particular subset of Stramenopiles.  
 
Decisions on inclusion were also made based on the assembly statistics for 
each available assembly, as the quality of the annotation is dependent on the quality 
of the assembled contigs (Figure 4.1.1). Assemblies with comparatively low scaffold 
and contig counts and high N50 values were used preferentially. High sequence 
coverage and BUSCO scores for completeness were also preferred.  
 
The clustering analysis was run using all three published and annotated 
genome sequences for Blastocystis sp. (ST1, ST4 and ST7), as well as the P. 
lacertae genome and the C. roenbergensis transcriptome, three parasitic oomycetes 
genome sequences (Phytophthora sojae, Pythium ultimum and Saprolegnia diclina), 
the free-living Thalassiosira pseudonana from the Bacillariophyta, and Ectocarpus 
siliculosus from PX clade. Together these sample all parts of Stramenopile diversity 
for which genome sequences are available. 
 
4.2.2 The genomes used in the analysis 
 
 The genomes of Blastocystis sp. ST1 ATCC 50177/Nand II [376], 
Blastocystis sp. ST4 WR1 [284], Blastocystis sp. ST7 Singapore isolate B [91], 
Pythium ultimum DAOM BR144 [305], Phytophthora sojae strain: P6497 [209], 
Saprolegnia diclina VS20 [392], Ectocarpus siliculosus strain Ec32 [374] and 
Thalassiosira pseudonana CCMP1335 [342] were downloaded for the comparative 
analysis and Bigelowiella natans CCMP2755, Bodo saltans BSAL, Chromera velia 
CCMP2878, Guillardia theta CCMP2712, Saccharomyces cerevisiae S288c and 
Tetrahymena thermophila SB210 were downloaded for the phylodiversity analysis. 
All genomes were downloaded from NCBI. 
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4.2.3 Clustering of orthologous genes 
 
OrthoMCL v2.0.9 [394] and OrthoFinder v0.2.8 [395] were used with default 
parameters to generate clusters of homologous genes either between species 
(orthologs) or within species (paralogs). OrthoMCL used an E-value threshold of 1e-
5 for step 7: all-v-all BLAST. MySQL was used as the relational database. 
Sequences that OrthoMCL failed to cluster were assumed to be single-copy 
species-specific and were therefore grouped with each species unique repertoire. 
 
 A cluster was considered ‘conserved’ if they contained at least one 
sequence from P. lacertae, C. roenbergensis and one Blastocystis subtype; these 
groups may also contain sequences from another Stramenopile genome. A cluster 
was ‘species-specific’ if it only contained sequences from a single organism, (except 
Blastocystis where it must be present in at least one subtype but may contain 
representative sequences from multiple subtypes).  
 
 Clusters were considered to represent losses from the Blastocystis genomes 
if they were absent from all Blastocystis genomes, but present in both P. lacertae 
and C. roenbergensis and at least one other Stramenopile. Similarly, clusters that 
represent losses from P. lacertae and C. roenbergensis contain sequences from 
only C. roenbergensis or P. lacertae respectively, at least one Blastocystis and 
another Stramenopile.  
 
 Otherwise conserved clusters contained sequences from either Blastocystis, 
P. lacertae or C. roenbergensis and at least one other Stramenopile. Clusters 
containing sequences from only Blastocystis and P. lacertae, Blastocystis and C. 
roenbergensis or P. lacertae and C. roenbergensis were classed as being gained in 
the common ancestor of those organisms. All other clusters were those containing 
sequences from multiple Stramenopile genomes but none from Blastocystis, P. 
lacertae and C. roenbergensis. Such clusters are not relevant to this analysis. 
 
4.2.4 Phylogenetic analyses 
  
 ClustalW [396] and MUSCLE [327] were used to align sequences with 
default parameters. Each alignment was also curated either manually or using 
Gblocks [328] which preserves only conserved blocks of residues. PhyML [245] 
generated maximum likelihood phylograms using automatic model selection and 
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providing bootstrap support. Ninja v1.2.2 [397] was used to build neighbour joining 
trees. Mr Bayes [398] was used to build Bayesian trees and to calculate posterior 
probability values. Default parameters were used unless otherwise stated. 
 
4.2.5 Enrichment analyses 
 
 Domain annotations were assigned to each genome using InterProScan 
[317] and KEGG annotations by Ghost koala [324] was used to assign KO terms. 
Enrichment analyses were performed in R [366] using a hypergeometric test. This 
calculates the probability of a domain being in a particular group based on the 
occurrences of that domain in the whole genome. For example, it calculates the 
probability of drawing a while ball from a box containing white and black balls where 
the number of balls and their colours are known.  
 
4.2.6 Phylodiversity 
 
 In order to determine if the Blastocystis sp. STs genomes were reduced in 
very highly conserved gene families, a reference panel of genomes from across the 
Eukaryota were selected and gene families conserved in all of them were extracted. 
These gene families were used to build baseline Neighbour-joining phylogenies and 
phylodiversity was calculated according to Faith 1992 [399] was calculated for each 
phylogeny (containing a conserved gene family) using the Picante package in R 
[400]. Phylodiversity was developed as an ecological measure of the species 
richness within a particular habitat. A higher score is awarded the less related a 
group of organisms is. I have used phylodiversity as a way of calculating the 
richness of gene families. This allows the value to be weighted to lower the 
contribution of genes that that are paralogous and increase the contribution of 
genes that represent different lineages. Orthologous sequences from Blastocystis 
sp. STs and P. lacertae were added to each phylogeny in turn to determine the 
contribution of these genomes to the increase in phylodiversity. The value for each 
Blastocystis sp. ST was subtracted from the P. lacertae value to get a comparison of 
which genome increased the phylodiversity of each gene family more.  
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4.3 Results 
 
4.3.1 OrthoMCL clustering results 
 
The clustering analysis using OrthoMCL assigned 113,129 genes from 10 
genomes and transcriptomes into 21,700 orthologous groups, with an additional 
39,631 sequences excluded from the analysis. The results are summarised in 
Figure 4.3.1. For the full table of results see S4.3.1. 
 
 It is assumed that the ‘unclustered’ sequences were excluded from the 
analysis because they have no orthologues or paralogues in any of the genomes 
included. Therefore, they have been labelled single copy species-specific 
sequences. OrthoMCL assigned 6,782 sequences from the P. lacertae genome, 
9,273 from the C. roenbergensis transcriptome and 1,084, 894 and 1,039 from 
Blastocystis sp. ST1, ST4 and ST7 respectively to the unclustered group (Figure 
4.3.1). 
 
The ‘conserved’ sequences that feature in the non-overlapping sections of 
Figure 4.3.1 denote sequences from orthogroups that contain a representative 
sequence from one of the P. lacertae, C. roenbergensis or Blastocystis sp. 
genomes, and another Stramenopile. For example, orthogroup MCL1012 contains 
187 sequences; 51 from P. lacertae, 66 from P. sojae, 42 from P. ultimum, 23 from 
S. diclina, 4 from E. siliculosus and 1 from T. pseudonana but none from any 
Blastocystis sp. STs or C. roenbergensis. Thus, these sequences are conserved 
throughout the Stramenopiles but do not overlap with the closest relatives of P. 
lacertae (Figure 4.3.1).  
 
OrthoMCL also assigned a number of multi-copy species-specific groups 
containing 13,642 sequences for P. lacertae, 6,291 for C. roenbergensis and 1,899, 
1,647 and 1,549 for Blastocystis sp. ST1, ST4 and ST7 respectively. These are 
species-specific and are labelled ‘specific’ in Figure 4.3.1 to differentiate them from 
‘conserved ’orthogroups (above). P. lacertae had the largest repertoire of species-
specific genes of any genome included in the analysis. The largest of these 
contained over 800 proteins, though by definition they are specific to P. lacertae and 
therefore many share little homology to sequences in the database.  
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There is a core group of 892 conserved orthogroups that are found in at 
least one Blastocystis genome, the C. roenbergensis transcriptome and the P. 
lacertae genome. They may also be present in one or more of the other 
Stramenopile genomes. 527 of these contain representatives from all the genomes 
included in the analysis, the largest of which (MCL1021) contains 131 sequences 
overall, 8 of which are from P. lacertae, 3 are from C. roenbergensis, 8 from 
Blastocystis sp. ST1, 5 from Blastocystis sp. ST7 and 2 are from Blastocystis sp. 
ST4. 134 of these orthogroups represent single-copy orthogroups, containing only a 
single sequence from each genome.  
 
 
Figure 4.3.1 Venn diagram showing numbers of shared orthologs between 
Blastocystis sp. ST7, P. lacertae and C. roenbergensis. Sequences clustered by 
OrthoMCL. ‘Specific’ refers to sequences from groups containing only one species, 
‘conserved’ sequences are those with no orthologs in the other genomes shown 
here but which do have orthologs in other genomes included in the analysis and 
‘unclustered’ sequences are assumed to represent single-copy species-specific 
proteins. 
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Blastocystis sp. ST7 appears to share fewer genes with C. roenbergensis 
than P. lacertae does. This is an interesting result as the phylogeny (Figure 2.3.6) 
shows that P. lacertae and Blastocystis are equidistant from C. roenbergensis and it 
may therefore be expected they would share roughly equal number of genes. This 
also shows that, while the Blastocystis genomes are much smaller than the P. 
lacertae genome, the majority of this size difference is accounted for by the large 
species-specific repertoire of P. lacertae. 
 
Interestingly, there were also substantial differences between the subtypes 
of Blastocystis, not just in terms of copy number within orthogroups but also in 
representation between orthogroups. The differences between the Blastocystis sp. 
STs species-specific repertoires is summarised in Figure 4.3.2. Only ~1000 
Blastocystis-specific genes are shared between all subtypes and each genome 
appears to have its own repertoire of subtype-specific genes greater than the 
number of genes shared between all three.  
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Figure 4.3.2 Venn diagram showing differences in orthologs between 
Blastocystis-specific sequences. Sequences clustered by OrthoMCL and 
represent the number sequences from each subtype in Blastocystis-specific 
orthologous groups. 
 
As the Blastocystis sp. STs have smaller genomes than other 
Stramenopiles, the origin of those differences was investigated. The largest 
differences came from species-specific orthogroups in P. lacertae, however, 
examination of conserved orthogroups showed differences in the number of 
sequences contributed to conserved groups by Blastocystis sp. STs. To understand 
these differences, the orthogroups were further broken down into conserved groups 
with differing conservation profiles (Figure 4.3.3).  
 
‘Lineage specific’ orthogroups were defined as any orthogroup that 
contained representatives from both P. lacertae and Blastocystis sp. STs only, such 
as MCL2961 which contains a single sequence from both Blastocystis sp. ST4 and 
ST7 as well as 8 sequences from P. lacertae. Only a single Blastocystis subtype 
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need be represented. In C. roenbergensis this was defined by including an 
orthogroup with a C. roenbergensis sequence and at least one other Stramenopile, 
but absent in P. lacertae and Blastocystis. ‘Core Stramenopile’ orthogroups must 
contain at least one sequence from each genome such as MCL1021 (above). ‘Lost 
from Stramenopiles’ are orthogroups which contain sequences from any two 
genomes of P. lacertae, Blastocystis sp. STs or C. roenbergensis but do not contain 
a sequence from another Stramenopile such as MCL5023 which contains a single 
sequence from C. roenbergensis, P. lacertae and Blastocystis sp. ST4 and two 
sequences each from Blastocystis sp. ST1 and ST7. 
 
The final group, ‘lost from sister species’ are examples of orthogroups with 
representative sequences from C. roenbergensis or another Stramenopile and 
either P. lacertae or Blastocystis sp. but not both. While, P. lacertae contains more 
orthologues than all Blastocystis sp. STs in each of these conserved orthogroups, 
the difference is most striking in the ‘lost from sister species’ group (Figure 4.3.3). 
This group is indicative of cases where it is expected that there would be roughly 
equal numbers orthologues between P. lacertae and Blastocystis sp. but all 
Blastocystis subtypes included here appear to have fewer. 
 
Conserved orthogroups were examined and found to routinely contain fewer 
representative sequences from Blastocystis. These are sequences that are 
otherwise conserved in the Stramenopiles but are present in lower copy number in 
all Blastocystis subtypes despite the differences between them. 
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Figure 4.3.3 Number of sequences contained in different cluster categories assigned by OrthoMCL for multiple Stramenopile 
genomes. Clusters have been defined as ‘lineage specific’ (only found in a given species), ‘core Stramenopile’ (found in all Stramenopile 
genomes), ‘lost from sister species’ (present in 2/3 species shown here), and ‘lost from Stramenopile’ (present in all three species shown here 
but absent in other Stramenopiles). 
1
0
0
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From figure 4.3.3 it is clear that the number of conserved sequences in P. 
lacertae is consistently higher than any Blastocystis genome, while the number of 
conserved sequences lost from Blastocystis is substantially smaller than the 
corresponding number in P. lacertae. This suggests that the Blastocystis sp. STs 
genomes are missing sequences from highly conserved gene families, common 
across the large phylogenetic distances within the Stramenopiles. Comparison with 
P. lacertae demonstrates that the absence of these widely conserved genes is 
unique to Blastocystis and must have occurred after the separation of Blastocystis 
and Proteromonas from their common ancestor. 
 
4.3.2 OrthoFinder clustering results 
 
 The clustering analysis using OrthoFinder assigned 152,760 genes from the 
10 genomes and transcriptomes to 69,052 orthologous groups. With an additional 
6,200 sequences excluded from the analysis. OrthoFinder failed to include 1,070 
sequences from the P. lacertae genome, 0 from the C. roenbergensis transcriptome 
and 876, 745 and 696 from Blastocystis sp. ST1, ST4 and ST7 respectively. It also 
assigned a number of multi-copy species-specific groups containing 15,964 
sequences for P. lacertae, 14,128 for C. roenbergensis and 1,703, 1,249 and 1,551 
for Blastocystis sp. ST1, ST4 and ST7 respectively. P. lacertae had the largest 
repertoire of species-specific genes of any genome included in the analysis (Figure 
4.3.4), though this number differed from that produced in the OrthoMCL analysis 
and is closely followed by the C. roenbergensis-specific sequences, which is a 
marked difference between OrthoMCL and OrthoFinder. For full table of results see 
S4.3.2. 
 
 Overall, OrthoFinder assigned more sequences from each genome to 
‘conserved’ orthogroups (present in P. lacertae, C. roenbergensis, at least one 
Blastocystis genome and at least one other Stramenopile) and to specific 
orthogroups (present in only one genus), except for Blastocystis sp. ST1 and ST4.  
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Figure 4.3.4 Venn diagram showing differences in orthologs between 
Blastocystis-specific sequences. Sequences clustered by OrthoFinder. ‘Specific’ 
refers to sequences from groups containing only one species, ‘conserved’ 
sequences are those with no orthologs in the other genomes shown here but which 
do have orthologs in other genomes included in the analysis and ‘unclustered’ 
sequences are assumed to represent single-copy species-specific proteins. 
 
 While the individual numbers of genes in the relationships between these 
three genomes are slightly different between OrthoMCL and OrthoFinder, the overall 
outcomes of the analyses are comparable: Blastocystis sp. ST7 still shares fewer 
genes with C. roenbergensis than P. lacertae and the Blastocystis genomes are still 
noticeably smaller when compared with the P. lacertae genome, although 
OrthoFinder has predicted a similarly sized species-specific repertoire in C. 
roenbergensis that’s absent from the OrthoMCL output. It also appears as though P. 
lacertae is overrepresented in all shared groups, again consistent with the results 
from OrthoMCL.  
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 The output from OrthoFinder also corroborates the findings that Blastocystis 
sp. STs contain fewer genes in conserved orthogroups (Figure 4.3.5). Although 
OrthoFinder has assigned fewer genes to the ‘lineage specific’ group, the greatest 
disparity between Blastocystis sp. and P. lacertae remains the ‘lost from sister 
species’ group. 
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Figure 4.3.5 Number of sequences contained in different cluster categories assigned by OrthoFinder for multiple Stramenopile 
genomes. Clusters have been defined as ‘lineage specific’ (only found in a given species), ‘core Stramenopile’ (found in all Stramenopile 
genomes), ‘lost from sister species’ (present in 2/3 species shown here), and ‘lost from Stramenopile’ (present in all three species shown here 
but absent in other Stramenopiles). 
1
0
4
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 While the outputs of OrthoMCL and OrthoFinder differ in the number of 
sequences assigned to orthogroups, the majority of the findings are consistent 
between the clustering programmes. P. lacertae contains a high proportion of 
species-specific genes, which may or may not be a similar proportion to C. 
roenbergensis. Despite this, all Blastocystis subtypes are routinely 
underrepresented in conserved gene clusters, especially with respect to sequences 
that appear to be absent with respect to P. lacertae.  
 
4.3.3 Blastocystis gains are enriched for diverse domains 
 
 To examine the functional relevance of Blastocystis-specific genes identified 
in the clustering analysis, these sequences were subjected to a domain enrichment 
analysis (Table 4.3.1, S4.3.3, S4.3.4) in R. OrthoMCL and OrthoFinder gave 
different results in the clustering analysis with respect to the overall numbers of 
genes gained and lost. OrthoMCL found 156 domains to be significantly enriched in 
Blastocystis sp. STs, whereas OrthoFinder found only 35 significantly enriched 
domains (where p < 0.001).  
 
While individual domains differ between the enrichment analyses for the 
OrthoMCL and OrthoFinder clusters, and therefore their associated protein 
sequence, there is some crossover between the enrichment results. For example, 
both enrichment analyses include Ankyrin or ANK repeat domains (p = 1.30e-21 
OrthoMCL, p = 6.97e-3 OrthoFinder), globular domains like Putative Ig domain or 
Von Willebrand factor type A domain signature (p = 4.52e-74 OrthoMCL, p = 5.88e-3 
OrthoFinder) as well as membrane associated domains: Major Facilitator 
Superfamily (p = 1.02e-4 OrthoMCL) and src homology 3 domains (p = 2.41e-4 
OrthoFinder). These suggest that while a specific sequence may have been placed 
differently, based on differing thresholds for homology, some of the same types of 
protein may characterise Blastocystis gains according to both programmes. 
 
 The enrichment from both OrthoMCL and OrthoFinder show that Blastocystis 
sp. STs have acquired novel genes associated with a range of cellular functions but 
that a majority of these can be linked to factors required for survival in a host 
environment. Among these are peptidases from the C13 family (IPR001096) (p = 
1.75e-5 OrthoMCL, p = 1.04e-3 OrthoFinder) (not included in the top 10 for 
OrthoMCL but still significant, S4.3.3). There are 17 sequences annotated with this 
domain in Blastocystis sp. ST1, 10 in Blastocystis sp. ST4 and 12 in Blastocystis sp. 
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ST7. Of the total 39 Blastocystis sequences, 17 (OrthoMCL) or 13 (OrthoFinder) are 
Blastocystis-specific. By comparison, the P. lacertae genome contains 21 
sequences annotated with this domain and none in the C. roenbergensis 
transcriptome. Peptidases are known factors that enable persistence within a host 
and so expansion of these in Blastocystis may indicate biological significance.  
 
Globular domains such as putative Ig domains (IPR008009) (p = 4.52e-74 
OrthoMCL) and Von Willebrand domain signatures (IPR002035) (p = 5.88e-3 
OrthoFinder) may also be important for cellular adhesion in vivo. Blastocystis sp. 
ST1, ST4 and ST7 contained 64, 158 and 59 putative Ig domain-containing proteins 
respectively in the OrthoMCL analysis. Of the 181 total putative Ig domain-
containing proteins, 140 were specific to Blastocystis sp. STs. In contract to this, P. 
lacertae contains 136 sequences with this annotation compared to C. 
roenbergensis, which does not contain any. Blastocystis sp. ST1, ST4 and ST7 also 
contained two, five and two Von Willebrand domain-containing proteins respectively 
in the OrthoFinder analysis. Of the nine sequences four are specific to Blastocystis 
sp. STs however, P. lacertae does not contain any while C. roenbergensis contains 
18 sequences with this annotation.  
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Table 4.3.1 Top 10 domains significantly enriched in Blastocystis spp. gains for OrthoMCL and OrthoFinder
Domain Names InterPro domain Gains P-value Domain Names InterPro domain Gains P-value
Putative Ig domain IPR008009 140 4.52E-74
Ankyrin repeat-containing 
domain
IPR020683 16 6.97E-03
Hsp70 protein IPR018181 73 5.32E-11 Peptidase C13 family IPR001096 13 1.04E-03
Serine/threonine 
phosphatase family signature
IPR006186 57 1.67E-39 EF-hand domain IPR002048 9 1.47E-03
Transforming protein P21 ras 
signature
PR00449 53 2.12E-22
Protein disulfide isomerase 
family
cd02961 8 5.85E-03
ankyrin repeats IPR002110 40 1.30E-21 Src homology 3 domain cd00174 5 2.41E-04
Major Facilitator Superfamily IPR011701 31 1.02E-04 Glycosyltransferase Family 4 IPR028098 4 9.86E-03
zinc finger IPR013085 29 6.06E-15
Aplha-amylase catalytic 
domain family
cd00551 3 <1.00E-100
Thioredoxin IPR001853 29 1.11E-04
Von Willebrand factor type A 
domain signature
PR00453 3 5.88E-03
DnaJ domain signature IPR001623 28 1.28E-07 Hemerythrin cd12107 2 <1.00E-100
Tetratricopeptide repeats IPR019734 27 1.53E-07 Leucine rich repeat IPR001611 2 <1.00E-100
OrthoMCL OrthoFinder
1
0
7
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4.3.4 Putative Ig domains 
 
 Putative Ig domains were the most highly enriched result from OrthoMCL as 
well as being potentially linked to activity at the cell surface the repertoire of putative 
Ig domains was investigated (PF05345). The sequences were extracted from the 
InterProScan output, aligned with ClustalW and used to build a phylogeny with 
PhyML (Figure 4.3.6). As there are no representative species from C. roenbergensis 
it is difficult to infer lineages, however, the phylogeny does show expansion of 
Blastocystis sequences in each subtype, especially in Blastocystis sp. ST4. These 
may therefore be required for subtype-specific activities, and may play a role in 
determining host range 
 
 
Figure 4.3.6 Maximum likelihood phylogeny of Ig domains-containing proteins 
built using WAG+G+F model and rooted at the midpoint. Bold lines indicate 
bootstrap support >75. Dark green branches are P. lacertae, red branches are 
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Blastocystis sp. ST1, light green are Blastocystis sp. ST7, light blue are Blastocystis 
sp. ST4 and dark blue are C. roenbergensis. 
 
 The tree appears to show P. lacertae-specific expansions as well as 
Blastocystis-specific ones. While this is difficult to determine in the absence of an 
outgroup, this tree may show the sensitivity of the enrichment analysis, in that it is 
able to detect 140 Blastocystis-specific putative Ig domain-containing proteins in the 
presence of P. lacertae-specific proteins. 
 
4.3.5 Peptidase C13 
 
To further investigate the results of the clustering analysis, all sequences 
from Blastocystis sp. STs, P. lacertae and C. roenbergensis containing a peptidase 
C13 family domain (PF01650) were extracted, aligned and used to build a 
phylogeny as above (Figure 4.3.7). This domain was selected because of its 
potential role in persistence within a host and virulence. Again, there were no 
sequences within the C. roenbergensis transcriptome annotated with this domain. 
The phylogeny shows again that there are species-specific expansions in both 
Blastocystis and in P. lacertae.  
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Figure 4.3.7 Maximum likelihood phylogeny of C13 family peptidase domains-
containing proteins built using WAG+G+F model and rooted at the midpoint. 
Bold lines indicate bootstrap support > 75. P. lacertae sequences are shown in dark 
green, Blastocystis sp. ST1 is shown in red, Blastocystis sp. ST4 show in light blue 
and Blastocystis sp. ST7 is shown in light green. There is clear separation of P. 
lacertae sequences from Blastocystis indicating independent expansion of this 
family in both Proteromonas and Blastocystis.  
 
The sequences included in this phylogeny show orthology between the 
Blastocystis subtypes and P. lacertae. Again, the lack of orthologues in C. 
roenbergensis makes the results of this difficult to interpret. In order to investigate 
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this, the orthogroups, produced by OrthoFinder, containing these sequences were 
examined. The 58 sequences correspond to nine orthogroups of which only six 
correspond to true Blastocystis gains. Orthogroup FDR02266 contains six 
sequences from Blastocystis sp. ST1, three from ST4 and one from ST7. FDR03217 
contains five sequences form ST1, one from ST4 and two from ST7. FDR07097, 
FDR07101 and FDR07142 contain a single sequence from each Blastocystis 
subtype and FDR09058 contains a single sequence from ST1 and ST4 only. The 
clustering analysis, then, identified 29 Blastocystis-specific C13 peptidase domain-
containing sequences of the 39 in all three genomes, however, the enrichment 
analysis identified only 13 of these as being significant.  
 
These results have shown that while Blastocystis sp. STs contains 
expansions of these genes, they have also expanded independently in P. lacertae 
and are therefore not unique to Blastocystis.  
 
4.3.6 Blastocystis losses are enriched for general functions 
 
 In order to interpret the functional significance of Blastocystis losses, 
conserved P. lacertae genes absent from Blastocystis were examined in a domain 
enrichment analysis. To qualify as a Blastocystis loss, a group must contain no 
representative sequences from any Blastocystis genome, at least one sequence 
from P. lacertae or C. roenbergensis and at least one sequence from another 
Stramenopile, to ensure that Proteromonas- and Cafeteria-specific sequences were 
not misinterpreted. 
 
The analysis identified 260 domains that were significantly enriched among 
Blastocystis losses according to OrthoMCL, and 310 from the output of OrthoFinder. 
These domains were associated with diverse functions (Table 4.3.2, S4.3.5, S4.3.6). 
The most striking results were those for the EGF domains (IPR000742) (p = 8.53e-
12). However, closer examination of the orthogroups revealed that this result is most 
likely due to high copy number in the P. lacertae genome. HMMs were built and 
used to search the other Stramenopile genomes for homologues to the EGF 
domain-containing proteins. These scores were then used to build a network. 
Inclusion of all these scores resulted in a single cluster in which no detail could be 
discerned. By only taking the top 30% of HMM scores (138 - 9,650) meaningful 
clusters were defined that allowed for analysis of the data (Figure 4.3.8). This 
analysis showed not only that Blastocystis sp. STs contained homologues, but also 
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that P. lacertae contained a large species-specific expansion. This may be the 
cause for the appearance of this domain in the enrichment analysis. Significance (p-
value) is based on the difference in copy number between the P. lacertae genes in 
the whole genome and the P. lacertae genes that form a cluster from which 
Blastocystis is absent. If the total number of genes annotated with a particular 
domain is high in the P. lacertae genome, in this case due to a species-specific 
expansion, then this may have the effect of skewing the p-value, resulting in inflated 
significance of the enrichment.  
 
The only domains to feature in both analyses were the EF hand calcium-
binding domain (IPR002048) (p = 4.35e-5 OrthoMCL, p = 2.20e-4 OrthoFinder), 
Trp/Asp WD repeats (IPR001680) (p = 1.17e-4, OrthoMCL, p = 5.22e-5 OrthoFinder) 
and Major Facilitator Superfamily MFS domain (IPR011701) (p = 1.47e-7 OrthoMCL, 
p = 1.10e-12 OrthoFinder).  
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Table 4.3.2 Top 10 domains significantly enriched in Blastocystis spp. losses for OrthoMCL and OrthoFinder
Domain Names InterPro domain Losses P-value Domain Names InterPro domain Losses P-value
EGF-like domain signature 
1
IPR013032 43 8.53E-12 Ion transport protein IPR005821 30 1.10E-26
Trp/Asp WD repeats profile IPR001680 23 1.17E-04
EF-hand calcium-binding 
domain profile
IPR002048 30 2.20E-04
EF-hand calcium-binding 
domain profile
IPR002048 19 4.35E-05
Trp/Asp WD repeats circular 
profile
IPR001680 27 5.22E-05
Ion transport protein IPR005821 11 1.99E-09
Fibronectin type-III domain 
profile
IPR003961 26 1.99E-03
Major Facilitator 
Superfamily
IPR011701 10 1.47E-07 Acyltransferase family IPR004299 21 4.61E-31
Kinesin motor domain 
profile
IPR001752 8 7.52E-04
Major Facilitator 
Superfamily
IPR011701 20 1.10E-12
Caenorhabditis protein of 
unknown function DUF268
IPR004951 7 <1.00E-100 TTL domain profile IPR004344 19 2.43E-24
GTP cyclohydrolase II IPR032677 7 <1.00E-100
Tubulin/tyrosine ligase 
family
IPR004344 19 4.85E-23
Voltage-dependent L-type 
calcium channel IQ-
associated
IPR031649 7 <1.00E-100 IQ motif profile IPR000048 19 2.76E-03
TTL domain profile IPR004344 7 1.12E-08
Zinc finger RING-type 
profile
IPR001841 16 5.03E-05
OrthoMCL OrthoFinder
1
1
3
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Figure 4.3.8 Network of EGF domains based on HMMER similarity scores. P. 
lacertae sequences are shown in red, Blastocystis sp. STs sequences are shown in 
dark blue, C. roenbergensis sequences are shown in light blue and Schizochytrium 
sequences are shown in yellow. Grey points represent other Stramenopile 
sequences. This network was built using the top 30% of HMM scores allowing for 
definition between clusters. While Blastocystis sp. STs have three conserved 
homologues, there are at least two separate P. lacertae-specific expansions. 
 
Interestingly, MFS domain-containing proteins were also enriched among 
Blastocystis gains after OrthoMCL clustering (IPR011701). For Blastocystis gains, 
MFS domains were annotated on 99 sequences, of which 31 were specific to 
Blastocystis (p = 1.02e-4). In contrast, in the Blastocystis losses for OrthoMCL, there 
are 72 MFS annotated sequences in the P. lacertae genome, of which 10 do not 
have an orthologue in Blastocystis. MFS transporters are a very diverse family of 
proteins and thus there may be gains and losses within different families labelled 
with the broad domain annotation of MFS. However, the OrthoFinder output shows 
enrichment of MFS domains of the same annotation as in the OrthoMCL 
Blastocystis gains (IPR011701) (p = 1.10e-12). This shows 72 sequences with this 
annotation in the P. lacertae genome of which 20 lack an ortholog in Blastocystis. In 
order to test loss and gain within this family, the sequences were extracted from the 
InterProScan output, aligned with ClustalW and used to build a phylogeny (Figure 
4.3.9).  
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Figure 4.3.9 Maximum likelihood phylogeny of MFS domain-containing 
sequences built using VT+G+F model and rooted at the midpoint. P. lacertae is 
shown in green, Blastocystis sp. ST1 is shown in red, Blastocystis sp. ST4 is shown 
in light blue, Blastocystis sp. ST7 is shown in light green and C. roenbergensis 
sequences are shown in dark blue.  
 
From the phylogeny, it is clear that there has been some species-specific 
expansion in both P. lacertae and Blastocystis sp. STs however; it is not obvious 
where the Blastocystis loss has occurred. The MFS enrichment in the Blastocystis 
losses may be the result of P. lacertae-specific expansions.  
 
Overall, inferred Blastocystis sp. STs losses are highly diverse, but they are 
dependent on the genome content of P. lacertae and that P. lacertae-specific 
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expansions can suggest gene loss in Blastocystis where phylogenetic analysis 
demonstrates that it has not occurred.  
 
4.3.7 P. lacertae gains and losses reflect wide scale genomic changes 
 
 In order to compare the Blastocystis gains and losses, enrichment analyses 
were also carried out on the P. lacertae genome. Enrichment of the OrthoMCL data 
contained 180 significantly enriched domains gained and 103 lost while the 
OrthoFinder data contained 263 significantly enriched domains gained and 222 lost. 
Losses were defined as any orthogroups with representatives from C. 
roenbergensis and at least one Blastocystis sp. STs as well as another 
Stramenopile. Gains were defined as any orthogroup containing only P. lacertae 
sequences.  
 
The top 10 P. lacertae gains are shown in Table 4.3.3 (S4.3.7, S4.3.8, 
S4.3.9, S4.3.10) are broadly similar between OrthoMCL and OrthoFinder. Both 
show enrichment for similar domains such as BTB/POZ domains (IPR000210) (p = 
7.84e-4 OrthoMCL, p = 1.34e-11 OrthoFinder), Ulp1 protease (IPR003653) (p = 1.11e-
6 OrthoMCL, p = 8.19e-14 OrthoFinder) and Glycosyltransferase family 92 
(IPR008166) (p = 4.62e-4 OrthoMCL, 5.39e-5 OrthoFinder). These domains are 
associated with a range of functions including genome regulation, and cell surface-
associated activity.  
 
 The top 10 P. lacertae losses are shown in Table 4.3.4 and again show 
consistency in the results between OrthoMCL and OrthoFinder. Both outputs show 
significant enrichment of ribosomal proteins (IPR001976) (p = 9.67e-4 OrthoMCL, p 
< 1.00e-100 OrthoFinder) and dynamin domains (IPR000375) (p < 1.00e-100 
OrthoMCL, p < 1.00e-100 OrthoFinder) among a large array of other functions spread 
across cellular physiology.  
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Table 4.3.3 Top 10 domains significantly enriched in P. lacertae gains in OrthoMCL and OrthoFinder
Domain Names InterPro domain Gains P-value Domain Names InterPro domain Gains P-value
7 transmembrane sweet-
taste receptor of 3 GCPR
IPR017978 109 4.20E-12
Periplasmic binding protein 
domain
PF13433 322 3.78E-03
BTB/POZ domain IPR003131 87 7.84E-04 BTB/POZ domain IPR003131 87 1.34E-11
Integrase catalytic domain 
profile
IPR001584 73 <1.00E-100
Integrase catalytic domain 
profile
IPR001584 73 <1.00E-100
Ulp1 protease family C-
terminal catalytic domain
IPR003653 63 1.11E-06 Sperm-tail PG-rich repeat IPR010736 66 4.28E-03
Glycosyltransferase family 
92
IPR008166 33 4.62E-04
Ulp1 protease family C-
terminal catalytic domain
IPR003653 63 8.19E-14
Rhodopsin-like GPCR 
transmembrane domain
IPR019336 19 2.89E-03
Glycosyltransferase family 
92
IPR008166 30 5.39E-05
Mitochondrial 28S ribosomal 
protein S22
IPR019374 12 <1.00E-100 ATP P2X receptor IPR001429 19 <1.00E-100
Opioid growth factor 
receptor OGFr conserved 
region
IPR006757 10 <1.00E-100
Zinc finger SWIM-type 
profile
IPR007527 17 3.39E-04
Domain of unknown function 
DUF303
IPR005181 9 <1.00E-100
Protein of unknown function 
DUF229
IPR004245 14 2.10E-04
Heat shock hsp20 proteins 
family profile
IPR002068 9 <1.00E-100
Domain in receptor 
targeting proteins Lin-2 and 
Lin-7
IPR004172 13 <1.00E-100
OrthoMCL OrthoFinder
1
1
7
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Table 4.3.4 Top 10 domains significantly enriched in P. lacertae losses for OrthoMCL and OrthoFinder
Domain Names
InterPro 
domain Losses P-value Domain Names
InterPro 
domain Losses P-value
Alpha-crystallin domain cd06464 6 1.64E-03 Ribosomal protein S24e IPR001976 11 <1.00E-100
Ribosomal protein L34e IPR008195 4 9.67E-04 Homeobox KN domain IPR008422 9 3.37E-16
La-type HTH domain profile IPR006630 4 4.52E-03 Dynamin central region IPR000375 8 <1.00E-100
Dynamin-like protein family cd08771 3 <1.00E-100 Lipase class 3 IPR002921 8 5.74E-11
Phosphatases of the 
metallophosphatase 
superfamily
cd00144 3 4.16E-04
Calponin homology CH 
domain
IPR001715 8 9.48E-09
ADP ribosylation factor 1 cd04151 2 <1.00E-100 short chain dehydrogenase IPR002347 8 6.09E-07
Cyclophilin-PPIL3-like cd01928 2 <1.00E-100
Aminopeptidase I zinc 
metalloprotease M18 
signature
IPR001948 7 1.11E-06
Diaphanous GTPase-binding 
Domain
IPR010473 2 <1.00E-100 DEAD/DEAH box helicase IPR011545 6 1.41E-04
Aromatic amino acid lyase IPR001106 2 <1.00E-100
Isoprenylcysteine carboxyl 
methyltransferase ICMT 
family
IPR007269 5 <1.00E-100
Dimerisation domain of Zinc 
Transporter
IPR027470 2 2.91E-03
Protein-S-isoprenylcysteine 
O-methyltransferase
IPR025770 5 <1.00E-100
OrthoMCL OrthoFinder
1
1
8
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 These enrichment analyses show that the P. lacertae genome has gained 
and lost sequences from across a large array of functions compared to Blastocystis 
sp. STs. There is no obvious loss of specific function in Blastocystis sp. STs, rather 
the differences are varied so that the significant results belong to the most generic 
terms within the genome.  
 
4.3.8 Metabolic comparison reveals loss of gene complexity in Blastocystis genome 
 
 The enrichment analysis of Blastocystis losses showed a number of 
metabolism-associated domains such as 3,4-dihydroxy-2-butanone 4-phosphate 
synthase (IPR000422, EC:4.1.99.12) (p < 1.00e-100 OrthoMCL and OrthoFinder), 
semialdehyde dehydrogenase (IPR012280) (p < 1.00e-100 OrthoMCL, p = 1.78-3 
OrthoFinder) and UTP-glucose-1-phosphate uridylyltransferase (IPR016267, 
EC:2.7.7.9) (p = 7.12e-6 OrthoMCL, p = 2.00e-5 OrthoFinder). In order to investigate 
the extent of the metabolic differences between P. lacertae and the Blastocystis sp. 
STs all four genomes and C. roenbergensis were annotated with KEGG terms and 
mapped to KEGG pathways and compared (Figure 4.3.10, S4.3.11).  
 
The Blastocystis sp. ST1 genome mapped 4,143 genes to 335 pathways, 
Blastocystis sp. ST4 mapped 3,741 genes to 309 pathways, and Blastocystis sp. 
ST7 mapped 3,746 genes to 316 pathways. This is compared to P. lacertae 
(Chapter Two) and C. roenbergensis (Chapter Three), which mapped 4,490 genes 
to 328 pathways and 3,545 genes to 354 pathways respectively. The comparison 
showed that Blastocystis sp. STs have retained largely the same metabolic 
capabilities as P. lacertae as 291 pathways are shared between all Blastocystis sp. 
STs, P. lacertae and C. roenbergensis. 
 
This suggests that Blastocystis sp. STs may have lost complexity from 
conserved metabolic pathways, which might indicate loss of redundancy. There is a 
difference of 347 genes between Blastocystis sp. ST1 and P. lacertae, which 
accounts for some of the metabolism-associated domains appearing in the 
enrichment analyses. There are seven pathways that are present in both P. lacertae 
and C. roenbergensis but absent from all Blastocystis sp. STs. 00591 Linoleic acid 
metabolism and 00550 Peptidoglycan biosynthesis both contain only one sequence 
from both P. lacertae and C. roenbergensis and therefore cannot be confidently 
attributed to Blastocystis losses. 00592 alpha-Linolenic acid metabolism and 05030 
Cocaine addiction were mapped to by two sequences from both P. lacertae and C. 
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roenbergensis. It is worth noting that in the context of the Stramenopiles it is unlikely 
that the proteins that mapped to the 05030 Cocaine addiction pathway are involved 
in synaptic signalling, rather they contain ubiquitous effectors, such as protein 
kinase A (K04345, EC:2.7.11.11), that also comprise part of the signalling pathway 
involved in addiction in a human setting. 00130 Ubiquinone and other terpenoid-
quinone biosynthesis was mapped to by a single sequence from P. lacertae, but by 
four sequences from C. roenbergensis. The two pathways that were most highly 
represented were 00261 Monobactam biosynthesis and 05032 Morphine addiction, 
which mapped three and four sequences and eight and three sequences from P. 
lacertae and C. roenbergensis respectively. 
 
The sequences that mapped to the 00261 Monobactam biosynthesis 
pathway were: aspartate kinase (K00928, EC:2.7.2.4), aspartate-semialdehyde 
dehydrogenase (K00133, EC:1.2.1.11) and 4-hydroxy-tetrahydrodipicolinate 
synthase (K01714, EC:4.3.3.7) from P. lacertae and those plus 4-hydroxy-
tetrahydrodipicolinate reductase (K00215, EC:1,17.1.8) from C. roenbergensis. The 
sequences that mapped to the 05032 Morphine addiction pathway were: guanine 
nucleotide-binding protein G(i) subunit alpha (K04630), beta-adrenergic-receptor-
kinase (K00910, EC:2.7.11.15) and calcium/calmodulin-dependent 3’,5’-cyclic 
nucleotide phosphodiesterase (K13755, EC:3.1.4.17) from C. roenbergensis and 
those plus gamma-aminobutyric acid type B receptor (K04615) and protein kinase A 
(K04345, EC:2.7.11.11) from P. lacertae. 
 
 There are seven pathways found in one or more Blastocystis genome and 
absent in both P. lacertae and C. roenbergensis. Of these there is only one pathway 
that was mapped to by all three Blastocystis genomes, 04614 Renin-angiotensin 
system, which mapped only a single gene from each Blastocystis genome thimet 
oligopeptidase (K01392, EC:3.4.24.15). Only Blastocystis sp. ST1 and ST4 mapped 
a single sequence to 04950 Maturity onset diabetes of the young. Blastocystis sp. 
ST1 contains regulatory factor X 6 (K19521) and Blastocystis sp. ST4 contains MFS 
transporter, SP family, solute carrier family 2 (facilitated glucose transporter), 
member 2 (K07593). 
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Figure 4.3.10 KEGG pathways mapped with P. lacertae and Blastocystis sp. ST7. KEGG annotations mapped in blue are conserved 
between both genomes, in red are pathways mapped only in P. lacertae and green represents pathways mapped only in Blastocystis sp. ST7. 
1
2
1
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The remaining Blastocystis-specific pathways were only mapped with one or 
two sequences but included, for Blastocystis sp. ST1; 00540 Lipopolysaccharide 
biosynthesis, 00524 Neomycin, kanamycin and gentamycin biosynthesis and 02026 
Biofilm formation – Escherichia coli and for Blastocystis sp. ST7; 00253 tetracycline 
biosynthesis and 05150 Staphylococcus aureus infection. 
 
While the majority of the pathways are blank (Figure 4.3.10 - grey) these 
pathways represent a fairly comprehensive account of all the metabolic pathways 
found in both eukaryotic and prokaryotic cells. The mapping of a single genome to a 
minority of these pathways is not unexpected though the similarity in the number of 
pathways mapped from each genome is. Despite the difference in genome sizes 
and the numbers of sequences mapped to KEGG between Blastocystis sp. STs and 
P. lacertae, they contain remarkably similar repertoires of pathways. If there is a 
fundamental difference between them, it is with respect to the number of genes 
involved in each pathway, the ‘gene richness’ of metabolism. Blastocystis 
apparently achieves a very comparable metabolism to P. lacertae, but with 
substantially fewer genes.  
 
4.3.9 Blastocystis has lost the ability to form a flagellum 
 
 Though many different life cycles and morphological forms of Blastocystis 
have been described with varying degrees of confidence, there has been no report 
of any stage developing a flagellum. The flagellum is conserved across the 
Stramenopiles even in multicellular kelp where it appears only during zoosporosis 
[401]. The flagellum is also a useful tool during infection with some organisms 
requiring their flagellum to cause disease [402]. In order to confirm this observation 
about Blastocystis and to comment of the life stages, morphological forms and 
possible mode of infection, the genomes of Blastocystis sp. STs were screened for 
flagellar apparatus.  
 
 Screening of the Blastocystis genomes was done using reciprocal BLAST 
and HMMER to search for orthologs to 1,063 flagellar-associated proteins from 
Judelson et al. (2012) [403]. This list represents a range of functions and includes 
many sequences which have functions other than those associated with the 
flagellum in each organism. The purpose of this list was to ensure capture of all 
flagellar associated proteins. Reciprocal BLAST found 67 sequences in the ST4 
genome and 113 in the ST7 genome, however, the identities of the hits revealed 
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that this list includes proteins with primary functions other than those associated 
with the flagellum and that all three Blastocystis genomes are lacking most kinesins 
and dyneins. The HMMER search revealed 1,732 sequences in the ST1 genome, 
1,401 in the ST4 from and 1,495 in the ST7 genome with the same pattern of loss of 
components required to produce a functional flagellum. 
 
 To filter some of the sequences that may not be associated with a functional 
flagellum in all organisms, a subset of 17 sequences from Judelson et al. (2012) 
[403] were chosen based on presence in organisms with a flagellum and absence 
from organisms without a flagellum (Figure 4.3.11). Orthologs to these 17 ‘core’ 
flagellar proteins were sought in the Blastocystis sp. STs genomes using BLAST 
and HMM search methods. None of these proteins had a reciprocal BLAST hit to 
any sequence in the Blastocystis sp. ST4 or ST7 genomes. However, a HMMER 
search found several proteins, some of which were annotated as dyneins, kinesins 
or actin binding in all three genomes. However, manual inspection of alignments for 
these genes revealed they were not true orthologs. In all examples, the reference 
sequence formed a clade including representatives from P. lacertae, C. 
roenbergensis or both with all Blastocystis sequences falling outside this group, 
showing that they were distant and partial homologues, rather than orthologous 
sequences.  
 
  124 
 
 
Figure 4.3.11 Table of 17 flagellar-associated proteins highly conserved in 
flagellates and absent from non-flagellates across the Eukaryota. 
Chlamydomonas, Homo, Tetrahymena, Trypanosoma, Caenorhabditis, Naegleria 
and Giardia are genera that contain flagellates. Schizosaccharomyces, 
Ostreococcus and Hyaloperonospora are genera that do not contain flagellates. Full 
circles indicate presence of an ortholog; empty circles indicate absence of an 
ortholog. For full list of gene names see S4.3.12. 
 
 From these results, it appears as though Blastocystis has completely lost the 
capacity to form a functioning flagellum at the genome level but that it may retain 
orthologues with other primary functions that no longer perform the flagellar-
associated secondary functions. 
 
4.3.10 Clustering of the putative secretome 
 
 To investigate changes at the cell surface, an in silico cell surface proteome 
was predicted using SignalP v4.1 to predict signal peptides, ModPred v1.0 to predict 
GPI anchor amidation sites and TMHMM v2.0c to predict transmembrane regions in 
the proteomes of the selected organisms. SignalP predicted 1,090 secreted proteins 
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for P. lacertae, 253 for Blastocystis sp. ST7, 257 for Blastocystis sp. ST4 and 1,386 
for C. roenbergensis. ModPred predicted GPI anchor amidation sites with ‘high’ 
probability on 968 proteins from P. lacertae, 236 from Blastocystis sp. ST7, 277 
from Blastocystis sp. ST4 and 993 from C. roenbergensis. Overall the two 
programmes predicted largely independent groups of proteins with only 36, 1, 8 and 
82 proteins from P. lacertae, Blastocystis sp. ST7 and ST4 and C. roenbergensis 
appearing in both sets respectively. Overall, this approach defined a predicted cell 
surface proteome of 1,972 for P. lacertae, 480 and 515 for Blastocystis sp. ST7 and 
ST4 respectively and 2,188 for C. roenbergensis. Putative cell surface proteomes 
were estimated in the same way for P. sojae, P. ultimum, S. diclina, T. pseudonana 
and E. siliculosus and together these sequences were used in a separate clustering 
analysis with OrthoMCL.  
 
 The clustering analysis organised the 19,206 sequences into 3,142 
orthologous groups while excluding 7,383 sequences in total. The results from the 
analysis are summarised in Figure 4.3.12 (S4.3.13) and show that the majority of 
sequences are specific to each species with very few shared between organisms. 
This may reflect large-scale changes at the cell surface, which is not unexpected, 
given the phylogenetic distances involved.  
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Figure 4.3.12 Venn diagram of clustering dome using a predicted cell surface 
proteome for each organism. ‘Specific’ refers to sequences from groups 
containing only one species, ‘conserved’ sequences are those with no orthologs in 
the other genomes shown here but which do have orthologs in other genomes 
included in the analysis and ‘unclustered’ sequences are assumed to represent 
single-copy species-specific proteins. 
 
 Domain enrichment of the clustering results revealed that the top gains for 
Blastocystis sp. STs were similar to the results of the whole-genome enrichment 
analysis of Blastocystis gene gains (Table 4.3.5, S4.3.14, S4.3.15) including Ig-like 
(IPR032812, IPR008009) and glycosyl transferase for dystroglycan domains 
(PF13896). However, these results also identified other protease (IPR001096, 
IPR000668) and thioredoxin domains (IPR006338), which may have a number of 
roles at the cell surface. 
 
  127 
 
Table 4.3.5 Top 10 domains significantly enriched in Blastocystis sp. ST4 and ST7 for putative cell surface proteome
Domain Names InterPro domain Gains Prob. Domain Names InterPro domain Gains Prob.
Putative Ig domain IPR008009 16 1.39E-03 Peptidase C13 family IPR001096 8 1.30E-10
Prokaryotic membrane 
lipoprotein lipid attachment 
site profile
PS51257 9 7.07E-07 Putative Ig domain IPR008009 8 1.15E-03
Major Facilitator Superfamily IPR011701 6 1.37E-03
Glycosyl-transferase for 
dystroglycan
PF13896 7 8.43E-06
Peptidase C13 family IPR001096 6 5.78E-08 Thioredoxin IPR006338 5 2.65E-03
Thioredoxin IPR006338 6 2.23E-03
Papain family cysteine 
protease
IPR000668 5 3.32E-02
Cathepsin propeptide 
inhibitor domain I29
IPR013201 4 2.30E-04 Bacterial Ig_like domain IPR032812 3 4.02E-06
Bacterial Ig-like domain IPR032812 2 1.10E-04
Domain involved in innate 
immunity and lipid 
metabolism
IPR003172 3 <1.00E-100
Cyclophilin-type peptidyl-
prolyl cis-trans isomerase 
signature
IPR020892 2 5.12E-03
Lung seven transmembrane 
receptor
IPR009637 3 1.26E-04
Endomembrane protein 70 IPR004240 2 1.02E-03
MD-2-related lipid-recognition 
domain
IPR003172 3 <1.00E-100
Homeobox domain profile IPR001356 2 1.02E-03 Nop domain profile IPR002687 3 4.02E-06
Blastocystis sp. ST4 Blastocystis sp. ST7
1
2
7
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Clustering of the putative cell surface proteome of Blastocystis sp. STs and 
P. lacertae has shown that it is largely species-specific; however, proteases and 
globular domains are highly enriched suggesting that these families may be 
changing more rapidly than the background and therefore may be of biological 
importance 
 
4.3.11 Blastocystis sp. STs have reduced phylodiversity across conserved gene 
groups 
 
Up to this point, I have shown that patterns of gene loss and metabolic 
pathways offer circumstantial evidence of genome reduction in the ancestor of 
Blastocystis sp. STs. If the Blastocystis sp. STs genomes have indeed experienced 
consistent gene loss, this should be evident when phylogenetic diversity of 
conserved gene families in Blastocystis is directly compared to other eukaryotes, 
both parasitic and free-living. To this end, a panel of seven genomes were selected 
from across the eukaryotic spectrum. Proteins with domains conserved in each of 
these genomes and at least five paralogs in either P. lacertae or a Blastocystis sp. 
STs were extracted, aligned in MUSCLE and used to build neighbour joining trees in 
Ninja. 169 domains were extracted under these criteria and a phylogeny built for 
each. The relative contributions of P. lacertae and Blastocystis sequences to the 
phylodiversity of these conserved families, were calculated using Faith’s 
phylodiversity [399].  
 
Beginning with the phylodiversity value for the background tree composed of 
sequences from the reference panel of eukaryotes, the increase in phylodiversity 
when either P. lacertae or Blastocystis sp. STs were added was measured. The 
difference between increases due to Blastocystis and P. lacertae sequences 
respectively was then plotted against the total number of sequences present in the 
tree (Figure 4.3.13). In Blastocystis sp. ST1 53.8% of the gene families had lower 
phylodiversity than P. lacertae, Blastocystis sp. ST4 was less phylodiverse in 62.7% 
of gene families and Blastocystis sp. ST7 was less phylodiverse in 66.3%. While the 
total number of conserved gene families may not be less phylodiverse in 
Blastocystis sp. STs than in P. lacertae, the difference in phylodiversity between 
them is likely to be greater in cases where Blastocystis sp. STs are less 
phylodiverse. There are very few gene families with a phylodiversity value of less 
than -2.5, however, in each subtype there are examples of gene families with 
phylodiversity values greater than 2.5 for all subtypes.  
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Figure 4.3.13 Phylodiversity of conserved gene families in P. lacertae versus 
Blastocystis sp. ST1, ST4 and ST7. Positive values indicate P. lacertae has higher 
phylodiversity, negative values indicate Blastocystis has higher phylodiversity. Each 
point represents a phylodiversity score for a protein family conserved in multiple 
eukaryotic lineages. The proportion of gene families with lower phylodiversity in 
Blastocystis sp. STs is between 53 and 66%. 
 
 In a slim majority of highly conserved gene families, Blastocystis sp. STs are 
less phylodiverse, but in cases where Blastocystis sp. STs are less phylodiverse, 
the scale of the reduction is larger in Blastocystis sp. STs than in P. lacertae.  
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4.4 Discussion 
 
 In this chapter, I have used the newly produced genome for P. lacertae 
(Chapter 2) and the transcriptome for C. roenbergensis (Chapter 3) in a comparative 
genomic analysis with Blastocystis sp. STs and other Stramenopiles. I have shown 
that several features of the Blastocystis sp. STs genomes indicate that they are 
reduced when compared to P. lacertae or other Stramenopiles, although various P. 
lacertae-specific expansions may complicate the interpretation of gene loss in 
Blastocystis. I have shown that the Blastocystis sp. STs genomes have reduced 
metabolism related gene richness as well as complete absence of genes required 
for a flagellum and other motility associated gene families.  
 
4.4.1 Genome selection 
 
 Selection of Stramenopile genomes was based on capture of Stramenopile 
diversity and genome assembly and annotation quality. While the genomes utilised 
in the analysis are of high quality assembly and annotation, there is no 
representative genome for the Labyrinthulomycetes, the only Class of 
Stramenopiles not represented in this analysis (Figure 4.1.1). This clade is located 
between the Bicosoecida and the Oomycetes; hence a Labyrinthulomycete genome 
would add more resolution to this analysis, for example, when searching for 
orthologues to the C13 peptidase family (Figure 4.3.7).  
 
 Future work should aim to increase the diversity of Stramenopile genomes 
available, especially within the Slopalinida. P. lacertae is the deepest branching 
species currently known in this clade [291], but genome sequences from other 
members of this group would serve to aid identification of P. lacertae-specific gene 
families. These were a source of interference in the enrichment analyses and further 
knowledge of their orthology within the Slopalinida may serve to clear some of the 
‘noise’ and allow more detailed insight into Blastocystis orthologues.  
 
The C. roenbergensis transcriptome was used to define losses in both P. 
lacertae and Blastocystis sp. STs while this may have introduced bias dependent on 
transcription this was taken into account during the clustering. Only genes that have 
orthologs in C. roenbergensis were used to define losses, rather than absence in C. 
roenbergensis being used to infer gain. The lack of orthologues in C. roenbergensis 
for some of the phylogenetic analyses may have been due to the inherent 
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incompleteness of the transcriptome or genuine absence. However, without 
genomic information for C. roenbergensis or a related organism this question cannot 
be answered. A genome sequence could potentially be procured by successfully 
removing the bacterial component prior to sequencing, for example with cell sorting 
and single cell sequencing. 
 
4.4.2 OrthoMCL Vs. OrthoFinder 
 
 While the OrthoFinder programme was developed as an improvement to the 
OrthoMCL package [395], the greatest difference between them in terms of the 
output from these analyses appears to be the number of sequences that are 
excluded and those assigned to single copy orthogroups. For OrthoMCL there are 
no single-copy groups (groups containing a single sequence from a single 
organism) and therefore it is assumed that these make up the cohort of sequences 
that do not form part of any group. For OrthoFinder, this becomes more of an issue 
as the programme does assign groups containing only a single sequence and so 
those that are not assigned to any group are more difficult to define. I have operated 
under the assumption that these sequences were excluded because of their 
uniqueness, though interrogation of the algorithm may show this not to be true. 
Regardless of the reason for the exclusion of a portion of sequences, the output of 
both programmes showed some overlap between the results produced from the 
enrichment analyses. This not only lends confidence to the results but also calls into 
question the advantage of one method over another.  
 
 Previous studies have shown a 25% difference in accuracy between these 
two programmes [395]. OrthoFinder claims to improve on the existing OrthoMCL 
package by transforming the BLAST bit scores to account for long sequences and 
long phylogenetic distances. It also uses a different algorithm for defining the 
similarity limits of an orthogroup. It is this final difference that most likely accounts 
for the differential exclusion of sequences. OrthoFinder uses the bit score from a 
reciprocal best hit (after normalisation for length) as the threshold for inclusion into 
the orthogroup. Presumably, hits that do not overcome this score in any orthogroup 
are either binned into their own orthogroup or excluded from the analysis. It is not 
clear what parameters define each of these behaviours. Refinement of the 
parameters used to run both OrthoFinder and OrthoMCL may reconcile the outputs 
from these packages and improve the resolution of individual genes, but the 
consensus between these methods means that there is confidence in the wider 
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implication of the results. In any case, trees and networks have been built using the 
results of BLAST and HMMER searches that manually corroborated the orthologous 
content.  
  
4.4.3 Losses from Blastocystis sp. STs  
 
The enrichment analyses were done either in the context of the P. lacertae 
genome, in the case of Blastocystis sp. STs or in the context of the Blastocystis sp. 
STs genomes in the case of P. lacertae for gains and losses. This skewed the 
enrichment analysis and produced artefacts in the enrichment analysis such as the 
EGF domains in the Blastocystis losses (Table 4.3.2, Figure 4.3.8). There is a large 
P. lacertae-specific expansion of EGF domain containing proteins, which is 
potentially responsible for the enrichment of this domain in this group. There are 
also other examples from across the enrichment analyses that distort the overall 
trend of loss from the Blastocystis genomes. When Blastocystis sp. ST gains were 
aligned to P. lacertae sequences with matching domain annotations, many of these 
sequences show orthology. This may suggest a previously unconsidered limitation 
of the clustering analysis whereby sequences that are too distantly related have 
been separated when more detailed analysis can show orthology. It may be 
possible to rectify this by utilising alternative enrichment tools [404] that are 
designed to account for genome bias such as GOrilla [405] though from our own 
data (not shown) GO term enrichment can only be applied to a fraction of each 
genome. 
 
 The losses from the Blastocystis sp. STs genomes were represented by a 
diverse array of gene families and functions from across cellular physiology. The 
most enriched domains were also small motifs that are often part of a protein with 
other primary functional domains. These are therefore some of the most abundant 
domains in eukaryotic cells. The fact that these domains feature heavily in the 
enrichment analyses may simply be due to their abundance in the genome, but 
more importantly, these suggest that the gene lost has occurred across the genome. 
Even in highly conserved gene families, while the number of conserved gene 
families was similar to P. lacertae, the scale of the reduction was much larger in 
Blastocystis sp. STs. This is consistent with the findings that Blastocystis sp. STs 
are reduced in very generic protein domains and in highly conserved gene families 
that have become redundant. If specific aspects of cell function were lost, these 
would feature in the analysis, as did motility and the flagellar apparatus (Sections 
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4.2.9, 4.3.11), however as genes have been lost from across the genome, the most 
generic domains in the genome come to the fore. This pattern is also consistent with 
other symbiont genomes and describes a streamlining process signifying adaptation 
to a restricted niche [206], [211], [218], [406].  
 
4.4.4 Blastocystis sp. STs gains 
 
The enrichment of Ig and peptidase domains in Blastocystis sp. STs gains in 
both the whole genome and the putative secretome suggests that these are 
biologically important to Blastocystis sp. STs. Peptidases in particular have a proven 
association with both the ability to persist in a host environment and with disease 
[238], [407]–[409]. The expansion of peptidases has occurred in each lineage of 
Blastocystis sp. rather than in the ancestor of all Blastocystis sp. STs (Figure 4.3.7) 
suggesting that these may play roles in determining different environmental 
tolerances such as host range and virulence. Genotyping of peptidase repertoire 
could therefore be used diagnostically to aid determination of infection outcome and 
even identification of zoonotic source of infections as has been done in 
Streptococcal infections [410]. 
 
 Ig domains were also enriched in the context of both the whole genome and 
the putative secretome. These may represent a change in life-strategy for 
Blastocystis sp. STs. P. lacertae possesses a flagellum and is presumably able to 
move within the intestinal lumen, however, Blastocystis sp. STs have lost the ability 
to form a flagellum as shown in section 4.3.9. This change, accompanied by 
expansion of Ig-like domains may be linked to adhesion within the host gut. 
Blastocystis sp. STs have been observed adhering to food particles and to the 
epithelium itself [70]. This may even represent the cause of the suspected 
pathogenicity in Blastocystis sp. STs, adherence to the epithelium may cause an 
inflammatory response in a similar way to Entamoeba infections [157], [411], [412].  
 
 There is much conflict in the literature as to whether Blastocystis sp. STs are 
able to cause disease [93], [94], [96], [97]. While it is true there are patients suffering 
symptoms associated with the carriage of Blastocystis sp. STs, the vast majority of 
carriers are asymptomatic. There are also studies suggesting that Blastocystis plays 
an important role in maintaining a healthy gut microbiome in humans and that the 
absence of this organism is associated with reduced intestinal floral diversity [98]. I 
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have observed expansion of peptidases which may be associated with virulence, 
but may equally be utilised for immune evasion [381], [382]. 
 
Overall, the Blastocystis sp. STs genomes show evidence of genome-wide 
streamlining, consistent with adaptation to a restricted niche. The conclusions are 
suggestive of adaptation to a closer association with the host mucosa through 
expansion of cell surface-associated protein families and adhesion domain-
containing proteins as well as loss of motility associated genes such as the flagellar 
apparatus. This proposed association with the host mucosa could potentially serve 
as the platform for influencing host factors and the association with disease. 
 
4.4.5 The last common ancestor of Proteromonas and Blastocystis 
 
 From the analyses, it is possible to infer the genomic qualities of the last 
common ancestor of Proteromonas and Blastocystis. Despite the genomic 
differences observed, these organisms inhabit similar vertebrate intestinal 
environments, which may be indicative of an ancestor that inhabited an environment 
under similar conditions.  
 
It is also possible to speculate that the last common ancestor possessed 
specific aspects of the cell apparatus such as the flagellum, and that these have 
been subsequently lost in Blastocystis. Motility is an important feature in intestinal 
protists with examples of a flagellum in Trichomonas and Giardia as well as other 
methods of motility such as pseudopodia locomotion in Entamoeba [413]. The 
absence of these in Blastocystis is suggestive of a highly derived phenotype. As 
both Proteromonas and Blastocystis contain independent expansions of Ig-like 
domain-containing families, it suggests that the ancestor of both had neither, and 
may have relied on motility alone or a subsequently lost subset of adhesins adapted 
for an entirely different environment. Our inferences of the last common ancestor 
are based on the contemporary genomes and environments. It is likely that the 
ancestor did not speciate under the conditions in which are observed the current 
descendants. The ancestor may have been adapted to an anaerobic environment 
outside of a host intestine all together. It is therefore also unlikely that the last 
ancestor was pathogenic.  
 
The contemporary genome sequences of P. lacertae and Blastocystis allow 
a small window into their last common ancestor. Further sequencing of organisms in 
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this clade will allow more detailed insight into the evolution of these highly important 
organisms. 
 
4.4.6 Conclusion 
 
 I have shown here that the Blastocystis sp. STs genomes are genuinely 
small in the context of the Stramenopiles and that this is due, in part, to genome 
wide reduction in the Blastocystis genomes. I have seen that reduction in the 
Blastocystis sp. STs genomes has influenced most, if not, all parts of the genome, 
but which has not resulted in the loss of metabolic function, rather a reduction in 
gene-richness’. Specific aspects of cellular function have also been lost, particularly 
with respect to the loss of the flagellum and other motility associated gene families. 
This may be indicative of a change in ecology whereby, in the absence of motility, 
Blastocystis sp. STs may have adapted to a more restrictive niche adhering to the 
host mucosa. The change in association with the mucosa may bestow an 
opportunistic quality, responsible for the symptoms seen in patients with 
compromised immune systems.  
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Chapter 5. Comparative genomics of Entamoeba histolytica 
virulence factors using free-living mastigamoebid relatives 
 
 In order to investigate the genome evolution of Entamoeba, a genomic 
resource for a free-living relative was required. In an effort to produce this resource, 
a transcriptome for Mastigamoeba sp. was produced. This resulted in two datasets, 
an inclusive dataset, which likely contained the majority of mastigamoebid 
sequences but in which there was also likely still bacterial contaminants from the 
cultures, and the exclusive dataset which was free from bacterial contamination but 
in which genuine Mastigamoeba sequences were absent. The comparison with 
Entamoeba revealed variation between out-groups that influenced the outcomes of 
analyses and evidence of gene expansion and reduction occurring within the same 
families. This is suggestive of high selection pressure acting on Cathepsins and Ras 
family proteins, highlighting their importance for colonisation and persistence within 
the host environment.  
5.1 Introduction 
 
Entamoeba histolytica is an intestinal symbiont responsible for invasive 
amoebiasis, a cause of global morbidity and mortality worldwide. Most infections are 
asymptomatic and virulent infection is rare, varying between strains of E. histolytica. 
The genome sequence of a virulent strain, HM-1:IMSS, was published in 2005 by 
Loftus et al. [414] and revised in 2010 by Lorenzi et al. [415]. Even after revision, 
many of the genes annotated in these approaches encode proteins of unknown 
function. Characterisation of these proteins by experimental procedure has been 
limited, as a model for knocking-out genes has yet to been achieved. Comparisons 
between virulent and avirulent species and strains of Entamoeba have identified a 
small number of virulence candidates though many of these are present in the 
genomes of avirulent strains, only differing in their expression levels in infection 
models [73].  
 
While a comparative approach has been applied among Entamoeba species 
and strains, no comparisons have been made to characterise features that predate 
the evolution of the Entamoeba genus. In order to determine the derived features of 
the E. histolytica genome that might plausibly contribute to pathogenicity, I will use 
free-living mastigamoebid relatives to investigate changes that occurred in the 
ancestral Entamoeba genome that may have facilitated its transition to a symbiotic 
life strategy. 
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5.1.1 The E. histolytica genome 
 
The initial assembly of the E. histolytica HM-1:IMSS genome by Loftus et al. 
[414] indicated a genome size of 23.8 Mb containing 9,938 genes. This assembly 
was made up of 888 scaffolds and almost a third of the genes annotated had no 
identifiable homologues in sequence databases. One of the more intriguing finds 
was that the metabolism has been influenced by secondary gene loss and 
acquisition of HGT genes. E. histolytica occupies an anaerobic environment and has 
lost a large proportion of mitochondrial machinery, including the mitochondrial 
genome, instead relying on laterally acquired bacterial-like fermentation genes to 
metabolise glucose from its environment [414]. These adaptations of the E. 
histolytica genome are similar to those found in other anaerobic parasites such as 
Giardia lamblia and Trichomonas vaginalis [416], [417]; such convergent evolution is 
thought to be driven by selection pressure applied within the intestinal environment. 
The first published assembly and annotation identified 96 HGT genes [414], which 
were identified as originating from bacterial lineages, most likely from the food 
sources of E. histolytica. The majority of these encode metabolic enzymes, which 
bestow increased capabilities especially with regards to carbohydrate and amino 
acid metabolism and may have facilitated the transition to an intestinal environment 
[414]. 
 
Reassembly and re-annotation of the E. histolytica genome slightly reduced 
the size of the assembly from 23 Mb to 20 Mb containing 8,201 genes [415]. This 
reduction was mostly due to the removal of artificial tandem duplications introduced 
in the initial assembly and 40% of the genes from the initial annotation required 
structural changes. This assembly and annotation was published and deposited in 
the database [418] allowing for outsourcing of work to add annotations and 
functional descriptors. At the time of writing the E. histolytica genome contains 8,306 
proteins and has been used as the ‘gold standard’ for investigations into E. 
histolytica and disease. 
 
5.1.2 E. histolytica genome and disease 
 
Initial observations about the E. histolytica genome identified a number of 
potential candidates for virulence-associated genes. E. histolytica has been called a 
professional phagocyte [419] and has the ability to phagocytose a range of cell 
types including epithelial cells, erythrocytes, bacterial and immune cells. However, 
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in order to reach the intestinal epithelium to phagocytose host cells, it must first 
penetrate the mucosal layer in the intestinal lumen. It is thought that this is achieved 
by secretion of cysteine proteases, which break down the extracellular matrix and 
allow the amoeba to adhere directly to the epithelium [420]. These cysteine 
proteases may also play a role in immune evasion by ‘clipping’ bound antibodies 
attached to the cell surface [73]. Cysteine proteases are widely accepted as being 
useful tools in the arsenal of many symbionts [407], [408].  
 
Ten new cysteine proteases with predicted cell-surface localisation were 
identified upon completion of the genome sequence [414]; however other studies 
have identified up to 20 cysteine proteases with predicted open reading frames 
[421]. At the time of writing 35 papain-family cysteine proteases, also known as 
cathepsins, have been identified in the E. histolytica genome [422]. These cysteine 
proteases, of which only a small subset are expressed in vivo, can be further 
separated into two distinct phylogenetic clades; EhCP-A and EhCP-B [421]. Both 
these clades show higher sequence similarity to cathepsin L-like enzymes than to 
cathepsin B-like enzymes and this is supported by the conservation of the ERFNIN 
motif in almost all sequences. Of the 35 cysteine proteases only four are expressed 
in vitro including EhCP-A5 which is strongly associated with virulence and the 
formation of liver abscesses [422]–[426].  
 
The activity of the proteases may also be dependent on the proximity of the 
symbiont to the mucosal layer. Trophozoites have been observed binding to both 
the mucosal layer and to the epithelial cells underneath [151]. The trophozoite form 
of E. histolytica is the stage at which the symbiont is able to adhere to the gut 
epithelium and thereby cause disease. This attachment is thought to be mediated 
via an N-acetyl-D-galactosamine-binding lectin (Gal/GalNAc-lectin) complex [151]. 
There is evidence for a close relationship between cysteine proteases and adhesins 
and there are examples of these proteins forming dimeric complexes at the cell 
surface [427]. Some studies attribute the outcome of infection to the adhesion of this 
family of lectins to either the mucosal layer or epithelial cells [151].  
 
The fact that human mucin is encoded by the MUC2 gene and is highly 
polymorphic has led to investigations into host factors determining the outcome of 
infection [151], [428]. Mucins are heavily modified in the Golgi by the addition of O-
linked GalNAc residues. It is to these residues that the trophozoite adheres, which 
can prevent contact-dependent cytotoxicity [429]. In infection models E. histolytica 
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Gal/GalNAc lectins, as well as EhCP2 and EhCP5 are highly upregulated when 
exposed to the intestinal environment reflecting the importance of these factors 
during infection [140], [411].  
 
Phagocytosis is a complex function which requires several genes with 
diverse functions. Contact-dependent toxicity, phagocytosis and motility are all 
functions that E. histolytica exhibits during an infection. These activities are 
mediated through the activity of Rho, Ras and Rab family proteins which are 
unusually abundant in the E. histolytica genome [414]. These families are upstream 
effectors of pathways associated with motility, effecting cytoskeleton rearrangement, 
and phagocytosis, mediating vesicular transport and fusion, required for invasion of 
host tissues [419]. They may also contribute to immune evasion whereby 
trophozoites are able to move bound antibodies to a pole of the cell, forming a 
‘uroid’ which is subsequently shed into the environment as a vesicle [73].  
 
5.1.3 Comparative genomics within Entamoeba  
 
In 1993, E. histolytica was redefined as two species: the invasive E. 
histolytica and the avirulent E. dispar [129]. It was thought that this would explain 
the high proportion of asymptomatic carriers. However, even when the difference 
between these two morphologically identical species was taken into account, the 
majority of E. histolytica infections still did not result in invasive amoebiasis. Several 
studies have shown that within E. histolytica, strain variation can play an important 
role in determining the outcome of an infection and that distinct genotypes can be 
isolated from different regions of the same patient and show different rates of liver 
abscess formation [73], [424], [430]. The Entamoeba clade contains several distinct 
yet morphologically indistinguishable species most of which are capable of causing 
disease. Comparison with these non-pathogenic species have only identified a small 
number of factors linked to disease. 
 
Other Entamoeba species that have been used in genome comparisons with 
E. histolytica mostly include the closest relative, E. dispar (Figure 5.1.1). It was 
thought to be a completely avirulent species, which nonetheless is still capable of 
inhabiting a human host, despite containing an almost identical gene repertoire to E. 
histolytica [129], [424], however recent studies have called for the avirulence of this 
species to be reassessed [431]. E. moshkovskii was thought to be a free-living 
representative of Entamoeba until it was isolated from human children [432], [433] 
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and its pathogenicity remains unresolved [434], [435]. E. invadens is more distantly 
related to E. histolytica and E. dispar [29] but is still capable of causing disease 
similar to E. histolytica in reptiles, and has been studied for its ability to encyst in 
vitro [436], something that has yet to be verified in human infective species of 
Entamoeba. All of these species of Entamoeba have published genomes available 
and have therefore been utilised in comparative analyses within the Entamoeba 
genus.  
 
 
 
Figure 5.1.1 Bayesian phylogeny of Entamoeba showing the relationships 
between genomes used in this analysis. Phylogeny redrawn based on SSU rRNA 
sequence data from Clark et al. 2006 [132]. Node support is shown as maximum-
likelihood/parsimony/distance/Bayesian analysis. An asterisk (*) denotes where 
support is < 50%. Tree is rooted with Entamoeba coli and Entamoeba species used 
in this chapter are highlighted in bold. 
 
The identification of strains of E. histolytica with varying virulence profiles, 
such as E. histolytica Rahman, and the closely related, avirulent E. dispar has led to 
several comparative studies within the Entamoeba genus [29], [73], [420], [422], 
[430], [433], [437]. Most of these studies have focused on differences in sequence 
content and transcriptional levels between virulent and avirulent strains and species. 
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The findings of these studies have revealed that expression of genes associated 
with nitric oxide and reactive oxygen species (ROS) such as peroxiredoxin, 
superoxide dismutase and NADPH:flavin oxidoreductase are more highly expressed 
in virulent strains [73]. It is possible that the ancestor of Entamoeba was highly 
virulent but that this invasiveness has been tempered over time similar to infection 
caused by Treponema pallidum [438].  
 
Comparative studies have also revealed a host of proteins that have weak 
support for influencing the virulence of a strain. This may suggest that the gene 
repertoire in the ancestral Entamoeba allowed colonisation of the host, but that 
colonisation in contemporary species is determined by epigenetic factors affecting 
expression of colonisation genes. Besides this debate however, these comparative 
studies within Entamoeba cannot provide insight into the evolutionary changes that 
coincide with the origin of the ancestral Entamoeba. All Entamoeba spp. live in close 
association with vertebrate guts, something we assume was also true of the 
common ancestor. To understand this common trait of Entamoeba spp. requires 
comparison with their nearest relatives, most of which are free-living. Here I will 
investigate this moment in evolutionary history using free-living mastigamoebid 
resources to illuminate genome evolution during the speciation of Entamoeba.  
 
5.1.4 Free-living relatives of Entamoeba 
 
In order to examine the ancestral Entamoeba, data was required for a free-
living organism closely related to, but phylogenetically distinct from the 
Entamoebidae (Figure 1.3.1). This means that selection of the free-living out-group 
should be based on the phylogenetic proximity to this clade. Ideal candidates should 
be within the Pelobiontida clade and available for culture. These criteria allowed 
identification of a number of potential candidates. 
 
Mastigella radicula AJC/RS/35 (ATCC 50342) was isolated from Stairfoot 
Quarry, Yorkshire, UK in 1990. To the best of my knowledge it has not appeared in 
the literature. Mastigamoeba aflagellifera AF065-Y (ATCC PRA-395) was isolated 
from the soil of a rice field in Aomori, Japan in 2006. A partial SSU rRNA sequence 
is available from NCBI under Archamoebae sp. AF065-Y [439]. This sequence was 
published only in the database and to the best of my knowledge has not appeared 
elsewhere in the literature. Mastigamoeba sp. WAC-6 (ATCC 50617) was isolated 
from freshwater Lake Waccamaw, North Carolina, USA in 1995 and was initially 
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deposited under the name Conopodamoeba sp. It also has not appeared in the 
literature. These organisms were selected because of their phylogenetic position 
relative to E. histolytica and their amenability in culture [133], [137]. 
 
As an important part of the comparative analysis an out-group was required 
from outside the Archamoebae in order to distinguish core amoeba genes that might 
be lost from Entamoeba, from mastigamoebid-specific genes that are uninformative 
about Entamoeba. Here I have used the genome of Dictyostelium discoideum AX4. 
This organism is a member of the Mycetozoa (Figure 1.3.1) and falls into a group of 
organisms commonly referred to as ‘dictyostelid cellular slime moulds’ [440]. This 
soil-dwelling amoeba has been the focus of many investigations because of its 
social nature, which enables it to exist as a free-living or a multicellular complex 
when starved. This trait has resulted in the study of this group of organisms, 
particularly D. discoideum, as it is a useful way of investigating motility, signalling 
and cellular interaction [441].  
 
The genome sequence of D. discoideum was published by Eichinger et al. in 
2005 [440] who estimated a genome size of 34 Mb. The assembly was organised 
into complete chromosomes and represents >95% of the chromosomal sequence 
and >99% of the genes encoded. The genome is quite gene dense, containing 
approximately 12,500 genes. The authors suggest that the high number of genes is 
related to the multicellular life stage exhibited by the organism and includes 
extensive secondary metabolic components useful in a social environment. 
 
The genomic data available for this organism and its taxonomic position 
outside of the Archamoebae means this organism provides a good measure with 
which to identify core Archamoebae genes and gene families [137].  
 
5.1.5 The Mastigamoeba balamuthi genome 
 
Mastigamoeba balamuthi is a multi-nucleate, free-living member of the 
Archamoebae. Originally isolated from a water well in West Africa as Phreatamoeba 
balamuthi, it can be cultured with relative ease xenically or axenically in anaerobic 
conditions [442]. As M. balamuthi is related to E. histolytica as demonstrated by 
SSU rRNA sequence data [133], [137] it has been previously used to compare with 
the symbiont [443].  
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Several protist lineages contain modified forms of mitochondria such as 
mitosomes, mitochondria-like organelles and hydrogenosomes that have been 
specialised to suite anaerobic or microaerophilic environments. It is thought that the 
mitochondria in M. balamuthi represent a midpoint between mitochondria and the 
reduced mitosomes possessed by E. histolytica [286]. The findings from this study 
showed that M. balamuthi contains two copies of the NIF (nitrogen fixation) 
machinery, which were acquired by HGT in the ancestor of both Mastigamoeba and 
Entamoeba, and that Entamoeba has subsequently lost one of these copies [286]. 
Nyvltova et al. partially sequenced and produced a preliminary assembly of the M. 
balamuthi genome in order to confirm the presence of both copies of the NIF 
machinery components [286].  
 
The genome assembly available for M. balamuthi was produced using both 
454 and Illumina sequencing. These data were combined and assembled into a 49 
Mb genome consisting of 2,462 contigs [286]. Nyvltova et al. did not systematically 
annotate this genome, though they did produce a transcriptome, which was mapped 
onto the genome assembly. By mapping this to the genome it was possible to 
validate both resources and obtain a rudimentary annotation of genes. As the 
genome was only partially sequenced, a robust assembly of the whole genome is 
not possible and is therefore of limited use. The data for M. balamuthi have been 
included here as a test of the integrity of the resource I have produced and as a 
second mastigamoebid data point for the investigation into Entamoeba.  
 
5.1.6 Aims of the chapter 
 
In this chapter, the aim is to produce transcriptomes for Mastigella radicula, 
Mastigamoeba aflagellifera and Mastigamoeba sp. in order to include a free-living 
mastigamoebid out-group to Entamoeba. Comparison of these transcriptomes with 
E. histolytica, D. discoideum and M. balamuthi to determine changes that occurred 
in the ancestral genome of Entamoeba will facilitate its transition from a free-living to 
a symbiotic life-strategy. There are six specific objectives: 
 
1. Prepare high integrity RNA preps from mastigamoebid cultures 
2. Sequence the mRNA with Illumina 
3. Assemble the reads into a transcriptome 
4. Remove contaminating transcripts from the assembly 
5. Annotate the transcriptome and provide a measure of completeness 
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6. Conduct a comparative genomic analysis to identify virulence factors in E. 
histolytica 
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5.2 Materials and Methods 
 
5.2.1 Cell culture maintenance 
 
All cultures were maintained as per instructions provided for each organism 
by ATCC. Mastigella radicula (ATCC 50342) and Mastigamoeba sp. (ATCC 50617) 
were maintained in ATCC Medium 802: Sonneborn’s Paramecium medium at 25.0 
˚C. The complete medium contained 2.5 g cerophyll in 1 l distilled water provided 
pre-prepared by Ward’s Natural Science Establishment. Upon receipt of the medium 
it was boiled for 5 minutes after which 100 ml distilled water was added to 
compensate for evaporation. It was filtered through Whatman #1 paper and added 
0.5 g Na2HPO4 (BDH).  
 
The cultures contained bacterial food source present at the time of isolation 
and supplemented with Klebsiella pneumoniae subsp. pneumoniae (Schroeter) 
Trevistan (ATCC 13883), the strain designation is NCTC 9633 [NCDC 298-53, 
NCDC 410-68] hereby referred to as K. pneumoniae. Plastic 15 ml screw-capped 
flat-bottom tubes were inoculated with K. pneumoniae 24 hours prior to passage. 
Cultures containing M. radicula or Mastigamoeba sp. were rubbed with a sterile loop 
and shaken vigorously to dislodge cells adhering to the surface of the tube. 250 μl 
were then transferred to fresh tubes pre-inoculated with K. pneumoniae and 
incubated at 25 ˚C. 
 
Mastigamoeba aflagellifera (ATCC PRA-395) was maintained in ATCC 
Medium 2832: Reduced YPD Medium at 25.0 0C. Complete medium contained 1.0 g 
KH2PO4, 1.0 g yeast extract, 10.0 g glucose (BDH), 0.5 g MgSO4 x 7H20, 5.0 g 
peptone, 3.0 ml wheat germ oil and 0.3 g cysteine x HCL (Sigma-Aldrich) dissolved 
in distilled water and adjusted to pH 6.8-7.2. This medium was autoclaved and 
vacuum filtered to preserve axenic conditions. Final medium also contained 50 
μg/ml gentamicin (Sigma-Aldrich).  
 
Optimisation of culture growth was informed by cell counts for each species. 
Counts were estimated using an average cell number per field of an Axiovert 25 
light microscope (x20) and were not used to calculate cell concentration, rather to 
monitor culture growth. Cultures were passaged and processed for RNA/DNA 
extraction at peak density.  
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5.2.2 DNA and RNA extraction and sequencing 
 
Cultures at peak density were chilled, rubbed with a sterile loop and shaken 
vigorously to dislodge cells adhering to the tube. Cell were pelleted at 850 x g for 5 
minutes then processed using either Qiagen DNeasy blood and tissue kit or Qiagen 
RNeasy kit according to manufacturer’s protocol. RNA samples were treated on the 
column with RNase-free DNase according to the manufacturer’s protocol. Both DNA 
and RNA were eluted in 30-40 μl of nuclease-free water. DNA and RNA 
quantification were measured using Tecan spectrophotometer and Magellan 
software according to the manufacturer’s protocol. 
 
Mastigamoeba sp. RNA samples were pooled and processed by the 
University of Liverpool’s Centre for Genomic Research (CGR) using ribosomal RNA 
depletion (Ribozyme) according to the manufacturer’s protocol. These were used to 
produce one Illumina RNASeq library using the strand-specific ScriptSeq kit. Paired-
end sequencing (2x250 bp) was carried out using Illumina MiSeq platform 
generating in excess of 12M clusters. Post sequencing qc (fastqc) and trimming of 
adapters from raw reads resulted in reads produced 15,459,938-paired reads for 
Mastigamoeba sp. 
 
5.2.3 Transcriptome assembly and annotation 
 
Bowtie2 was used to map the trimmed reads against the K. pneumoniae 
genome, obtained from NCBI [439]. Reads that did not map (14,561,548-paired 
reads) were used to carry out a de novo assembly using Trinity v2.1.1 [312] with 
default parameters producing 75,506 unique transcripts. 
 
Resolution and annotation of the transcriptome were attempted as described 
in Chapter 3. The negative control group was defined as any sequence with > 98% 
homology to a known bacterial sequence using BLAST. Failure to successfully 
resolve the bacterial contaminants from the transcriptome meant that a more 
stringent cut-off was required to filter bacterial contamination from the dataset. This 
was set at >70% sequence identity to a known bacterial sequence and the 
transcriptome was redefined as two datasets, the ‘exclusive’ set which contained 
only sequences of high confidence, >40% sequence identity to a known eukaryotic 
sequence, a top hit to an Archamoebae sequence or a reciprocal BLAST to the M. 
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balamuthi contigs. The ‘inclusive’ dataset included the exclusive dataset as well as 
any sequence that did not show a robust BLAST hit to a bacterium in the database. 
 
5.2.4 Assessing completeness of transcriptome 
 
The proteomes for E. histolytica HM-1:IMSS, E. dispar SAW760, E. invadens 
IP1 and E. moshkovskii Laredo were downloaded from AmoebaDB 
(http://amoebadb.org), part of the EuPathDB family of databases [418]. The 
Dictyostelium discoideum AX4 proteome was downloaded from NCBI [439]. A 
genome-guided assembly of the M. balamuthi transcriptome was used downloaded 
from http://mastigamoeba.img.cas.cz/ 
  
 The clustering analysis was performed as described in Chapter 4. Other 
measures of completeness and phylogenomics were conducted as described in 
Chapter 3.  
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5.3 Results 
 
5.3.1 Identification of bacterial sequences in Mastigamoeba sp. transcriptome 
 
To remove sequences originating from the food source, K. pneumoniae, 
prior to assembly, the raw reads were mapped to the K. pneumoniae genome, using 
Bowtie. This accounted for 5.8% of the total number of RNASeq reads. These reads 
were removed and the unmapped reads were assembled into 75,506 transcripts 
using Trinity. This assembly was assessed by BUSCO, which returned a score of 
34.73% complete (149 of 429 eukaryotic BUSCOs present). In order to remove the 
remaining contaminating bacterial sequences from the environmental flora, the 
transcripts were organised into groups based on their properties. Each transcript 
was assigned to one of three categories based on their homology to sequences in a 
non-redundant database and to the M. balamuthi contigs. 
 
The positive group, those confidently ascribed as being Mastigamoeba sp. 
sequences, were defined as any transcript with a top BLAST hit to a eukaryotic 
sequence with >40% sequence identity, a BLAST hit to the M. balamuthi contigs or 
a top blast hit to an Entamoeba species. These criteria defined 3,394 transcripts. 
The negative group, those confidently ascribed to bacteria, were defined as any 
transcript with a top BLAST hit to any bacterial sequence with >98% sequence 
identity. This criterion defined 9,709 transcripts. The unassigned group contained 
any transcript, which did not satisfy the criteria of either the positive or negative 
groups. Transcripts in this group predominantly share little homology to any 
sequences in the database and therefore cannot be included or excluded based on 
homology alone, this group contained 62,403 transcripts (Figure 5.3.1). 
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Figure 5.3.1 Pie chart showing proportions of the whole assembled 
transcriptome, which fall into each category. Positives are those confidently 
ascribed to Mastigamoeba, negative are those confidently ascribed to bacteria and 
unassigned are those which cannot be placed in either positive or negative groups 
based on sequence homology.  
 
Negative transcripts may be immediately excluded from the analysis, 
however the unassigned group, which represents >80% of the assembled 
transcriptome cannot be automatically excluded, but also cannot be assumed to be 
genuinely mastigamoebid. Similarity of base composition, read depth and codon 
usage of any unassigned transcript to transcripts in either the positive or negative 
group may serve to inform on the eukaryotic or bacterial origin of each transcript. 
These metrics were calculated as an average per transcript and plotted pairwise in 
an attempt to visualise any distinction between positive and negative groups and 
similarity to these of transcripts in the unassigned group (Figure 5.3.2). Base 
composition is expressed as GC percentage per transcript, read coverage is 
expressed as number of reads mapped per transcript and codon usage is 
expressed as effective number of codons (Nc) per transcript. 
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Figure 5.3.2 Pairwise comparison of codon usage, read coverage and base composition for 3 groups defined within the 
Mastigamoeba sp. transcriptome. Metrics were plotted pairwise against each other: A. read coverage vs. base composition B. read coverage 
vs. codon usage. 
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These results show that the codon usage, read coverage and base 
composition do not provide adequate separation of the transcripts. There is no 
distinction between the positive and negative groups and therefore I cannot infer 
similarity to either of these groups of transcripts in the unassigned group. Instead, I 
attempted to use kmer frequency to separate transcripts as in Chapter 3. The 
results of the kmer analysis are shown in Figure 5.3.3.  
 
 
Figure 5.3.3 A principle components analysis of 3mer values. PC1 and PC2 
account for >95% of the variation. Negative transcripts are those with >98% 
sequence homology to a bacterial sequence. Positive sequences are those with 
>40% sequence homology to a eukaryote or a BLAST hit to the M. balamuthi 
contigs. Unassigned transcripts are those, which do not fall into either category. 
 
This approach also failed to produce adequate separation of the positive and 
negative groups. The unassigned group could therefore not be included in either the 
positive group as it likely contains contaminating bacterial sequences or the 
negative group as it may contain genuine Mastigamoeba sp. sequences. To resolve 
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this issue, the criterion for inclusion in the negative control group was relaxed from 
>98% sequence identity to a known bacterium to >70% sequence similarity [444]. 
This had the effect of reassigning 27,752 transcripts from the unassigned group to 
the negative group. Two datasets were then used in subsequent analyses: an 
inclusive dataset, which contains transcripts from both, the positive set and the 
modified unassigned set (37,685 transcripts) which scored 31.7% complete with 
BUSCO and an exclusive dataset, which contains only the positive set (3,394 
transcripts) which scored 18.4% complete with BUSCO. These datasets were also 
passed through TransDecoder to extract protein sequences, which identified 16,135 
protein sequences and a BUSCO score of 39.6% complete for the inclusive dataset 
and 1,953 protein sequences with a BUSCO score of 24.0% complete for the 
exclusive dataset.  
 
Both of the transcriptome scores are lower than the protein scores. This may 
be due to the fact that BUSCO must first extract protein-coding sequences from 
transcripts in order to test for homology to the BUSCOs. TransDecoder may be 
more efficient at this process resulting in fewer BUSCOs being recovered from the 
transcripts.  
 
In comparison, the E. histolytica genome scored 70.4%, the D. discoideum 
genome scored 95.3% and the M. balamuthi predicted proteome scored 68.9% with 
BUSCO. The C. roenbergensis transcriptome produced in Chapter 3 also scored 
70.4%. It may therefore be possible to conclude that only a partial transcriptome for 
Mastigamoeba sp. was recovered in either dataset. In order to validate the 
transcriptome further, its content was examined in more detail.  
 
5.3.2 E. histolytica has similar metabolic capabilities to Mastigamoeba 
 
One method of validation for the Mastigamoeba sp. datasets was to 
investigate the metabolic capabilities of the transcriptome and compare them to 
those of E. histolytica. To this end the predicted proteome for E. histolytica, M. 
balamuthi, D. discoideum and the inclusive protein dataset for Mastigamoeba sp. 
were annotated using GhostKoala, which assigns KEGG annotations to protein 
sequences. These annotations were then mapped back to the KEGG pathways 
(Figure 5.3.4, S5.3.1). 
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Figure 5.3.4 Venn diagram showing proteins mapped to KEGG pathways 
using the inclusive dataset for Mastigamoeba sp., M. balamuthi, E. histolytica 
and D. discoideum. Values in bold represent metabolic pathways containing at 
least one protein, other values represent total proteins involved in all pathways. 
 
The KEGG comparison revealed that the majority of metabolic capabilities 
are shared between all four organisms. There are 20 pathways absent from E. 
histolytica but present in all other organisms but only 5 pathways absent from M. 
balamuthi and 1 pathway absent from both Mastigamoeba sp. and D. discoideum 
which are otherwise conserved. Mastigamoeba sp. has mapped to 29 unique 
pathways. D. discoideum has mapped to 4 specific pathways and M. balamuthi has 
mapped to 3 pathways. E. histolytica did not map to any species-specific pathways.  
 
It might be expected that, if all the genomes were complete, the organisms 
that are more closely related will be more similar both in terms of the number of 
pathways mapped to and the number of individual proteins mapping to those 
pathways. However, it appears that the number of Mastigamoeba sp. proteins is 
overrepresented in all groups when compared with M. balamuthi, which may be due 
to incompleteness of one of more of the resources, for example Mastigamoeba sp. 
has 4,768 proteins that mapped to pathways conserved in all organisms whereas M. 
balamuthi has 2,526 proteins. These organisms are the most closely related and the 
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M. balamuthi genome was used to aid the identification of genuine Mastigamoeba 
transcripts and therefore such drastic disparity is potentially unexpected and may 
suggest that there is a high proportion of bacterial contaminants adding sequences 
to ‘Mastigamoeba’ pathways, or that the M. balamuthi transcriptome captured only a 
portion of the protein-coding sequences.  
 
To test whether the apparent overrepresentation of Mastigamoeba sp. was 
due to the inclusion of bacterial transcripts, the analysis was repeated using the 
exclusive dataset. This provides an estimation of how much the unassigned group is 
contributing to the predicted Mastigamoeba sp. metabolism (Figure 5.3.5, S5.3.2).  
 
 
Figure 5.3.5 Venn diagram showing number of proteins mapped to KEGG 
pathways using the exclusive dataset for Mastigamoeba sp., M. balamuthi, E. 
histolytica and D. discoideum. Values in bold represent metabolic pathways 
containing at least one protein, other values represent total proteins involved in all 
pathways. 
 
 The results from this second analysis seem to support the findings of the 
previous one with the majority of pathways being shared between all four 
organisms, though the number of Mastigamoeba sp. proteins mapping to these 
pathways has dropped from 4,768 to 2,104 sequences. There are still 12 pathways 
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that are specific to Mastigamoeba sp. but this is now comparable to D. discoideum, 
which mapped to 18 specific pathways. M. balamuthi contains 6 species-specific 
pathways and E. histolytica did not map to a specific pathway as seen in the 
previous analysis.  
 
Mastigamoeba sp. is no longer overrepresented in conserved pathways 
when compared with M. balamuthi. This supports the idea that the inclusive dataset 
contains contaminating sequences that reduce the validity of the Mastigamoeba 
transcriptome. The results of these comparisons show that the majority of metabolic 
capabilities are shared between all four organisms. However, there is disparity in the 
number of genes participating in shared pathways with D. discoideum containing the 
most and Mastigamoeba sp. containing the fewest. It also appears that the 
Mastigamoeba sp. predicted proteome maps to specific pathways not present in the 
transcriptome of its closest relative M. balamuthi suggesting that the M. balamuthi 
genome may be missing components of otherwise conserved metabolism. 
 
5.3.3 Clustering analysis of orthologous proteins  
 
In order to assess how many core amoeba and mastigamoebid genes have 
been included in the Mastigamoeba sp. transcriptome, and to determine to what 
extent the Mastigamoeba sp. and M. balamuthi resources were similar, they were 
used in a clustering analysis provided by OrthoMCL and OrthoFinder along with the 
proteomes for E. histolytica, M. balamuthi and D. discoideum (Figure 5.3.6, S5.3.3, 
S5.3.4). For this analysis, the inclusive protein dataset for Mastigamoeba sp. was 
used as contaminating bacterial sequences will most likely cluster together into 
bacterial specific groups or be excluded from the analysis as single copy, species-
specific genes. 
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Figure 5.3.6 Venn diagram showing numbers of species-specific and 
orthologous proteins for Mastigamoeba sp., M. balamuthi, E. histolytica and 
D. discoideum. Numbers were produced by OrthoMCL and represent the number 
proteins from each species in orthologous groups. Numbers in bold represent the 
number of orthologous groups. Species-specific groups include unclustered proteins 
are assumed to represent single-copy species-specific proteins. 
 
OrthoMCL and OrthoFinder differed slightly in their estimation of organising 
clusters of proteins into orthologous groups. Most notably OrthoMCL failed to cluster 
10,699 proteins from Mastigamoeba sp., 11,930 from M. balamuthi, 2,975 from E. 
histolytica and 5,667 from D. discoideum. It is assumed that these sequences 
represent species-specific single-copy genes that were excluded because they 
cannot be placed into an orthologous or a paralogous cluster. OrthoFinder did not 
fail to cluster proteins, however, unlike OrthoMCL it does assign single-copy 
species-specific proteins to individual clusters. OrthoFinder assigned 12,184 
Mastigamoeba sp. proteins, 21,471 M. balamuthi proteins, 4,688 E. histolytica 
proteins and 7,630 D. discoideum proteins to single-copy species-specific clusters. 
The output from OrthoMCL was preferred, as it managed to cluster the greatest 
proportion of each genome or transcriptome and this allows us to comment on a 
higher proportion of genes.  
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Overall OrthoMCL identified 627 clusters, which contains orthologs from all 
species. These clusters contain a total of 4,340 genes, which represent ancestral 
conserved protein lineages present in the common ancestor of all four species. The 
number of proteins in the species-specific clusters for each organism is correlated 
with the total genome size. Mastigamoeba sp. contains 1,239 groups with 3,613 
multi-copy species-specific proteins and 9,461 single copy species-specific proteins 
the highest proportion of single-copy species-specific proteins of any organism 
included here.  
 
While the number of proteins in species-specific clusters is correlated with 
overall genome size, this pattern is not observed in conserved groups. E. histolytica, 
when compared to Mastigamoeba sp. and D. discoideum is consistently 
overrepresented. This is most obvious when looking at proteins in clusters 
conserved across all four species where E. histolytica is overrepresented by 
approximately 400 proteins (1,307 compared to 823 and 884) but is true across 
other conserved clusters as well. Conversely, in conserved clusters Mastigamoeba 
sp. is underrepresented when compared to D. discoideum. 
 
The phylogenetic proximity of two organisms is sometimes correlated with 
the number of homologous clusters, though this is an unreliable measure of 
phylogenetic relationship. It is interesting to note that Mastigamoeba sp. and M. 
balamuthi are the most closely related organisms in this analysis and share 626 
clusters only between themselves, which is the highest proportion of pairwise 
conserved orthogroups. While this result conforms to the inference of phylogeny, 
other relationships do not. The clusters generated by OrthoMCL appear to suggest 
that E. histolytica is more related to D. discoideum than to either of the 
Mastigamoeba species (231 groups compared to 50 and 113). It also suggests that 
both Mastigamoeba species are more related to D. discoideum than to E. histolytica 
(352 compared to 50 and 514 compared to 113 for Mastigamoeba sp. and M. 
balamuthi respectively). This result contradicts the established phylogeny in the 
literature and is mirrored in the output produced by OrthoFinder as well. This may 
reflect the incompleteness of both the mastigamoebid resources. 
 
Overall, the Mastigamoeba sp. transcriptome contains a higher than 
expected proportion of single-copy species-specific proteins, though the total 
number of species-specific proteins (including those in paralogous clusters) 
conforms to the correlation observed with genome size. It can also be seen that 
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Mastigamoeba sp. is underrepresented and E. histolytica is overrepresented in 
conserved orthogroups.  
 
5.3.4 Acquisition of HGTs in Entamoeba occurred in the common ancestor of 
Mastigamoeba and Entamoeba 
 
As a final measure of how complete the transcriptome was and in order to 
investigate horizontal gene content in the Mastigamoeba genomes, 96 previously 
identified HGTs in Entamoeba [285], [414] were used to search the inclusive 
Mastigamoeba sp. transcriptome, the M. balamuthi predicted proteome and the M. 
balamuthi contigs using reciprocal BLAST. This approach identified homologues for 
67 of these in Mastigamoeba sp. and 50 in M. balamuthi. Those missing from the M. 
balamuthi transcriptome were searched for in the M. balamuthi contigs. This 
revealed 90 homologues within the genome.  
 
From this it may be concluded that a majority of the previously identified 
HGTs were present in the ancestor of both Entamoeba and Mastigamoeba but that 
the mastigamoebid transcriptomes contain only a partial record of these. 
Interestingly, the Mastigamoeba sp. transcriptome appears to contain more HGTs 
than the M. balamuthi transcriptome, despite the greater number of M. balamuthi 
transcripts. This is yet another indication that the Mastigamoeba sp. transcriptome is 
a useful resource to identify variation between mastigamoebids. 
 
5.3.5 Species-specific E. histolytica proteins are enriched for Ras superfamily 
domain-containing proteins 
 
The clustering analysis described in the preceding section identified 2,757 
genes in 718 paralogous clusters that are specific to E. histolytica. In order to 
determine if these proteins correspond to specific functions, a domain enrichment 
analysis was performed despite many lacking any annotation or similarity to 
sequences in the database. InterProScan was used to assign domain annotations 
the proteins and these were tested for enrichment in the context of the whole E. 
histolytica genome. The enrichment analysis was a hypergeometric distribution 
analysis performed in R. This analysis showed 183 domains enriched with a 
probability of < 0.001 (Table 5.3.1, S5.3.5, S5.3.6). These domains represent a 
diverse range of functions including domains linked to metabolism, signalling, 
trafficking and transport, structural domains, DNA binding and ribosomal subunits. 
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However, a particularly prominent result shows that the E. histolytica genome 
contains an expanded repertoire of Ras superfamily domain-containing proteins 
(PR00449) (p = 7.65e-32). A result that has also been noted in the literature [414], 
[436], [445]. This may reflect an expansion of these effectors, which are associated 
with a broad range of function including motility, phagocytosis and virulence.  
 
 
 
 Inclusion of the Hsp70 protein domain (IPR018181) (p = 8.27e-5) may reflect 
adaptation to the intestinal environment and the temperature stresses that occur 
during the transmission cycle of E. histolytica. Other domains such as SH3 domain 
(IPR001452) (p = 6.02e-5) are membrane associated and may hint at changes in the 
cell surface proteome that are associated with the host environment. Overall, the E. 
histolytica genome seems to be enriched for a wide variety of functions, but 
especially for Ras and Ras-associated gene families. 
 
5.3.6 Entamoeba contains genus-specific expansion of Ras-family proteins 
 
In order to investigate the expansion of Ras superfamily domain-containing 
proteins identified as being significantly enriched in E. histolytica-specific groups 
assigned by OrthoMCL, a single Entamoeba Ras domain-containing protein 
(EHI151610) was compared, using BLAST, to the transcriptome of Mastigamoeba 
sp. and the proteomes of E. histolytica, M. balamuthi and D. discoideum as well as 
E. dispar, E. moshkovskii and E. invadens to extract orthologous sequences (E-
value <0.001 and >35% sequence identity). This approach identified 18 orthologs 
from Mastigamoeba sp., 11 from M. balamuthi, 30 from D. discoideum, 48 from E. 
histolytica, 47 from E. dispar, 56 from E. moshkovskii and 42 from E. invadens. 
Table 5.3.1 Top 10 domains significantly enriched in E. histolytics gains
Domain name InterPro domain Gains P-value
Transforming protein P21 ras signature PR00449 386 7.65E-32
EF-hand calcium-binding domain profile IPR002048 63 2.95E-05
TLDc domain IPR006571 39 2.22E-16
Dbl homology (DH) domain profile IPR000219 38 2.14E-05
Hsp70 protein IPR018181 38 8.27E-05
SH3 domain signature IPR001452 37 6.02E-05
Pumilio RNA_binding repeat profile IPR001313 37 6.42E-04
Pleckstrin homology domain profile IPR001849 26 7.60E-03
DENN AEX-3 domain IPR001194 22 9.06E-12
NHL repeat profile IPR013017 19 <1.00E-100
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Simply from the numbers of recovered sequences it is possible to show that 
Entamoeba appears to contain more copies of this gene. These sequences were 
aligned using ClustalW, manually curated and used to build a maximum likelihood 
phylogeny (Figure 5.3.7). 
 
 
Figure 5.3.7 Maximum likelihood phylogeny of Ras-family amino acid 
sequences built using LG+G+F model and rooted with the Entamoeba-specific 
clade. Node robustness was assessed with non-parametric bootstraps 100 
replicates, bold lines indicate bootstrap support >75. Red lines represent 
Entamoeba sequences and blue lines represent Mastigamoeba sequences and 
black lines represent D. discoideum sequences. Red arrows denote Entamoeba 
expansion, blue arrows denote Entamoeba absence. 
  162 
The phylogenetic analysis revealed that Entamoeba has retained almost all 
of the ancestral lineages of the Ras superfamily, and in many instances, has 
expanded these lineages (marked by red arrows Figure 5.3.7). There are also 
examples where no ortholog was identified in either of the mastigamoebid 
transcriptomes; however, this may not be due to gene loss, rather due to the limited 
information available from the transcriptomes. The striking feature of this tree is the 
Entamoeba-specific clade, which is most likely the reason for the identification of 
this family in the enrichment analysis. The absence of any orthologous sequences 
from Mastigamoeba or D. discoideum suggests a large expansion in the ancestor of 
Entamoeba. 
 
5.3.7 E. histolytica losses are enriched for diverse domain functions 
 
In addition to identifying genes specific to E. histolytica, the clustering 
analysis also identified 391 clusters that indicate loss from E. histolytica. They 
contained 529 proteins from Mastigamoeba sp., 1,101 from M. balamuthi and 921 
from D. discoideum only. InterProScan provided domain annotations for the 583 
Mastigamoeba sp. proteins, which were used in an enrichment analysis in the 
context of the Mastigamoeba sp. transcriptome. This enrichment analysis showed 
144 domains enriched with a probability of < 0.001 (Table 5.3.2, S5.3.7, S5.3.8) that 
represent a vast array of functions including metabolism, vesicular regulation and 
DNA binding proteins.  
 
 
 
 This list of enriched domains is based on a small number of proteins but may 
still provide clues about the losses from the E. histolytica genome. Interestingly, 
Table 5.3.2 Top 10 domains significantly enriched in E. histolytica losses
Domain name InterPro domain Losses P-value
Receptor for egg jelly domain IPR002859 5 <1.00E-100
Peptidase C1A CathepsinB cd02620 4 <1.00E-100
2Fe-2S ferredoxin-type iron-sulfur binding region 
signature
IPR006058 3 <1.00E-100
Biotin carboxylase C-terminal domain IPR005482 3 <1.00E-100
Vacuolar sorting protein 9 VPS9 domain IPR003123 3 <1.00E-100
3'5'-cyclic nucleotide phosphodiesterase IPR002073 2 <1.00E-100
AP endonucleases family 2 profile IPR001719 2 <1.00E-100
CO dehydrogenase flavoprotein C-terminal 
domain
IPR005107 2 <1.00E-100
Cobalamin adenosyltransferase IPR016030 2 <1.00E-100
dDENN domain profile IPR005112 2 <1.00E-100
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although vesicle associated domains are enriched among gene losses (IPR003123) 
(p < 1.00e-100); they were also enriched in the E. histolytica gains (IPR003123) (p = 
7.73e-5). This may be due to expansion and contraction within the same gene family, 
or between families with the same domain annotation. The most abundant loss 
domain (IPR002859) (p < 1.00e-100) is for a receptor for egg jelly domain that has no 
known function, though it does contain polycystic kidney disease domain (PKD) 
regions, which may be involved in protein-protein or protein-carbohydrate 
interactions [446]. 
 
The loss of the peptidase domain (cd02620) (p < 1.00e-100) may suggest a 
biologically important change, as cathepsins are known for their ability to aid 
persistence within a host environment and for causing disease. In order to 
investigate these losses, the sequences with this domain annotation were extracted 
and used to build a phylogeny (Figure 5.3.8). 
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Figure 5.3.8 Maximum likelihood phylogeny of Peptidase C1A Cathepsin B 
domain-containing proteins built using BLOSUM62+G+F model and rooted at 
the midpoint. Node robustness assess by non-parametric bootstraps 100 
replicates, nodes in bold denote support >75. 
 
 From the phylogeny, it appears as though the majority of the sequences are 
M. balamuthi-specific acquisitions. However, there appear to be four lineages 
represented in the tree, of which E. histolytica is present in only one in two copies. 
This confirms the enrichment analysis results in that E. histolytica possesses fewer 
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lineages of C1A peptidases than Mastigamoeba sp., M. balamuthi and D. 
discoideum.  
 
5.3.8 Entamoeba has an expanded arsenal of cathepsins, which show reduced 
phylodiversity when compared to free-living relatives 
 
In order to identify orthologs of cathepsins in the other species each 
proteome was searched for its cathepsin repertoire. The cluster produced by 
OrthoMCL assigned only 15 sequences to the same one as EHI181230 and all were 
paralogs. Therefore, cathepsin sequences were extracted from all four genomes by 
comparing a single cathepsin sequence (EHI181230/EhCP112) from the literature 
[414], [421], [427], [447]–[449] using BLAST. This approach identified 24 cathepsin 
sequences from the E. histolytica genome, 14 from D. discoideum and 8 and 7 from 
Mastigamoeba sp. and M. balamuthi respectively. This method was also applied to 
other members of the Entamoeba genus: E. dispar, E. invadens and E. moshkovshii 
yielding 16, 30 and 22 cathepsin sequences respectively as well as 13 sequences 
from Naegleria fowleri which served as a more distant outgroup. As with the Ras 
family proteins (above), the number of orthologs recovered from each species 
suggests that members of the Entamoeba genus may contain more copies of these 
proteins. These sequences were aligned using ClustalW, manually curated and 
used to build a maximum likelihood phylogeny (Figure 5.3.9). 
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Figure 5.3.9 Maximum likelihood phylogeny of cathepsin amino acid 
sequences sampled from Archamoebae built using WAG+G model. Node 
robustness was assessed with non-parametric bootstraps; branches with bootstrap 
support >75 are shown with bold lines. Posterior probability values were estimated 
using Bayesian inference. The two clades of Entamoeba sequences are marked 
except for the single cluster, which does not fall into these clades marked with a red 
arrow. Red lines indicate Entamoeba sequences, blue lines indicate Mastigamoeba 
sequences and black lines are other eukaryotes. The two clades of Entamoeba 
sequences are marked except for the single cluster, which does not fall into these 
clades marked with a red arrow, Mastigamoeba sequences with no homologues in 
Entamoeba marked with a blue arrow. 
 
This phylogeny shows that all Entamoeba cathepsins appear to cluster into 
two distinct clades, EhCP-A and EhCP-B. There is however, a single E. histolytica 
sequence and its orthologs which appears to branch away from the other clades; 
EHI_062480 marked by a red arrow (Figure 5.3.9). However, there are no robust 
nodes to support the observation that these clades are separate and that the outlier 
clade (containing EHI_062480) does not cluster with either of these clades and 
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therefore its placement is not certain. It can also be seen that there is a clade in 
which no Entamoeba sequences are found but that contains orthologs from 
Mastigamoeba and Naegleria, which may represent ancestral lineages lost from 
Entamoeba (Figure 5.3.9, blue arrow).  
 
To add confidence to our observations, a panel of genomes representing an 
array of organisms from across the eukaryota were screened for their cathepsin 
repertoire using BLAST. These sequences were added to the existing alignmnent 
and the phylogeny was reestimated (Figure 5.3.10). 
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Figure 5.3.10 Maximum likelihood phylogeny of cathepsin amino acid 
sequences, sampled from across the Eukaryota built using WAG+G model. 
Node robustness was assessed with non-parametric bootstraps; branches with 
bootstrap support >75 are shown with bold lines Posterior probability values were 
estimated using Bayesian inference. Red lines indicate Entamoeba sequences, blue 
lines indicate Mastigamoeba sequences and black lines are other eukaryotes. The 
two clades of Entamoeba sequences are marked; lineages absent from Entamoeba 
are marked with blue arrows. 
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This phylogeny further shows that the Entamoeba-specific clades cluster 
more closely to sequences from other eukaryotes than to each other. This confirms 
that almost all Entamoeba cathepsins can be separated into two clades with distinct 
ancestral lineages. These clades have also been expanded in the ancestor of 
Entamoeba as the majority of the nodes within the clade are organised into 
orthologous groups of the Entamoeba species. Coupled with the lack of 
Mastigamoeba sequences within these clades, this shows that this expansion 
occurred after the split from Mastigamoeba.  
 
EHI062480 and its orthologs still clusters outside of EhCP-A and EhCP-B 
together with representative sequences from M. balamuthi and other eukaryotes 
(marked by red arrow). To test this, the tree was constrained to include this clade 
within EhCP-A and tested with log likelihood ratios in RaxML. The difference in log-
likelihood between the unconstrained tree (-lnL = 133176.3) and a constrained tree 
(-lnL = 133194.8) was 18.5 (df = 1; p < 0.01) on the X2 distribution. Therefore 
constraining EHI062480 to fall within the established cathepsin-L clade produces a 
significantly reduced likelihood.  
 
Interestingly, M. balamuthi cathepsin sequences represent three distinct 
lineages, whereas Mastigamoeba sp. sequences represent six lineages of which 
two are shared between both. Given the state of completeness of these data, this 
variation between the mastigamoebid resources is most likely due to missing data 
but might be due to be species variation. This observation shows that both of these 
resources may be incomplete, but that they are not incomplete in the same way. 
Using both transcriptomes in combination provides a better overview of 
mastigamoebid genomics than either in isolation.  
 
In all other clades Mastigamoeba and D. disciodeum all have a far more 
diverse set of sequences which cluster more closely with distant eukaryotes than 
with sequences from Entamoeba. This suggests that the loss of cathepsin repertoire 
in Entamoeba occurred after the split from Mastigamoeba. These suggest that 
changes which happened in the ancestor of Entamoeba after its split from 
Mastigamoeba have contributed to both the expansion and lack of diversity 
observed. 
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5.4 Discussion 
 
 In this chapter I have sequenced and assembled a transcriptome for 
Mastigameoba sp. and used this in a comparative analysis with E. histolytica. I have 
attempted to validate the transcriptome and shown that it can be used to infer 
character states in the last common ancestor with Entaoeba. I have shown that 
species variation can also impact the outcomes of analyses. I have also reported on 
the Ras and cathepsin repertoires of Entamoeba spp. and infered reduction and 
expansion in the ancestor of Entamoeba.  
 
5.4.1 Validity of the Mastigamoeba sp. transcriptome 
 
The greatest issue in drawing any conclusion from the data presented here 
is that the Mastigamoeba sp. transcriptome used for these comparisons either 
contains sequences which are of bacterial origin, in the inclusive dataset, or which 
only represents a small protion of the genuine proteome, in the exclusive dataset. I 
have used multiple methods to validate the content of the transcriptome including an 
analysis of metabolism and identification of orthologous sequences between 
Mastigamoeba sp., M. balamuthi, E. histolytica and D. discoideum.  
 
The metabolic validation of the transcriptome showed that there were few 
differences between the inclusive and exclusive datasets considering that the 
number of Mastogamoeba sp. genes annotated by KEGG was more than double 
(2,266 up to 5,245) (Figure 5.3.4, Figure 5.3.5). The most striking difference is 
between the species-specific pathways in Mastigamoeba sp. which increased from 
82 genes in 12 pathways to 200 genes in 29 pathways. The pathways that were 
most differentially mapped to by the exclusive dataset were 02040 Flagellar 
assembly, containing 17 sequences and 01503 Cationic antimicrobial peptide 
resistance, containing 11 sequences. The remaning pathways mapped three or 
fewer sequences. These sequences may well represent contaminating bacterial 
sequences, however, it is also possible that these are genuine Mastigamoeba 
sequences. Mastigamoeba sp. and M. balamuthi both posess the ability to form 
flagellar apparatus [134]. It is possible that the M. balamuthi resource utilised does 
not contain these sequences. To test if they were present in the genome assembly, 
the Mastigamoeba sp. sequences were compared to the M. balamuthi contigs using 
BLAST and this showed that the M. balamuthi genome does not contain the 
sequences from the 02040 Flagellar assembly pathway. However, the antimicrobial 
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genes found homology to two Mastigamoeba sp. sequences annotated as UDP-N-
acetylglucosamine acyltransferase (K00677, EC:2.3.1.129) and peptidyl-prolyl cis-
trans isomerase A (cyclophilin A) (K03767, EC:5.2.1.8). This highlights both a 
limitation of using a transcriptomic resource and a benefit of using the 
Mastigamoeba sp. transcriptome. While there is considerable overlap between 
these transcriptomes, there are also aspects that may only be captured by using 
both. This method shows that the inclusive dataset allows for the identification of 
conserved pathways without much fear of including a large proportion of bacterial 
contamination. It has also identified sequences that may otherwise have been 
missed from the M. balamuthi genome. 
 
The second validation method was a clustering analysis which showed that 
the majority of the Mastigamoeba sp. transcriptome is species-specific. This is most 
likely due to the inclusion of the unassigned group which, by definition does not 
have orthologues in the other genomes. Also, the majority of the M. balamuthi, E. 
histolytica and D. discoideum proteins are species-specific too. In this respect, the 
Mastigamoeba sp. transcriptome appears to conform to the patterns of its closest 
relatives. We must consider the possibility that these sequences represent 
contaminating bacterial sequences. However, the presence of a larger group of 
species-specific sequences in the M. balamuthi genome suggests that a high 
proportion of expanded sequences may be a feature of the Mastigamobids. In the 
conserved clusters Mastigamoeba sp. appeared to be underepresented in 
comparison to all other species (Figure 5.3.6). This is most likely a result of the low 
mastigamoebid content of the genome rather than a true reflection of Mastigamoeba 
sp. conserved genes families.  
 
The conclusion from both of these validations is that while many genuine 
Mastigamoeba sp. sequences are missing from the inclusive dataset, it is unlikely 
that a high proportion of bacterail transcripts has distroted the results. The 
Mastigamoeba sp. transcriptome can uncover shortcomings in the existing M. 
balamuthi transcriptome and is therefore a useful resource for investigation into 
Entamoeba evolution.  
 
5.4.2 Ras family proteins are expanded specifically in Entamoeba 
 
The enrichment analysis identified numerous E. histolytica-specific gene 
families, the most compelling of which concerned an expansion Ras , Rho and Rab 
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domain-containing proteins. Further analysis of this particular family (Figure 5.3.7, 
Table 5.3.1), revealed that E. histolytica posesses a large assemblage of species-
specific Ras family proteins. while this may plausibly be attributed to incomplete 
transcriptomes on the aprts of the mastigamoebids, there is also no ortholog from D. 
discoideum.  
 
This expansion of this family of proteins is potentially associated with the 
phagocytic and trogocytic qualities of E. histolytica. Phagocytosis is an important 
aspect of E. histolytica virulence [419] enabling the symbiont to feed on surrounding 
bacteria [450] as well as a number of host cells including epithelial cells [419]. It has 
even been shown that phagocytic-deficient variants are less virulent in vivo [451]. 
Amebic trogocytosis is another mechanism by which E. histolytica has been shown 
to disrupt epithelial cells upon contact. It involves taking ‘pieces’ of the target cell in 
a similar manner to phagocytosis, except that the whole cell is not ingested [155], 
[156]. The expansion of these gene families may be what allows E. histolytica to 
engulf such a variety of different cell types and in a number of different ways.  
 
Expansion of this family may also be associated with cytoskeleton 
rearrangament for the purpose of motility. E. histolytica is able to migrate via the 
blood stream to other organs where it is able to form abcesses [157], [431]. It is also 
able to move via bleb and pseudopodia formation [413] which may be polarised by 
members of the Ras superfamily [452]. This is different from the motility exhibited by 
the mastigamoebids which locomote using flagellar apparatus [134]. If the 
expansion of Ras family proteins is associated with the acquisition of a type of 
locomotion that enables E. histolytica to disseminate outside of the intestine and 
cause ALAs then presence or expression profiles of this family may aid diagnostic or 
treatment targets specific to Entamoeba.  
 
 Here I have shown that proteins in the Ras superfamily are expanded in the 
genome of Entamoeba spp. Further, I have shown that this expansion occurred in 
the ancestor of Enatmoeba and not in the last common ancestor with Mastigamoeba 
suggesting that this may be an adaptation with biological significance for 
persistence within a host environment or even with respect to virulence in vivo by 
expanding the range of cell types that Entamoeba spp. are able to engulf, or by 
bestowing migratory capabilities linked to the formation of ALAs.  
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5.4.3 Cathepsin gain in the ancestor of Entamoeba  
 
 There are estimated to be approximately 35 cysteine proteases in the E. 
histolytica genome [422]. Our method for extracting orthologous sequences only 
captured 24 of these (Table 5.4.1). There are several reasons why these may have 
been excluded from the analysis, the first of which being that the BLAST search 
may not have been sensitive enough to include all the papain-family proteins. 
Secondly, some of these sequences may have been removed from the alignment 
because they did not align. In either case there may be sequences missing from the 
phylogeny from all species. There may also be untranscribed sequences absent 
from both mastigamoebid transcriptomes (Figures 5.3.9 and 5.3.10).  
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 Our study shows that the two groups of Entamoeba cathepsin, EhCP-A and 
EhCP-B are more closely related to distant eukaryotes than to each other. This has 
been hinted at in the literature [421] which used neighbour joining phylogenies to 
show both Entamoeba cathepsin groups EhCP-A and EhCP-B have outgroups 
provided by sequences from across the eukaryota. Here, I have confirmed this with 
a more robust phylogenetic analysis but also raised questions about the 
classification of EHI062480 as EhCP-A. I have also shown that this pattern is not 
conserved in the free-living outgroups, suggesting this is an adaptation which 
Table 5.4.1 Gene names and ID's for E. histolytica cathepsins.
Names in bold are not in the analysis. CP denotes cysteine protease.
AmoebaDB Old Name Current Name Annotation
EHI074180 EhCP1 EhCP-A1 CP1, putative
EHI062480 EhCP17 EhCP-A10 CP, putative
EHI197490 EhCP19 EhCP-A11 CP, putative
EHI180170 - EhCP-A12 CP, putative
EHI033710 EhCP2 EhCP-A2 CP2
EHI159610 EhCP3 EhCP-A3 CP, putative
EHI050570 EhCP4 EhCP-A4 CP, putative
EHI168240 EhCP5 EhCP-A5 CP, putative
EHI151440 EhCP6 EhCP-A6 CP, putative
EHI039610 EhCP8 EhCP-A7 CP, putative
EHI151400 EhCP9 EhCP-A8 CP, putative
EHI096740 EhCP10 EhCP-A9 CP, putative
EHI117650 EhCP7 EhCP-B1 CP, putative
EHI180650 - EhCP-B10 CP, putative
EHI179600 EhCP11 EhCP-B2 CP, putative
EHI140220 EhCP12 EhCP-B3 CP, putative
EHI030720 EhCP13 EhCP-B4 CP, putative
EHI200690 EhCP14 EhCP-B5 CP, putative
EHI126170 EhCP15 EhCP-B6 CP, putative
EHI091450 EhCP16 EhCP-B7 CP, putative
EHI097900 EhCP18 EhCP-B8 CP, putative
EHI181230 EhCP112 EhCP-B9 CP, putative
EHI006920 EhCP-C1 -
Papain family CP domain 
containing protein
EHI010850 - - CP, putative
EHI019390 - - CP, pseudogene
EHI084060 - - CP, putative
EHI108240 - - CP, putative
EHI121160 - - CP, putative
EHI123950 - - CP, putative
EHI127470 - - CP, pseudogene
EHI132640 - - CP, pseudogene
EHI138460 EhCP-C3 -
Papain family CP domain 
containing protein
EHI144040 - - CP, pseudogene
EHI160330 - - CP, putative
EHI182260 - - CP, putative
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evolved in the ancestral Entamoeba, and therefore may be associated with 
adaptation to a host environment and virulence.  
 
 Cathepsins have previously been associated closely with the severity, 
outcome and the mode of E. histolytica infection [152], [422], [423], [427], [430], 
[449]. Cathepsins are not only associated with degradation of the mucosa, but also 
of immune evasion by clipping of bound antibodies. The greatly expanded repertoire 
of cathepsins in E. histolytica form an arsenal which enable the symbiont to invade 
and persist within the host. The loss of other lineages otherwise present in 
Mastigamoeba suggest that these have been redundant after the shift to a parasitic 
or commensal lifestyle. Characterisation of the function of the mastigamoebid 
proteins that cluster with these expanded repertoires may suggest what function 
these proteases served in the ancestor and subsequently how they have evolved to 
fulfil the functions they serve in the current situation.  
 
 In summary, all Entamoeba cathepsins are derived from three ancestral 
lineages with orthologs in mastigamoebids. However, mastigamoebids possess an 
additional four lineages that are present in other eukaryotes but absent from all 
Entamoeba spp., and therefore represent losses from the ancestral symbiont. Thus, 
cathepsin phylodiversity is reduced in Entamoeba in comparison with 
Mastigamoeba but two of the lineages that Entamoeba spp. have retained are 
expanded. All cathepsins are derrived from three ancestral lineages, two of which 
were expanded in the ancestor of Entamoeba. Functional categorisation of the 
‘ancestral’, mastigamoebid proteins may elucidate the role these proteins played in 
the ancestor of Entamoeba and may give clues about how the current Entamoeba 
sequences have evolved to alter their function.  
 
5.4.4 HGT events occurred in the ancestor of Entamoeba  
 
 I have found evidence to suggest that Entamoeba and Mastigamoeba have 
inherited some of the same HGTs from a common ancestor. The difference in 
content may be due to the limitation of using a transcriptome to identify genes with 
low or transient expression or that may have been removed during the resolution of 
the bacterial sequences. Despite there being two transcriptomes it is concievable 
that some orthologous genes are not expressed in vitro and therefore are not 
present in either transcriptome. However, when the genome assembly was 
investigated, there were still some HGTs missing. While, possible that these are due 
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to sequencing gaps, it is possible that some of the HGT events ocurred after 
Entamoeba split form Mastigamoeba. It may be these HGTs that confer qualities to 
Entamoeba that enable it to lead a different lifestyle from Mastigamoeba. This 
observation supports the findings of previous studies which have found that while 
some lineages of HGT are indeed not conserved between Entamoeba and 
Mastigamoeba, there are HGTs which are present in all Archamoebae and 
potentially even shared with organisms as distantly realted as Dictyosteluim [437], 
[443].  
 
Identification of HGTs is highly dependent on sampling and the older a gene 
acquisition by HGT is, the less idenity the sequence shares with contemporary 
bacterial sequences. Our, cutoff of >70% sequence identity should have preserved 
genuine HGTs shared with Entamoeba or even older [444]. HGT in and between 
protists requires additional sampling and comprehensive studies in order to extract 
the identity, timing and donor of genes in this continuing and dynamic process and 
transcriptomic resources cannot be used to infer loss [453].  
 
5.4.5 Conclusions 
 
 In this chapter I have presented an assembled transcriptome for 
Mastigamoeba sp. and attempted to remove contaminating bacterial sequences. I 
have validated the transcriptome with multiple approaches and shown this resource 
exposes variation between mastigamoebid transcriptomes that can affect the 
outcomes of analyses and is therefore a useful complementary resource to the 
existing M. balamuthi genome. These resources have shown the E. histolytica 
genome has an expansion of Ras superfamily domain-containing proteins that may 
be involved in the pathogenicity of Entamoeba spp. Finally I have confirmed the 
reduction in cathepsin diversity in the ancestral Entamoeba, followed by masisve 
expansion of the remaining cathepsin-L using appropriate outgroups.  
 
 Overall, the Mastigamoeba transcriptome has helped to identify changes that 
occurred in the ancestor of Entamoeba that may be associated with the ability of 
Entamoeba spp. to persist in a different environment to that of the last common 
ancestor with Mastigamoeba and may be important factors in diagnosis and 
treatment of Entamoeba infections. 
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Chapter 6. General discussion and concluding remarks 
 
Following recent advances in sequencing technology, comparative genomics 
now represents an important tool in the study of parasites and other host-associated 
symbionts [212]. The majority of previous studies have focused on comparisons 
within parasitic clades involving closely related organisms and are therefore unable 
to provide information on the emergence of symbiosis [206], [250], and studies that 
have utilised a free-living out-group have often focused on vector-borne diseases 
[206], [261], [454]. This thesis has applied the concept of comparative genomics 
using a free-living comparator to investigate the evolution of symbiosis within two 
abundant intestinal symbionts of humans.  
 
6.1 Genome production and future work 
 
In Chapter 2, a genome sequence of P. lacertae, a free-living relative of 
Blastocystis, was produced. I concluded that the 52.2 Mb draft genome of P. 
lacertae, consisting of 1,449 contiguous contigs with an N50 of 92,586 bp is 
comparable, in terms of its contiguity and coverage, to other published genomes 
sequenced using the same technology. I also assessed the completeness of the 
gene annotation and showed that the 35,706 genes account for >85% of the total 
BUSCOs. This genome represents a much-needed data point, not only for the 
sampling of this under-studied clade, but also for protist biology in general. 
 
The P. lacertae genome and its annotation may be used as a reference 
against which future genomes from this clade may be compared. Future work 
should aim to improve the sampling within this group of organisms and provide 
genome sequences for species of the Karotomorpa and Protoopalina genera [291], 
which may help to explore the repertoire of 13,642 currently labelled ‘P. lacertae 
specific’ genes. Many of these will be uniquely derived in Proteromonas, but some 
will inevitably represent authentic losses from Blastocystis, and so will be relevant to 
understanding the latter’s evolution. Better understanding of the ecology of P. 
lacertae would also serve to place features of the genome into biological context, 
such as why the flagellar apparatus has been retained in P. lacertae, but lost in 
Blastocystis, and what the large species-specific gene families are contributing to. 
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6.2 Transcriptome production and future work 
 
In addition to the P. lacertae genome, I have produced transcriptomes for C. 
roenbergensis and Mastigamoeba sp. in Chapters 3 and 5 respectively. Both these 
transcriptomes were generated from xenic cultures, which contained an unknown 
number of bacterial food sources. As a result, the data collected was akin to 
metatranscriptomic data, and was treated accordingly. In the case of C. 
roenbergensis the resolution of the bacterial contaminants was achieved using 
sequence homology and kmer frequencies producing a transcriptome consisting of 
28,952 transcripts, and scoring >70% with BUSCO. Conversely, the Mastigamoeba 
sp. transcriptome was resolved using sequence homology alone and contained only 
>30% of the BUSCO content. This means that there is insufficient confidence in 
Mastigamoeba sp. specific genes in the transcriptome because they may be the 
result of contamination. However, this resource was still able to provide information 
about losses in Entamoeba, for instance of cathepsin.  
 
A genome sequence for C. roenbergensis may help to answer some of the 
remaining questions about the Blastocystis transition from a free-living environment 
in terms of genome structure and non-coding elements. However, in order to 
achieve this, the cultures must either be grown on a controlled subset of bacteria as 
a food source, or successfully separated from the bacterial component prior to 
sequencing. After sequencing, the transcriptome presented here will be a useful tool 
in the annotation process that is still the rate-limiting step for genome production.  
 
In addition to the previously published Mastigamoeba balamuthi genome 
[286], here I presented a transcriptome of Mastigamoeba sp. for use as a free-living 
out group to Entamoeba and as a second Mastigamoeba representative which 
allowed for identification of high variability within the Mastigamoeba genus. I present 
a transcriptome consisting of 10,507 transcripts, which are confidently ascribed to 
Mastigamoeba sp. and 40,930 transcripts of unconfirmed origin based on sequence 
homology. While these organisms can be difficult to culture, I have shown that the 
typical ‘lab strains’ such as M. balamuthi may not be entirely representative of the 
other species in the genus or other genera in the clade. While the sequencing of 
important pathogens will always take priority, care should be taken to avoid 
assumptions about representative genomes and reduction of diverse clades to a 
single or a few token free-living out-groups. 
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A concerted attempt to annotate the M. balamuthi genome would 
undoubtedly identify aspects of the genome that may have been absent from this 
analysis but mapping of the newly sequenced transcriptome to the M. balamuthi 
contigs may uncover similarities and differences between the Mastigamoeba 
species and may even reveal previously unidentified M. balamuthi genes. There are 
also other genera that may prove useful in rounding out the sampling bias seen in 
this clade of organisms and add more data to investigate Pelobiontida specific gene 
families such as Pelomyxa and Rhizomastix [137].  
 
6.3 Comparative genomic analyses  
 
The addition of Mastigamoeba sp. to the genomic resources available for the 
study of the Archamoebae facilitated a comparative analysis between M. balamuthi, 
Mastigamoeba sp., E. histolytica and D. discoideum. I found very little evidence of 
reduction of metabolic genes in E. histolytica when compared to the free-living out-
groups, but saw expansion of Ras superfamily, potentially indicative of mechanisms 
that allow Entamoeba to lyse host cells, invade host epithelium and migrate to other 
host organs. 
 
I confirmed that the cathepsin repertoire in E. histolytica is separated into 
two distinct clades but I showed that this adaptation is specific to the ancestor of 
Entamoeba and also called into question the established phylogeny of E. histolytica 
cathepsins and show that while two cathepsin lineages have been expanded, other 
lineages have been lost when compared to other eukaryotic cathepsin diversity. The 
dichotomy of expansion and contraction within the same gene family is indicative of 
extreme selective pressures acting on these genes.  
 
The production of the P. lacertae genome and the C. roenbergensis 
transcriptome allowed a comparative analysis with the previously published 
genomes of three Blastocystis subtypes and five other Stramenopile genomes. 
Simple size comparison between Blastocystis and the other genomes showed that 
the Blastocystis genomes are reduced and using domain annotations it was 
possible to infer this reduction was genome wide. However, when looking in detail at 
the metabolic component, there was very little reduction in the capabilities of 
Blastocystis compared with P. lacertae, what was observed was a loss of gene-
richness in metabolic pathways, perhaps indicative of a loss of functional 
redundancy. I also observed loss of complete cellular components such as the loss 
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of the flagellum. Once one of the definitive morphological features of the 
Stramenopiles, the flagella apparatus and other motility-associated gene families 
are absent from the Blastocystis genomes. I assessed the phylodiversity of gene 
families conserved across eukaryotes and found that even highly conserved gene 
families, Blastocystis sp. STs were more likely to exhibit more extensive reduction in 
cases where the phylodiversity was greater in P. lacertae. I have shown that the 
Blastocystis genomes contain a record of genomic streamlining that appears to 
have occurred in the ancestor of Blastocystis. I have proposed a possible ecology 
for Blastocystis based on its lack of flagellum and other motility associated gene 
families and the expansion of adhesin-like molecules at the cell surface. 
 
Future work should include examination of the non-coding region of the 
genomes. This work has focused on proteome data available from the genomic and 
transcriptomic resources, non-coding aspects of the genome may improve our 
understanding of regulation influencing changes in protein-coding regions. I have 
worked to improve the understanding of two under-studied groups of organisms but, 
as I have shown, variation between these is capable of altering interpretations. 
Further sampling and sequencing of the genomes of these organisms will not only 
increase the knowledge of these organisms, but of the whole clade as species and 
genus-specific genes and gene families are identified. Functional categorisation of 
Blastocystis specific gene families may also deepen our understanding of the role of 
Blastocystis both in healthy and diseased individuals. As more Blastocystis 
genomes are sequenced and become available it may also be possible to 
determine, with the aid of the out-groups produced and presented here, the 
genotypic differences that drive host specificity, preference and disease outcome 
between Blastocystis subtypes and isolates. 
 
The genome and transcriptomes presented here are an example of the effort 
being made to collect genetic data on a huge range of organisms. Traditionally, 
model organisms have been selected based on traits that have more to do with their 
manageability, rather than their genetic features or phylogenetic position. 
Sequencing technology is becoming increasingly faster, more efficient and able to 
sequence longer pieces of DNA. Eventually, sequencing, assembly and annotation 
will occur in the same step as genomes are read end-to-end. This will dispense with 
the need for assembly programmes or metagenomic approaches to separating the 
genomes of organisms, as individual genomes will be sequenced in a single piece. 
At this point, judging the quality of an assembly will be moot. Therefore, the 
  181 
interpretation will be influenced by the diversity of genomes available and the 
knowledge of how representative they are about the wider clade.  
 
I have conducted these analyses in silico and provided predictions and 
direction for future studies that should aim to localise and categorise the 
function of potentially important proteins identified in this study. The addition of 
a viable animal infection model for both Blastocystis and E. histolytica would 
also help to generate much needed understanding of how these organisms 
behave in vivo.  
 
6.4 Genomic reduction 
 
In this thesis, I have made frequent reference to genome reduction, 
specifically to the loss of genes and gene families, rather than reduction of the 
physical size or capabilities of the genome. Genomic reduction is widespread across 
many organisms [455], but is especially obvious in single-celled organisms that 
inhabit a very stable environment, such as symbionts of both bacterial and 
eukaryotic origins [456]. These represent some of the most extreme examples of 
genomic reduction and there have been several attempts to explain why there might 
be so much pressure for symbiont genomes to become reduced [457]. Explanations 
for this widespread phenomenon include the need to conserve resources during 
replication or to keep replication time to a minimum [458]–[460]. While this selective 
pressure is not so obvious in multicellular organisms, which do not compete for 
resources in the same way, there is clear evidence for selective pressure acting, 
particularly on protist and bacterial genomes, to clear non-functional genes from the 
genome.  
 
Genes accumulate mutations and become non-functional when they are 
non-essential to the survival or reproduction of the cell. In a free-living environment, 
cells need to be able to cope with large-scale environmental changes, including 
among others; salinity, temperature, predation and nutrients. These conditions may 
change suddenly and for extended periods of time. The genomes of free-living 
organisms must therefore retain their versatility and redundancy in order to persist in 
a constantly changing environment. Symbionts, however, rely on their host to 
accommodate the majority of environmental changes and thus, redundancies in 
symbiont genomes are truly superfluous and are subsequently lost. In Buchnera, an 
endosymbiont of aphids, this is exemplified by large reduction in genome size and 
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metabolism, except for certain amino acid biosynthesis pathways, as the host 
provides a consistent flow of the necessary nutrients required by the cell, bar the 
essential amino acids that the endosymbiont provides for the host [461], [462]. In 
tapeworms, the parasite has lost both its gut and light detection organs. The gut is 
unnecessary as it is able to take up nutrients from the host and even light detection 
has been lost because detection of this stimuli cannot influence the survival of the 
tapeworm [463]. The closer the association to the host, the less need there is for 
versatility and consequently, the greater the genomic reduction (e.g. mitochondria). 
 
In parasitic lineages, this produces an interesting pattern. While genomic 
reduction is not ubiquitous across all parasitic lineages, many parasites do have 
reduced genomes. The Oomycetes [209], [210], [464] and nematodes [219], [220], 
[465] are examples of parasites that have comparatively large (unreduced) 
genomes. If the link between reduction and parasitism were true then why do these 
parasites not exhibit reduction in their genomes? This is linked not only to the level 
of association with the host, but also to the duration of that association. Both the 
Oomycetes and nematodes are free-living for a portion of their life-cycles [466], 
[467]. For the Oomycetes, this occurs during the zoospore stage, after sexual 
reproduction, when cells are disseminated into the aquatic environment in order to 
search out new hosts. At this point they must persist in the fluid conditions of a free-
living environment. Nematodes also have a free-living life-stage after the eggs 
develop prior to infection of another host [468]. As a result, these parasitic lineages 
cannot dispense of their versatility and thus retain large genomes containing 
redundancies. 
 
In symbionts that are parasitic throughout their life cycles, such as 
Apicomplexa and Trypanosomatids that parasitise a vector, and Entamoeba and 
Blastocystis that encyst in order to transmit, there is no need for such versatility and 
redundancy. These symbiont lineages are prime examples of genomic reduction 
[216], [223], [250]. In vector borne parasites, despite the need for versatility between 
hosts, there is not the same range of potential environmental conditions to cope 
with. Each host provides homeostasis of certain conditions and the parasite 
transmits directly between them. In intestinal symbionts, transmission is often 
faecal-oral and requires only the formation of a cyst [52], [73]. Cysts are resistant to 
environmental changes, without the need for versatility, they are metabolically 
dormant, content to wait until they are ingested by another host. This, minimal 
requirement, may help to explain why intestinal symbionts have such highly reduced 
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genomes even when compared to parasites with alternative modes of transmission. 
If true, then it is logical to enquire why the P. lacertae genome is so large compared 
to the Blastocystis genomes. If they inhabit similar environments, why has the P. 
lacertae genome not undergone a similar phenotype of reduction? The answer to 
this, is to admit that little is known about the natural ecology of P. lacertae and while 
it has been isolated from the faeces of lizards, this may only form part of its natural 
life cycle and it must be conceded that it may well inhabit environments outside the 
host for extended periods of time. The need of some symbionts to maintain their 
versatility for habitation of a free-living environment, even for a portion of their life 
cycle, may be the root of their respective lack of genome reduction.  
 
6.5 Genomic expansion 
 
This thesis has also identified a number of species-specific gene family 
expansions. Symbionts require a number of innovations in order to overcome the 
two major obstacles to inhabiting a host: the host immune system and transmission 
between hosts. Parasites also have the added need to invade and thus require the 
genes to facilitate this. It is precisely these parasite-specific tools that are used 
against them in the immune response and vaccine development. Cell surface 
expressed proteins are the most sought-after candidates for vaccine development; 
provided they are conserved among strains or even species of the parasite and are 
expressed constitutively. Proteins that are expressed in alternative life-stages or that 
are different between species may also be useful as diagnostic markers that allow 
differentiation between species or strains that may affect the outcome of the 
disease.  
 
6.6 Free-living out-groups 
 
The use of free-living organisms in this thesis means that it is possible to 
investigate the origin of symbiosis within a particular clade. This approach has been 
taken before to investigate the trypanosomes [206], Strongyloides [469] and 
Apicomplexa [250]. These studies reached similar conclusions about how symbiosis 
has arisen in each of these clades: adaptations that have arisen in the ancestor of 
the symbionts have provided a platform that enabled the transition from free-living to 
symbiotic. In the Kinetoplastida, ancestral bodonin, used for adhesion to prey, 
formed the basis for pathogenic adhesion to host cells as well as repurposing of the 
flagellum, which occurred in the ancestor of the Apicomplexa and facilitates their 
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invasive abilities [206].  
 
This thesis has added two clades to this list, the intestinal Stramenopiles and 
the Archamoebae. Its findings also reflect the findings of the previous studies, which 
suggest that adaptations in the ancestors of symbiotic clades allowed the transition 
into the host environment. In the case of both the intestinal Stramenopiles and the 
Archamoebae, the other members of the clade are marine or freshwater dwelling. It 
is therefore reasonable to assume that the common respective ancestors of the 
intestinal Stramenopiles and Archamoebae also fell into this category. However, 
Blastocystis and Entamoeba are both anaerobic and so we must consider an 
aquatic, yet anaerobic environment that suited the transition into the intestine of an 
ancestral host. This was potentially sediment surrounding a freshwater drinking 
source. It may be that P. lacertae still spends some of its time in an environment 
similar to this. 
 
6.7 The origins of parasitism 
 
It may be interesting to speculate on the emergence of symbiosis in this 
clade, given the predicted habitat of these organisms prior to the evolution of 
symbiosis. Mechanisms for immune evasion may have arisen from methods initially 
useful for escape from binding agents released by bacteria or fungal competitors 
and contemporary virulence factors may have initially suited the degradation of 
bacterial biofilms or other protein-rich sources of nutrients. The encystation for 
transmission was likely already an evolved response to unfavourable condition such 
as oxygen stress or desiccation and this was simply used to bypass the hostile 
conditions in the stomach until the more favourable condition of the intestine were 
reached. After being passed in the stool of the host, encystation again allows the 
organism to wait until ingestion by another host. Successive passage through this 
system may have produced variants that became better suited to this environment 
until a variant emerged that was only able to persist within a host. 
 
6.8 Final thoughts 
 
 Genomic reduction is seen in some, but not all symbionts depending on their 
ancestral state and the degree of obligate biotrophy throughout their life cycles. But 
all symbiont genomes are adapted for survival within the host and transmission 
between hosts. This thesis has provided a first insight into how these processes 
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have shaped the Blastocystis genome (loss of motility, genomic streamlining, 
expansion of adhesive proteins), and the Entamoeba genome (HGT, expansion of 
proteases and of Ras family proteins).  
 
 These are processes and adaptations that have been seen in other 
symbiotic clades, suggesting that there are some aspects of becoming a symbiont 
that are reproducible in broadly different organisms. This most likely represents the 
common challenge of interacting with hosts, principally immunity, and the similar 
physical constraints of surviving and prospering in a living environment.  
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Supplementary legends 
 
S4.3.1 Output from OrthoMCL clustering of Stramenopile genomes. ‘groups.txt’ 
contains the raw output from the programme. Other sheets contain the breakdown 
of how the raw output was interpreted. The numbers of sequences that contributed 
to these groups from each genome is included in the ‘summary’ sheet. Refer to 
Section 4.2.3 for cluster definitions.  
 
S4.3.2 Output from OrthoFinder clustering of Stramenopile genomes. 
‘OrthologousGroups.txt’ contains the raw output from the programme. Other sheets 
contain the breakdown of how the raw output was interpreted. The numbers of 
sequences that contributed to these groups from each genome is included in the 
‘summary’ sheet. Refer to Section 4.2.3 for cluster definitions.  
 
S4.3.3 Full table of results for the enrichment of OrthoMCL Blastocystis sp. STs 
gains. The columns contain the domain annotation, the number of Blastocystis-
specific sequences annotated with a domain, the total number of sequences in the 
Blastocystis sp. STs genomes annotated with a domain, the total number of genes 
in the Blastocystis sp. STs genomes that are not annotated with a domain, the total 
number of Blastocystis-specific sequences, the P-value for the enrichment, the 
significance (* p < 0.1, ** p < 0.05, *** p < 0.01) and the gene identifiers for all the 
genes in the Blastocystis sp. STs genomes with a domain annotation.  
 
S4.3.4 Full table of results for the enrichment of OrthoFinder Blastocystis sp. STs 
gains. The columns contain the domain annotation, the number of Blastocystis-
specific sequences annotated with a domain, the total number of sequences in the 
Blastocystis sp. STs genomes annotated with a domain, the total number of genes 
in the Blastocystis sp. STs genomes that are not annotated with a domain, the total 
number of Blastocystis-specific sequences, the P-value for the enrichment, the 
significance (* p < 0.1, ** p < 0.05, *** p < 0.01) and the gene identifiers for all the 
genes in the Blastocystis sp. STs genomes with a domain annotation. 
 
S4.3.5 Full table of results for the enrichment of OrthoMCL Blastocystis sp. STs 
losses. The columns contain the domain annotation, the number of P. lacertae 
sequences with no orthologue in Blastocystis annotated with a domain, the total 
number of sequences in the P. lacertae genome annotated with a domain, the total 
number of genes in the P. lacertae genome that are not annotated with a domain, 
the total number of P. lacertae sequences with no orthologue in Blastocystis, the P-
value for the enrichment, the significance (* p < 0.1, ** p < 0.05, *** p < 0.01) and 
the gene identifiers for all the genes in the P. lacertae genome with a domain 
annotation. 
 
S4.3.6 Full table of results for the enrichment of OrthoFinder Blastocystis sp. STs 
losses. The columns contain the domain annotation, the number of P. lacertae 
sequences with no orthologue in Blastocystis annotated with a domain, the total 
number of sequences in the P. lacertae genome annotated with a domain, the total 
number of genes in the P. lacertae genome that are not annotated with a domain, 
the total number of P. lacertae sequences with no orthologue in Blastocystis, the P-
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value for the enrichment, the significance (* p < 0.1, ** p < 0.05, *** p < 0.01) and 
the gene identifiers for all the genes in the P. lacertae genome with a domain 
annotation. 
 
S4.3.7 Full table of results for the enrichment of OrthoMCL P. lacertae gains. The 
columns contain the domain annotation, the number of P. lacertae-specific 
sequences annotated with a domain, the total number of sequences in the P. 
lacertae genome annotated with a domain, the total number of genes in the P. 
lacertae genome that are not annotated with a domain, the total number of P. 
lacertae-specific sequences, the P-value for the enrichment, the significance (* p < 
0.1, ** p < 0.05, *** p < 0.01) and the gene identifiers for all the genes in the P. 
lacertae genome with a domain annotation.  
 
S4.3.8 Full table of results for the enrichment of OrthoFinder P. lacertae gains. The 
columns contain the domain annotation, the number of P. lacertae-specific 
sequences annotated with a domain, the total number of sequences in the P. 
lacertae genome annotated with a domain, the total number of genes in the P. 
lacertae genome that are not annotated with a domain, the total number of P. 
lacertae-specific sequences, the P-value for the enrichment, the significance (* p < 
0.1, ** p < 0.05, *** p < 0.01) and the gene identifiers for all the genes in the P. 
lacertae genome with a domain annotation. 
 
S4.3.9 Full table of results for the enrichment of OrthoMCL P. lacertae losses. The 
columns contain the domain annotation, the number of Blastocystis sp. STs 
sequences with no orthologue in P. lacertae annotated with a domain, the total 
number of sequences in the Blastocystis sp. STs genomes annotated with a 
domain, the total number of genes in the Blastocystis sp. STs genomes that are not 
annotated with a domain, the total number of Blastocystis sp. STs sequences with 
no orthologue in P. lacertae, the P-value for the enrichment, the significance (* p < 
0.1, ** p < 0.05, *** p < 0.01) and the gene identifiers for all the genes in the 
Blastocystis sp. STs genomes with a domain annotation. 
 
S4.3.10 Full table of results for the enrichment of OrthoFinder P. lacertae losses. 
The columns contain the domain annotation, the number of Blastocystis sp. STs 
sequences with no orthologue in P. lacertae annotated with a domain, the total 
number of sequences in the Blastocystis sp. STs genomes annotated with a 
domain, the total number of genes in the Blastocystis sp. STs genomes that are not 
annotated with a domain, the total number of Blastocystis sp. STs sequences with 
no orthologue in P. lacertae, the P-value for the enrichment, the significance (* p < 
0.1, ** p < 0.05, *** p < 0.01) and the gene identifiers for all the genes in the 
Blastocystis sp. STs genomes with a domain annotation. 
 
S4.3.11 Full table of gene numbers mapped to metabolic (KEGG) pathways in 
Blastocystis sp. STs, P. lacertae and C. roenbergensis. Conserved are those found 
in all genomes, specific are those found in only one genome. ‘Blast sp’ are those 
only found in two or more Blastocystis genomes and ‘Blast loss’ are those found in 
only in P. lacertae and C. roenbergensis.  
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S4.3.12 List of gene names and species from 4.3.8.   
 
S4.3.13 Output from OrthoMCL clustering of Stramenopile putative secretome. 
Sheets contain the breakdown of how the raw output was interpreted. The numbers 
of sequences that contributed to these groups from each genome is included in the 
‘summary’ sheet. 
 
S4.3.14 Full table of results for the enrichment of OrthoMCL Blastocystis sp. ST4 
putative secretome gains. The columns contain the domain annotation, the number 
of Blastocystis sp. ST4-specific sequences annotated with a domain, the total 
number of sequences in the Blastocystis sp. ST4 putative secretome annotated with 
a domain, the total number of genes in the Blastocystis sp. ST4 putative secretome 
that are not annotated with a domain, the total number of Blastocystis sp. ST4-
specific sequences, the P-value for the enrichment, the significance (* p < 0.1, ** p < 
0.05, *** p < 0.01) and the gene identifiers for all the genes in the Blastocystis sp. 
ST4 putative secretome with a domain annotation. 
 
S4.3.15 Full table of results for the enrichment of OrthoMCL Blastocystis sp. ST7 
putative secretome gains. The columns contain the domain annotation, the number 
of Blastocystis sp. ST7-specific sequences annotated with a domain, the total 
number of sequences in the Blastocystis sp. ST7 putative secretome annotated with 
a domain, the total number of genes in the Blastocystis sp. ST7 putative secretome 
that are not annotated with a domain, the total number of Blastocystis sp. ST7-
specific sequences, the P-value for the enrichment, the significance (* p < 0.1, ** p < 
0.05, *** p < 0.01) and the gene identifiers for all the genes in the Blastocystis sp. 
ST7 putative secretome with a domain annotation. 
 
S5.3.1 Full table of gene numbers mapped to metabolic (KEGG) pathways in E. 
histolytica, M. balamuthi, D. discoideum and the inclusive dataset for Mastigamoeba 
sp. ‘Conserved’ are those found in all genomes, ‘specific’ are those found in only 
one genome. ‘Mastig sp’ contains pathways found only in the mastigamoebids. 
Pairwise sheets contain pathways in only two genomes and ‘loss’ sheets contain 
pathways present in all genomes but one.  
 
S5.3.2 Full table of gene numbers mapped to metabolic (KEGG) pathways in E. 
histolytica, M. balamuthi, D. discoideum and the exclusive dataset for 
Mastigamoeba sp. ‘Conserved’ are those found in all genomes, ‘specific’ are those 
found in only one genome. ‘Mastig sp’ contains pathways found only in the 
mastigamoebids. Pairwise sheets contain pathways in only two genomes and ‘loss’ 
sheets contain pathways present in all genomes but one. 
 
S5.3.3 Output from OrthoMCL clustering of Archamoebae genomes, using the 
inclusive dataset for Mastigamoeba sp. ‘MCL_Inclusive.txt’ contains the raw output 
from the programme. Other sheets contain the breakdown of how the raw output 
was interpreted. The numbers of sequences that contributed to these groups from 
each genome is included in the ‘summary’ sheet. Refer to Section 4.2.3 for cluster 
definitions. 
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S5.3.4 Output from OrthoFinder clustering of Archamoebae genomes, using the 
inclusive dataset for Mastigamoeba sp. ‘FDR_Inclusive.txt’ contains the raw output 
from the programme. Other sheets contain the breakdown of how the raw output 
was interpreted. The numbers of sequences that contributed to these groups from 
each genome is included in the ‘summary’ sheet. Refer to Section 4.2.3 for cluster 
definitions. 
 
S5.3.5 Full table of results for the enrichment of OrthoMCL E. histolytica gains. The 
columns contain the domain annotation, the number of E. histolytica-specific 
sequences annotated with a domain, the total number of sequences in the E. 
histolytica genome annotated with a domain, the total number of genes in the E. 
histolytica genome that are not annotated with a domain, the total number of E. 
histolytica-specific sequences, the P-value for the enrichment, the significance (* p < 
0.1, ** p < 0.05, *** p < 0.01) and the gene identifiers for all the genes in the E. 
histolytica genome with a domain annotation. 
 
S5.3.6 Full table of results for the enrichment of OrthoFinder E. histolytica gains. 
The columns contain the domain annotation, the number of E. histolytica-specific 
sequences annotated with a domain, the total number of sequences in the E. 
histolytica genome annotated with a domain, the total number of genes in the E. 
histolytica genome that are not annotated with a domain, the total number of E. 
histolytica-specific sequences, the P-value for the enrichment, the significance (* p < 
0.1, ** p < 0.05, *** p < 0.01) and the gene identifiers for all the genes in the E. 
histolytica genome with a domain annotation. 
 
S5.3.7 Full table of results for the enrichment of OrthoMCL E. histolytica losses. The 
columns contain the domain annotation, the number of Mastigamoeba sp. 
sequences with no orthologue in E. histolytica annotated with a domain, the total 
number of sequences in the Mastigamoeba sp. transcriptome annotated with a 
domain, the total number of genes in the Mastigamoeba sp. transcriptome that are 
not annotated with a domain, the total number of Mastigamoeba sp. sequences with 
no orthologue in E. histolytica, the P-value for the enrichment, the significance (* p < 
0.1, ** p < 0.05, *** p < 0.01) and the gene identifiers for all the genes in the 
Mastigamoeba sp. transcriptome with a domain annotation. 
 
 
S5.3.8 Full table of results for the enrichment of OrthoFinder E. histolytica losses. 
The columns contain the domain annotation, the number of Mastigamoeba sp. 
sequences with no orthologue in E. histolytica annotated with a domain, the total 
number of sequences in the Mastigamoeba sp. transcriptome annotated with a 
domain, the total number of genes in the Mastigamoeba sp. transcriptome that are 
not annotated with a domain, the total number of Mastigamoeba sp. sequences with 
no orthologue in E. histolytica, the P-value for the enrichment, the significance (* p < 
0.1, ** p < 0.05, *** p < 0.01) and the gene identifiers for all the genes in the 
Mastigamoeba sp. transcriptome with a domain annotation. 
 
